10331074	Estrogens	Guengerich FP	Cytochrome P-450 3A4: regulation and role in drug metabolism.	Annual review of pharmacology and toxicology	1999	171
10579320	Estrogens	Hall JM	The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.	Endocrinology	1999	193
15181027	Estrogens	Bray GA	Medical consequences of obesity.	The Journal of clinical endocrinology and metabolism	2004	228
16112414	Estrogens	Tsuchiya Y	Cytochrome P450-mediated metabolism of estrogens and its regulation in human.	Cancer letters	2005	99
18974155	Estrogens	Studebaker AW	Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.	Cancer research	2008	70
19027010	Estrogens	Liu WH	MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.	Gastroenterology	2009	65
19318219	Estrogens	Geer EB	Gender differences in insulin resistance, body composition, and energy balance.	Gender medicine	2009	122
19421758	Estrogens	Fang YJ	Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.	International journal of colorectal disease	2009	47
19646654	Estrogens	Yoon M	The role of PPARalpha in lipid metabolism and obesity: focusing on the effects of estrogen on PPARalpha actions.	Pharmacological research	2009	46
20219941	Estrogens	Schmidt D	A CTCF-independent role for cohesin in tissue-specific transcription.	Genome research	2010	159
20813970	Estrogens	Esteva FJ	PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.	The American journal of pathology	2010	100
20863372	Estrogens	Hoefnagel LD	Receptor conversion in distant breast cancer metastases.	Breast cancer research 	2010	52
21212030	Estrogens	Rønneberg JA	Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer.	Molecular oncology	2011	52
21914172	Estrogens	Sihto H	Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.	Breast cancer research 	2011	50
22178456	Estrogens	Amir E	Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.	Cancer treatment reviews	2012	35
23328895	Estrogens	Isoherranen N	Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?	Drug metabolism and disposition	2013	27
24258260	Estrogens	Sørensen KP	Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer.	Breast cancer research and treatment	2013	66
24373287	Estrogens	Serandour AA	Development of an Illumina-based ChIP-exonuclease method provides insight into FoxA1-DNA binding properties.	Genome biology	2013	25
24975878	Estrogens	Li CL	Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma.	International journal of cancer	2015	15
25009010	Estrogens	De Mattos-Arruda L	Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle.	Annals of oncology 	2014	63
26261103	Estrogens	Chu D	ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients.	Clinical cancer research 	2016	32
26286584	Estrogens	Strong AL	Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers.	Breast cancer research 	2015	20
26311719	Estrogens	Deng L	MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.	Circulation research	2015	26
26919573	Estrogens	Klair JS	A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.	Hepatology	2016	12
27939373	Estrogens	Nault JC	Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.	Gastroenterology	2017	7
12869762	Blood Glucose	Grimsby J	Allosteric activators of glucokinase: potential role in diabetes therapy.	Science	2003	98
15837923	Blood Glucose	Xu A	Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice.	Proceedings of the National Academy of Sciences of the United States of America	2005	74
19373249	Blood Glucose	Matschinsky FM	Assessing the potential of glucokinase activators in diabetes therapy.	Nature reviews. Drug discovery	2009	95
19623253	Blood Glucose	Muzumdar RH	Humanin: a novel central regulator of peripheral insulin action.	PloS one	2009	51
20027213	Blood Glucose	Stocks T	Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts.	PLoS medicine	2009	56
20225132	Blood Glucose	Jitrapakdee S	Regulation of insulin secretion: role of mitochondrial signalling.	Diabetologia	2010	70
20424233	Blood Glucose	German JP	Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.	Diabetes	2010	46
21241070	Blood Glucose	Graham GG	Clinical pharmacokinetics of metformin.	Clinical pharmacokinetics	2011	127
21282364	Blood Glucose	Xiao F	Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways.	Diabetes	2011	67
21805476	Blood Glucose	Borena W	Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.	International journal of cancer	2012	41
21824266	Blood Glucose	D'Alessio D	The role of dysregulated glucagon secretion in type 2 diabetes.	Diabetes, obesity & metabolism	2011	55
22355316	Blood Glucose	Liang Y	Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.	PloS one	2012	47
24847880	Blood Glucose	Madiraju AK	Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.	Nature	2014	164
26077345	Blood Glucose	Abu-Farha M	Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance.	Scientific reports	2015	22
28053201	Blood Glucose	Noakes TD	Evidence that supports the prescription of low-carbohydrate high-fat diets: a narrative review.	British journal of sports medicine	2017	5
20798346	Glucagon	Unger RH	Paracrinology of islets and the paracrinopathy of diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2010	71
22927400	Glucagon	Owen JL	Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase.	Proceedings of the National Academy of Sciences of the United States of America	2012	58
23305646	Glucagon	Habegger KM	Fibroblast growth factor 21 mediates specific glucagon actions.	Diabetes	2013	31
23863937	Glucagon	Siu FY	Structure of the human glucagon class B G-protein-coupled receptor.	Nature	2013	98
24393785	Glucagon	Pernicova I	Metformin--mode of action and clinical implications for diabetes and cancer.	Nature reviews. Endocrinology	2014	151
24467746	Glucagon	Pyke C	GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.	Endocrinology	2014	68
24703698	Glucagon	Song WJ	Glucagon regulates hepatic kisspeptin to impair insulin secretion.	Cell metabolism	2014	35
8156941	Insulin	Thissen JP	Nutritional regulation of the insulin-like growth factors.	Endocrine reviews	1994	136
9153284	Insulin	Vidal-Puig AJ	Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.	The Journal of clinical investigation	1997	130
9495343	Insulin	Withers DJ	Disruption of IRS-2 causes type 2 diabetes in mice.	Nature	1998	328
9525995	Insulin	Patti ME	Bidirectional modulation of insulin action by amino acids.	The Journal of clinical investigation	1998	104
9793760	Insulin	Duckworth WC	Insulin degradation: progress and potential.	Endocrine reviews	1998	155
10358076	Insulin	Guo S	Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.	The Journal of biological chemistry	1999	145
10409121	Insulin	Winder WW	AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.	The American journal of physiology	1999	165
11826410	Insulin	Pagano G	Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association.	Hepatology	2002	109
11826411	Insulin	Chitturi S	NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.	Hepatology	2002	167
12096082	Insulin	Sandhu MS	Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer.	Journal of the National Cancer Institute	2002	117
12512031	Insulin	Ruhl CE	Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.	Gastroenterology	2003	120
12606503	Insulin	Daitoku H	Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.	Diabetes	2003	84
12634421	Insulin	Farris W	Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2003	329
12750520	Insulin	Petersen KF	Mitochondrial dysfunction in the elderly: possible role in insulin resistance.	Science	2003	471
12959935	Insulin	Barthel A	Novel concepts in insulin regulation of hepatic gluconeogenesis.	American journal of physiology. Endocrinology and metabolism	2003	85
14960526	Insulin	Hickman IJ	Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.	Gut	2004	73
14988838	Insulin	Shintani Y	Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.	Gastroenterology	2004	133
15047607	Insulin	Morton NM	Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.	Diabetes	2004	87
15082519	Insulin	Watson RT	Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes.	Endocrine reviews	2004	91
15085196	Insulin	Engelking LJ	Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis.	The Journal of clinical investigation	2004	80
15094074	Insulin	Zhao WQ	Insulin and the insulin receptor in experimental models of learning and memory.	European journal of pharmacology	2004	86
15199412	Insulin	Horie Y	Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.	The Journal of clinical investigation	2004	165
15201411	Insulin	Klein S	Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.	The New England journal of medicine	2004	117
15205477	Insulin	Cohen HY	Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase.	Science	2004	554
15536017	Insulin	Bartke A	Life extension in the dwarf mouse.	Current topics in developmental biology	2004	116
15604215	Insulin	Khamzina L	Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.	Endocrinology	2005	152
15655035	Insulin	Lihn AS	Adiponectin: action, regulation and association to insulin sensitivity.	Obesity reviews 	2005	95
15662003	Insulin	Rhodes CJ	Type 2 diabetes-a matter of beta-cell life and death?	Science	2005	202
15734146	Insulin	Plum L	The role of insulin receptor signaling in the brain.	Trends in endocrinology and metabolism	2005	111
15951550	Insulin	Fartoux L	Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.	Gut	2005	75
16445986	Insulin	Summers SA	Ceramides in insulin resistance and lipotoxicity.	Progress in lipid research	2006	209
16456680	Insulin	Yki-Järvinen H	Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.	Diabetologia	2006	84
16731817	Insulin	Cancello R	Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity.	Diabetes	2006	112
17132539	Insulin	Sugden MC	Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases.	Archives of physiology and biochemistry	2006	65
17167487	Insulin	Hafner M	Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance.	Nature	2006	74
17192339	Insulin	Abdul-Ghani MA	Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test.	Diabetes care	2007	86
17341552	Insulin	Cobelli C	Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests.	American journal of physiology. Endocrinology and metabolism	2007	77
17341558	Insulin	Balagopal P	Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation.	The Journal of clinical endocrinology and metabolism	2007	63
17344645	Insulin	Ferré P	SREBP-1c transcription factor and lipid homeostasis: clinical perspective.	Hormone research	2007	59
17586614	Insulin	Cooper SA	Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.	American journal of physiology. Heart and circulatory physiology	2007	67
17620421	Insulin	Kolak M	Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity.	Diabetes	2007	79
17681171	Insulin	Gastaldelli A	Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.	Gastroenterology	2007	98
18081738	Insulin	Jarrar MH	Adipokines and cytokines in non-alcoholic fatty liver disease.	Alimentary pharmacology & therapeutics	2008	74
18094066	Insulin	Wei Y	Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species.	American journal of physiology. Regulatory, integrative and comparative physiology	2008	52
18197261	Insulin	Chao KC	Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes.	PloS one	2008	70
18223156	Insulin	Chung J	HSP72 protects against obesity-induced insulin resistance.	Proceedings of the National Academy of Sciences of the United States of America	2008	122
18281274	Insulin	Zabolotny JM	Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo.	The Journal of biological chemistry	2008	91
18355813	Insulin	Korenblat KM	Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.	Gastroenterology	2008	117
18769626	Insulin	Schenk S	Insulin sensitivity: modulation by nutrients and inflammation.	The Journal of clinical investigation	2008	331
18929493	Insulin	Tilg H	Insulin resistance, inflammation, and non-alcoholic fatty liver disease.	Trends in endocrinology and metabolism	2008	85
19207680	Insulin	Ricchi M	Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.	Journal of gastroenterology and hepatology	2009	83
19490822	Insulin	Gross DN	The role of FOXO in the regulation of metabolism.	Current diabetes reports	2009	57
19651814	Insulin	Kantartzis K	Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.	Diabetes	2009	72
20022465	Insulin	Das UN	Obesity: genes, brain, gut, and environment.	Nutrition	2010	49
20216312	Insulin	Summers SA	Sphingolipids and insulin resistance: the five Ws.	Current opinion in lipidology	2010	51
20225248	Insulin	Gupta NA	Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway.	Hepatology	2010	79
20357365	Insulin	Sarruf DA	Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats.	Diabetes	2010	68
20484465	Insulin	Fu Z	Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice.	Endocrinology	2010	42
20858492	Insulin	Williams CD	Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.	Gastroenterology	2011	398
20952387	Insulin	Peterson JM	C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output.	The Journal of biological chemistry	2010	58
21145828	Insulin	Ratziu V	A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis.	Journal of hepatology	2011	52
21435450	Insulin	Link A	Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans.	The American journal of pathology	2011	36
21705062	Insulin	Tahrani AA	Management of type 2 diabetes: new and future developments in treatment.	Lancet	2011	74
21829446	Insulin	Anand SS	Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE).	PloS one	2011	36
21829658	Insulin	Karolina DS	MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.	PloS one	2011	88
21864752	Insulin	Dimitriadis G	Insulin effects in muscle and adipose tissue.	Diabetes research and clinical practice	2011	41
21865652	Insulin	Kim KY	Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells.	The Journal of clinical investigation	2011	62
21979934	Insulin	Hussain K	An activating mutation of AKT2 and human hypoglycemia.	Science	2011	54
22307032	Insulin	Liu J	Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice.	Gastroenterology	2012	45
22385956	Insulin	Samuel VT	Mechanisms for insulin resistance: common threads and missing links.	Cell	2012	436
22431523	Insulin	Norseen J	Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism.	Molecular and cellular biology	2012	62
22492369	Insulin	Bjermo H	Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial.	The American journal of clinical nutrition	2012	55
22560209	Insulin	Farese RV Jr	The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance.	Cell metabolism	2012	65
22569073	Insulin	Ren G	Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism.	American journal of physiology. Endocrinology and metabolism	2012	63
22577490	Insulin	Longato L	Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease.	Oxidative medicine and cellular longevity	2012	36
22609549	Insulin	Straßburger K	Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP.	Developmental biology	2012	42
22719752	Insulin	Hsieh MC	The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese.	Experimental diabetes research	2012	42
22796579	Insulin	Sparks JD	Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia.	Arteriosclerosis, thrombosis, and vascular biology	2012	31
23381014	Insulin	Singh S	Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.	The American journal of gastroenterology	2013	51
23471659	Insulin	Ye J	Mechanisms of insulin resistance in obesity.	Frontiers of medicine	2013	47
23633480	Insulin	Chettouh H	Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.	Cancer research	2013	35
23832089	Insulin	Pajvani UB	Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability.	Nature medicine	2013	38
23931760	Insulin	Ahrens M	DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery.	Cell metabolism	2013	63
24051378	Insulin	Tamaki M	The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance.	The Journal of clinical investigation	2013	51
24241533	Insulin	Bojsen-Møller KN	Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.	Diabetes	2014	31
24380887	Insulin	de la Monte SM	Brain metabolic dysfunction at the core of Alzheimer's disease.	Biochemical pharmacology	2014	55
24670599	Insulin	Pirazzi C	PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells.	Human molecular genetics	2014	43
24931034	Insulin	Kleinridders A	Insulin action in brain regulates systemic metabolism and brain function.	Diabetes	2014	52
24947355	Insulin	Tubbs E	Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance.	Diabetes	2014	36
25596529	Insulin	Keembiyehetty C	Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis.	The Journal of biological chemistry	2015	20
25733449	Insulin	Rahman SA	Molecular mechanisms of congenital hyperinsulinism.	Journal of molecular endocrinology	2015	17
25776943	Insulin	Guo K	Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals.	Obesity	2015	18
25999530	Insulin	Stewart AF	Human β-cell proliferation and intracellular signaling: part 3.	Diabetes	2015	26
26044465	Insulin	Simó R	Novel insights in SHBG regulation and clinical implications.	Trends in endocrinology and metabolism	2015	20
26212089	Insulin	Kapil S	Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease.	Journal of gastroenterology and hepatology	2016	12
26542580	Insulin	Perelis M	Pancreatic β cell enhancers regulate rhythmic transcription of genes controlling insulin secretion.	Science	2015	49
26696633	Insulin	Gommers LM	Hypomagnesemia in Type 2 Diabetes: A Vicious Circle?	Diabetes	2016	15
27527746	Insulin	Feldman A	Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.	The American journal of gastroenterology	2017	11
11034317	Peptides	Krause A	LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity.	FEBS letters	2000	208
12050285	Peptides	Gnanapavan S	The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.	The Journal of clinical endocrinology and metabolism	2002	192
15205345	Peptides	Liang Z	Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.	Cancer research	2004	91
15353804	Peptides	Walensky LD	Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix.	Science	2004	295
16622600	Peptides	Werle M	Strategies to improve plasma half life time of peptide and protein drugs.	Amino acids	2006	63
18757748	Peptides	Hansson Petersen CA	The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae.	Proceedings of the National Academy of Sciences of the United States of America	2008	159
19785645	Peptides	Kalliokoski A	Impact of OATP transporters on pharmacokinetics.	British journal of pharmacology	2009	119
19802382	Peptides	Jaiswal S	Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice.	PloS one	2009	60
20068138	Peptides	Arakawa M	Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.	Diabetes	2010	102
20385185	Peptides	Nettles DL	Applications of elastin-like polypeptides in tissue engineering.	Advanced drug delivery reviews	2010	40
22182510	Peptides	King TD	Frizzled7 as an emerging target for cancer therapy.	Cellular signalling	2012	35
22659620	Peptides	Cho YM	Targeting the glucagon receptor family for diabetes and obesity therapy.	Pharmacology & therapeutics	2012	31
23150796	Peptides	Yan H	Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.	eLife	2012	288
23297075	Peptides	Wu Z	Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.	Journal of nuclear medicine 	2013	32
25384421	Peptides	Zhou Z	Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.	FASEB journal 	2015	17
25485909	Peptides	Finan B	A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.	Nature medicine	2015	30
25645567	Peptides	Blonde L	Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes.	Cardiovascular diabetology	2015	17
25825497	Peptides	Nguyen H	LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2.	The Journal of biological chemistry	2015	18
1532777	Glucose	DeFronzo RA	Pathogenesis of NIDDM. A balanced overview.	Diabetes care	1992	218
3894418	Glucose	DeFronzo RA	Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.	The Journal of clinical investigation	1985	184
8247074	Glucose	Lillioja S	Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.	The New England journal of medicine	1993	212
8945471	Glucose	Yamagata K	Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)	Nature	1996	216
9867845	Glucose	Postic C	Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.	The Journal of biological chemistry	1999	389
10209084	Glucose	Andrews RC	Glucocorticoids and insulin resistance: old hormones, new targets.	Clinical science	1999	104
10395191	Glucose	Hotamisligil GS	The role of TNFalpha and TNF receptors in obesity and insulin resistance.	Journal of internal medicine	1999	97
11118008	Glucose	Hundal RS	Mechanism by which metformin reduces glucose production in type 2 diabetes.	Diabetes	2000	181
11171994	Glucose	Haase VH	Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.	Proceedings of the National Academy of Sciences of the United States of America	2001	167
11375115	Glucose	Delerive P	Peroxisome proliferator-activated receptors in inflammation control.	The Journal of endocrinology	2001	142
11584370	Glucose	Paradis V	High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis.	Hepatology	2001	92
11742415	Glucose	Moller DE	New drug targets for type 2 diabetes and the metabolic syndrome.	Nature	2001	114
11854024	Glucose	Berg AH	ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.	Trends in endocrinology and metabolism	2002	199
12021250	Glucose	Petersen KF	Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.	The Journal of clinical investigation	2002	172
12626323	Glucose	Jiang G	Glucagon and regulation of glucose metabolism.	American journal of physiology. Endocrinology and metabolism	2003	128
12791994	Glucose	Du K	TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver.	Science	2003	250
12829641	Glucose	Basu R	Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance.	Diabetes	2003	87
15016359	Glucose	Kamata K	Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase.	Structure	2004	99
15107844	Glucose	Koo SH	PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3.	Nature medicine	2004	164
15118095	Glucose	Paterson JM	Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.	Proceedings of the National Academy of Sciences of the United States of America	2004	85
15294056	Glucose	Storlien L	Metabolic flexibility.	The Proceedings of the Nutrition Society	2004	74
15315937	Glucose	Higgins DF	Hypoxic induction of Ctgf is directly mediated by Hif-1.	American journal of physiology. Renal physiology	2004	83
15371448	Glucose	Zang M	AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells.	The Journal of biological chemistry	2004	103
15509521	Glucose	Kawaguchi T	Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3.	The American journal of pathology	2004	130
15520383	Glucose	Zhang EE	Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism.	Proceedings of the National Academy of Sciences of the United States of America	2004	99
15662004	Glucose	Lowell BB	Mitochondrial dysfunction and type 2 diabetes.	Science	2005	502
15734833	Glucose	Petersen KF	Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.	Diabetes	2005	194
15747110	Glucose	Bugianesi E	Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.	Diabetologia	2005	117
16148943	Glucose	Koo SH	The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.	Nature	2005	306
16186396	Glucose	Plomgaard P	Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.	Diabetes	2005	96
16250043	Glucose	Bugianesi E	Insulin resistance: a metabolic pathway to chronic liver disease.	Hepatology	2005	117
16409152	Glucose	Beaven SW	Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.	Annual review of medicine	2006	78
16463046	Glucose	Adiels M	Overproduction of large VLDL particles is driven by increased liver fat content in man.	Diabetologia	2006	110
16567827	Glucose	Stefan N	Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.	Diabetes care	2006	96
16613757	Glucose	Bastard JP	Recent advances in the relationship between obesity, inflammation, and insulin resistance.	European cytokine network	2006	413
16644654	Glucose	Abdul-Ghani MA	Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.	Diabetes care	2006	150
16644802	Glucose	Viollet B	Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.	The Journal of physiology	2006	96
16709629	Glucose	Xue B	AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues.	The Journal of physiology	2006	78
16823475	Glucose	Long YC	AMP-activated protein kinase signaling in metabolic regulation.	The Journal of clinical investigation	2006	179
16885160	Glucose	Ma L	ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver.	The Journal of biological chemistry	2006	119
16890538	Glucose	Uyeda K	Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis.	Cell metabolism	2006	150
17114290	Glucose	Petersen KF	Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.	Proceedings of the National Academy of Sciences of the United States of America	2006	89
17201070	Glucose	Fischer CP	Interleukin-6 in acute exercise and training: what is the biological relevance?	Exercise immunology review	2006	85
17261637	Glucose	Gromada J	Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.	Endocrine reviews	2007	158
17498512	Glucose	Parekh S	Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.	Gastroenterology	2007	76
17618858	Glucose	Klöting N	Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass.	Cell metabolism	2007	92
17666010	Glucose	Tremblay F	Role of dietary proteins and amino acids in the pathogenesis of insulin resistance.	Annual review of nutrition	2007	60
17671651	Glucose	Lyssenko V	Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.	The Journal of clinical investigation	2007	204
17690317	Glucose	Kotronen A	Fatty liver: a novel component of the metabolic syndrome.	Arteriosclerosis, thrombosis, and vascular biology	2008	167
17885689	Glucose	Nogueiras R	The central melanocortin system directly controls peripheral lipid metabolism.	The Journal of clinical investigation	2007	129
17981116	Glucose	Pospisilik JA	Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.	Cell	2007	154
18023282	Glucose	Reue K	The lipin protein family: dual roles in lipid biosynthesis and gene expression.	FEBS letters	2008	58
18039092	Glucose	Waki H	Endocrine functions of adipose tissue.	Annual review of pathology	2007	83
18048764	Glucose	Eizirik DL	The role for endoplasmic reticulum stress in diabetes mellitus.	Endocrine reviews	2008	306
18323454	Glucose	Dentin R	Hepatic glucose sensing via the CREB coactivator CRTC2.	Science	2008	119
18338393	Glucose	Hruska KS	Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).	Human mutation	2008	124
18391974	Glucose	Gross DN	The role of FoxO in the regulation of metabolism.	Oncogene	2008	152
18446789	Glucose	Sheikh MY	Hepatitis C virus infection: molecular pathways to metabolic syndrome.	Hepatology	2008	56
18726182	Glucose	Iynedjian PB	Molecular physiology of mammalian glucokinase.	Cellular and molecular life sciences 	2009	80
18752331	Glucose	Fracanzani AL	Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.	Hepatology	2008	105
19009016	Glucose	Rabe K	Adipokines and insulin resistance.	Molecular medicine	2008	141
19240267	Glucose	Møller N	Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.	Endocrine reviews	2009	147
19245656	Glucose	Viollet B	AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.	Acta physiologica	2009	89
19273282	Glucose	Viollet B	Targeting the AMPK pathway for the treatment of Type 2 diabetes.	Frontiers in bioscience	2009	52
19286567	Glucose	Amann T	GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.	The American journal of pathology	2009	59
19291785	Glucose	Miele L	Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.	Hepatology	2009	222
19332493	Glucose	Brøns C	Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men.	The Journal of physiology	2009	52
19434725	Glucose	Cali AM	Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?	Hepatology	2009	46
19478200	Glucose	Verschuren L	MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease.	Circulation research	2009	47
19487637	Glucose	Chavez AO	Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.	Diabetes care	2009	71
19501581	Glucose	Meshkani R	Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.	Clinical biochemistry	2009	68
19602480	Glucose	Prokunina-Olsson L	Tissue-specific alternative splicing of TCF7L2.	Human molecular genetics	2009	45
19643913	Glucose	Beer NL	The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.	Human molecular genetics	2009	100
19696361	Glucose	Pedersen BK	Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines.	Journal of applied physiology	2009	50
19779498	Glucose	Colell A	Novel roles for GAPDH in cell death and carcinogenesis.	Cell death and differentiation	2009	49
19800254	Glucose	Lynn FC	Meta-regulation: microRNA regulation of glucose and lipid metabolism.	Trends in endocrinology and metabolism	2009	59
20005308	Glucose	Dominy JE Jr	Nutrient-dependent regulation of PGC-1alpha's acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5.	Biochimica et biophysica acta	2010	53
20222092	Glucose	Das K	Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.	Hepatology	2010	64
20336705	Glucose	Speliotes EK	Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.	Hepatology	2010	86
20376506	Glucose	Nicolucci A	Epidemiological aspects of neoplasms in diabetes.	Acta diabetologica	2010	48
20451522	Glucose	Dushay J	Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.	Gastroenterology	2010	113
20480025	Glucose	Hanhineva K	Impact of dietary polyphenols on carbohydrate metabolism.	International journal of molecular sciences	2010	83
20546255	Glucose	Gerich JE	Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.	Diabetic medicine 	2010	82
20631354	Glucose	Zhao Y	NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology.	Arteriosclerosis, thrombosis, and vascular biology	2010	63
20664173	Glucose	Tam J	Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.	The Journal of clinical investigation	2010	116
20803499	Glucose	Santoro N	A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents.	Hepatology	2010	51
20817486	Glucose	Ernst MC	Chemerin: at the crossroads of inflammation and obesity.	Trends in endocrinology and metabolism	2010	60
20842602	Glucose	Yessoufou A	Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.	Swiss medical weekly	2010	40
20876708	Glucose	Musso G	Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?	Diabetes care	2010	119
20944545	Glucose	Yvan-Charvet L	Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity.	Kidney international	2011	40
21035759	Glucose	Misu H	A liver-derived secretory protein, selenoprotein P, causes insulin resistance.	Cell metabolism	2010	69
21233852	Glucose	Donath MY	Type 2 diabetes as an inflammatory disease.	Nature reviews. Immunology	2011	545
21325336	Glucose	Liu C	PGC-1 coactivators in the control of energy metabolism.	Acta biochimica et biophysica Sinica	2011	50
21358696	Glucose	Mather A	Glucose handling by the kidney.	Kidney international. Supplement	2011	42
21599535	Glucose	Leavens KF	Insulin signaling to hepatic lipid metabolism in health and disease.	Critical reviews in biochemistry and molecular biology	2011	41
21614570	Glucose	Camastra S	Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.	Diabetologia	2011	41
21723505	Glucose	Yadav H	Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling.	Cell metabolism	2011	117
21809358	Glucose	Cardinale V	Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets.	Hepatology	2011	75
21811631	Glucose	Jeong YS	Integrated expression profiling and genome-wide analysis of ChREBP targets reveals the dual role for ChREBP in glucose-regulated gene expression.	PloS one	2011	41
21816244	Glucose	Kousteni S	FoxO1, the transcriptional chief of staff of energy metabolism.	Bone	2012	43
21965330	Glucose	Wang RH	Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.	The Journal of clinical investigation	2011	91
22001757	Glucose	Chambers JC	Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.	Nature genetics	2011	141
22038520	Glucose	Rees MG	Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.	Diabetologia	2012	31
22173168	Glucose	Bechmann LP	The interaction of hepatic lipid and glucose metabolism in liver diseases.	Journal of hepatology	2012	103
22343897	Glucose	Ichimura A	Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human.	Nature	2012	126
22476949	Glucose	Zhou B	Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity.	Diabetologia	2012	42
22586588	Glucose	Metukuri MR	ChREBP mediates glucose-stimulated pancreatic β-cell proliferation.	Diabetes	2012	35
22778263	Glucose	Racioppi L	Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology.	The Journal of biological chemistry	2012	46
22883232	Glucose	Ruan HB	O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability.	Cell metabolism	2012	55
23107255	Glucose	Müller MJ	Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome.	Obesity reviews 	2012	39
23134073	Glucose	Woo YC	Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.	Clinical endocrinology	2013	47
23139352	Glucose	Boon J	Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance.	Diabetes	2013	45
23159449	Glucose	Zechner JF	Weight-independent effects of roux-en-Y gastric bypass on glucose homeostasis via melanocortin-4 receptors in mice and humans.	Gastroenterology	2013	29
23160966	Glucose	Piya MK	Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin.	The Journal of endocrinology	2013	45
23249272	Glucose	Passos-Silva DG	Angiotensin-(1-7): beyond the cardio-renal actions.	Clinical science	2013	37
23257294	Glucose	Li X	SIRT1 and energy metabolism.	Acta biochimica et biophysica Sinica	2013	42
23325474	Glucose	Fernández-Hernando C	MicroRNAs in metabolic disease.	Arteriosclerosis, thrombosis, and vascular biology	2013	57
23337953	Glucose	Stefan N	The role of hepatokines in metabolism.	Nature reviews. Endocrinology	2013	42
23431266	Glucose	Girousse A	Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass.	PLoS biology	2013	41
23439261	Glucose	Safar Zadeh E	The liver diseases of lipodystrophy: the long-term effect of leptin treatment.	Journal of hepatology	2013	26
23475416	Glucose	Moon HS	Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.	Endocrine reviews	2013	25
23516412	Glucose	de Bock M	Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial.	PloS one	2013	25
23562074	Glucose	Silvestri C	The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders.	Cell metabolism	2013	76
23597489	Glucose	Filhoulaud G	Novel insights into ChREBP regulation and function.	Trends in endocrinology and metabolism	2013	51
23597726	Glucose	Fabbrini E	Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals.	Gastroenterology	2013	57
23716591	Glucose	Ramírez CM	MicroRNA 33 regulates glucose metabolism.	Molecular and cellular biology	2013	38
23886976	Glucose	Geurts L	Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.	Beneficial microbes	2014	46
24037093	Glucose	Taniguchi CM	Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.	Nature medicine	2013	33
24141775	Glucose	Chen WT	GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.	Oncogene	2014	24
24166096	Glucose	Yan JW	The emerging role of miR-375 in cancer.	International journal of cancer	2014	38
24215793	Glucose	Mezza T	Insulin resistance alters islet morphology in nondiabetic humans.	Diabetes	2014	31
24238363	Glucose	Oh KJ	CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis.	BMB reports	2013	32
24384568	Glucose	Boucher J	Insulin receptor signaling in normal and insulin-resistant states.	Cold Spring Harbor perspectives in biology	2014	78
24651807	Glucose	Cobelli C	The oral minimal model method.	Diabetes	2014	28
24813368	Glucose	Gallego-Escuredo JM	Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.	International journal of obesity	2015	18
25009184	Glucose	Zhang P	Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion.	Proceedings of the National Academy of Sciences of the United States of America	2014	42
25035342	Glucose	Lim S	Links between ectopic fat and vascular disease in humans.	Arteriosclerosis, thrombosis, and vascular biology	2014	32
25043058	Glucose	Suh JM	Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer.	Nature	2014	32
25281430	Glucose	Murahovschi V	WISP1 is a novel adipokine linked to inflammation in obesity.	Diabetes	2015	16
25287711	Glucose	Rutter GA	SLC30A8 mutations in type 2 diabetes.	Diabetologia	2015	19
25295788	Glucose	Turpin SM	Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.	Cell metabolism	2014	80
25304002	Glucose	Vrhovac I	Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart.	Pflugers Archiv 	2015	23
25307742	Glucose	Haeusler RA	Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.	Nature communications	2014	32
25421524	Glucose	Thorens B	GLUT2, glucose sensing and glucose homeostasis.	Diabetologia	2015	42
25476696	Glucose	Everard A	Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status.	Nature communications	2014	42
25563886	Glucose	Goos JA	Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.	Annals of surgery	2016	10
25637831	Glucose	Satin LS	Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes.	Molecular aspects of medicine	2015	19
25688211	Glucose	Poher AL	Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance.	Frontiers in physiology	2015	35
25688231	Glucose	Ma X	Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy.	Frontiers in endocrinology	2015	17
25703085	Glucose	Francque S	PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis.	Journal of hepatology	2015	24
25726255	Glucose	Higuchi C	Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.	Metabolism	2015	26
25747274	Glucose	Monga SP	β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis.	Gastroenterology	2015	58
25751139	Glucose	Wang W	AMPK modulates Hippo pathway activity to regulate energy homeostasis.	Nature cell biology	2015	73
26248647	Glucose	Pajvani UB	The new biology of diabetes.	Diabetologia	2015	17
26365179	Glucose	Dupuy F	PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.	Cell metabolism	2015	51
26409295	Glucose	Dongiovanni P	Genetics of nonalcoholic fatty liver disease.	Metabolism	2016	14
26422395	Glucose	Cao Y	SIRT1 and insulin resistance.	Journal of diabetes and its complications	2016	10
26435271	Glucose	Koo JH	Endoplasmic Reticulum Stress in Hepatic Stellate Cells Promotes Liver Fibrosis via PERK-Mediated Degradation of HNRNPA1 and Up-regulation of SMAD2.	Gastroenterology	2016	13
26453144	Glucose	Bock KW	The UDP-glycosyltransferase (UGT) superfamily expressed in humans, insects and plants: Animal-plant arms-race and co-evolution.	Biochemical pharmacology	2016	13
26727229	Glucose	Samuel VT	The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.	The Journal of clinical investigation	2016	78
26742071	Glucose	Kim Y	Polyphenols and Glycemic Control.	Nutrients	2016	19
26743209	Glucose	An H	Current understanding of metformin effect on the control of hyperglycemia in diabetes.	The Journal of endocrinology	2016	14
26947067	Glucose	Kung CP	The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction.	Cell reports	2016	18
26993047	Glucose	Wang ZV	Adiponectin, the past two decades.	Journal of molecular cell biology	2016	18
27002059	Glucose	Steven S	Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders.	Diabetes care	2016	12
27070352	Glucose	Cobb LJ	Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers.	Aging	2016	18
27076077	Glucose	Yoshihara E	ERRγ Is Required for the Metabolic Maturation of Therapeutically Functional Glucose-Responsive β Cells.	Cell metabolism	2016	14
27099265	Glucose	Willeit P	Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?	European heart journal	2016	11
27197151	Glucose	Hirata H	Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.	Cancer research	2016	12
27238018	Glucose	Zhao X	Circadian Amplitude Regulation via FBXW7-Targeted REV-ERBα Degradation.	Cell	2016	11
27335433	Glucose	Tanimura Y	Acute exercise increases fibroblast growth factor 21 in metabolic organs and circulation.	Physiological reports	2016	10
27636730	Glucose	Gross B	PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.	Nature reviews. Endocrinology	2017	26
27928162	Glucose	Hashimoto N	Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.	Journal of human genetics	2017	6
28039838	Glucose	Gómez-Sámano MÁ	Fibroblast growth factor 21 and its novel association with oxidative stress.	Redox biology	2017	7
28183444	Glucose	Katsagoni CN	Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.	Metabolism	2017	10
28211512	Glucose	Perakakis N	Physiology and role of irisin in glucose homeostasis.	Nature reviews. Endocrinology	2017	10
28293093	Glucose	Rinaldi L	Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.	World journal of gastroenterology	2017	5
28314735	Glucose	Adams LA	Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.	Gut	2017	12
28533672	Glucose	Gelli C	Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.	World journal of gastroenterology	2017	5
9121257	Ethanol	Poynard T	Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.	Lancet	1997	421
12395331	Ethanol	Hassan MM	Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.	Hepatology	2002	143
12717385	Ethanol	Paik YH	Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.	Hepatology	2003	166
12759473	Ethanol	Lencioni RA	Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.	Radiology	2003	129
14744237	Ethanol	Caro AA	Oxidative stress, toxicology, and pharmacology of CYP2E1.	Annual review of pharmacology and toxicology	2004	93
15099407	Ethanol	Crabb DW	Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology.	The Proceedings of the Nutrition Society	2004	86
15578509	Ethanol	Lin SM	Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.	Gastroenterology	2004	104
15670660	Ethanol	Lieber CS	Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.	Alcohol	2004	141
15830281	Ethanol	Llovet JM	Updated treatment approach to hepatocellular carcinoma.	Journal of gastroenterology	2005	129
16009687	Ethanol	Lin SM	Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.	Gut	2005	99
16455479	Ethanol	Boffetta P	Alcohol and cancer.	The Lancet. Oncology	2006	150
16573591	Ethanol	Crews FT	Cytokines and alcohol.	Alcoholism, clinical and experimental research	2006	104
17728149	Ethanol	Adams LA	Nonalcoholic fatty liver disease.	Annals of epidemiology	2007	70
18045675	Ethanol	Albano E	Oxidative mechanisms in the pathogenesis of alcoholic liver disease.	Molecular aspects of medicine	2008	55
18162065	Ethanol	Tang Y	Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease.	Alcoholism, clinical and experimental research	2008	99
18393390	Ethanol	Straub BK	Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis.	Hepatology	2008	58
18395093	Ethanol	Horiguchi N	Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury.	Gastroenterology	2008	70
18666317	Ethanol	Gomaa AI	Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.	World journal of gastroenterology	2008	139
19250206	Ethanol	Berasain C	Inflammation and liver cancer: new molecular links .	Annals of the New York Academy of Sciences	2009	113
19448996	Ethanol	Cederbaum AI	Role of oxidative stress in alcohol-induced liver injury.	Archives of toxicology	2009	132
20238398	Ethanol	Szabo G	Alcoholic liver disease and the gut-liver axis.	World journal of gastroenterology	2010	101
20628345	Ethanol	Yang JD	Hepatocellular carcinoma: A global view.	Nature reviews. Gastroenterology & hepatology	2010	286
20639898	Ethanol	Whittaker S	The role of signaling pathways in the development and treatment of hepatocellular carcinoma.	Oncogene	2010	208
20664081	Ethanol	Malhi H	Hepatocyte death: a clear and present danger.	Physiological reviews	2010	108
20692331	Ethanol	Lu Y	Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice.	Free radical biology & medicine	2010	57
20953207	Ethanol	Severi T	Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.	Acta pharmacologica Sinica	2010	48
21145844	Ethanol	Malhi H	Endoplasmic reticulum stress in liver disease.	Journal of hepatology	2011	244
21252049	Ethanol	Gao B	Innate immunity in alcoholic liver disease.	American journal of physiology. Gastrointestinal and liver physiology	2011	64
21284667	Ethanol	Miller AM	Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.	Alcoholism, clinical and experimental research	2011	46
21372407	Ethanol	Takeuchi F	Confirmation of ALDH2 as a Major locus of drinking behavior and of its variants regulating multiple metabolic phenotypes in a Japanese population.	Circulation journal 	2011	39
21497796	Ethanol	Li D	Strong association of the alcohol dehydrogenase 1B gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases.	Biological psychiatry	2011	52
22308024	Ethanol	Yin H	MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1.	The Journal of biological chemistry	2012	43
22320924	Ethanol	Gao B	Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease.	Journal of gastroenterology and hepatology	2012	51
22427130	Ethanol	Volynets V	Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD).	Digestive diseases and sciences	2012	33
22841474	Ethanol	Meng F	Epigenetic regulation of miR-34a expression in alcoholic liver injury.	The American journal of pathology	2012	41
23452163	Ethanol	Aron-Wisnewsky J	Gut microbiota and non-alcoholic fatty liver disease: new insights.	Clinical microbiology and infection 	2013	42
23532958	Ethanol	Bertola A	Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin.	Hepatology	2013	77
23857333	Ethanol	Tikhanovich I	Regulation of FOXO3 by phosphorylation and methylation in hepatitis C virus infection and alcohol exposure.	Hepatology	2014	22
23921128	Ethanol	Chen CL	Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.	The Journal of clinical investigation	2013	46
24222941	Ethanol	Dongiovanni P	PNPLA3 I148M polymorphism and progressive liver disease.	World journal of gastroenterology	2013	32
24262277	Ethanol	Yin H	Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.	Gastroenterology	2014	40
24382882	Ethanol	Chen CH	Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.	Physiological reviews	2014	62
24400890	Ethanol	McDaniel K	The functional role of microRNAs in alcoholic liver injury.	Journal of cellular and molecular medicine	2014	34
24445574	Ethanol	Singal AG	The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis.	The American journal of gastroenterology	2014	46
25278688	Ethanol	Williams JA	New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.	World journal of gastroenterology	2014	20
25457206	Ethanol	Page A	Alcohol directly stimulates epigenetic modifications in hepatic stellate cells.	Journal of hepatology	2015	16
25465468	Ethanol	Song BJ	Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications.	Redox biology	2014	20
25479137	Ethanol	Markwick LJ	Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis.	Gastroenterology	2015	32
25622857	Ethanol	Wang F	Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma.	Molecular cancer	2015	16
25747273	Ethanol	Lee JH	Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.	Gastroenterology	2015	42
25822088	Ethanol	Schulze K	Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.	Nature genetics	2015	142
25930080	Ethanol	Roh YS	TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration.	American journal of physiology. Gastrointestinal and liver physiology	2015	17
26005677	Ethanol	Basaranoglu M	Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.	Hepatobiliary surgery and nutrition	2015	20
26264599	Ethanol	Momen-Heravi F	Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.	Journal of translational medicine	2015	37
26482880	Ethanol	Buch S	A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis.	Nature genetics	2015	35
26527689	Ethanol	Saha B	MicroRNA Cargo of Extracellular Vesicles from Alcohol-exposed Monocytes Signals Naive Monocytes to Differentiate into M2 Macrophages.	The Journal of biological chemistry	2016	23
26582088	Ethanol	Uthaya Kumar DB	TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.	Gastroenterology	2016	11
26632633	Ethanol	Verma VK	Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles.	Journal of hepatology	2016	26
26642859	Ethanol	Llopis M	Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease.	Gut	2016	21
26769846	Ethanol	Wang S	Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury.	Oncotarget	2016	11
26844476	Ethanol	Jamali R	Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.	Medicine	2016	12
27575312	Ethanol	Stickel F	The genetics of alcohol dependence and alcohol-related liver disease.	Journal of hepatology	2017	5
27639178	Ethanol	Eguchi A	Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood.	Hepatology	2017	8
27679493	Ethanol	Li M	MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils.	Gut	2017	17
28107775	Ethanol	Varga ZV	β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.	British journal of pharmacology	2018	6
28467924	Ethanol	Søberg S	FGF21 Is a Sugar-Induced Hormone Associated with Sweet Intake and Preference in Humans.	Cell metabolism	2017	9
28530644	Ethanol	Yang AM	Intestinal fungi contribute to development of alcoholic liver disease.	The Journal of clinical investigation	2017	9
8298639	Copper	Bull PC	The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene.	Nature genetics	1993	208
9414160	Copper	Brown DR	The cellular prion protein binds copper in vivo.	Nature	1997	191
11296694	Copper	Chitturi S	Etiopathogenesis of nonalcoholic steatohepatitis.	Seminars in liver disease	2001	93
12955875	Copper	Ferenci P	Diagnosis and phenotypic classification of Wilson disease.	Liver international 	2003	80
15772423	Copper	Draganov DI	Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities.	Journal of lipid research	2005	134
21593220	Copper	Zhang S	Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin.	Human molecular genetics	2011	38
25496901	Copper	Bandmann O	Wilson's disease and other neurological copper disorders.	The Lancet. Neurology	2015	39
26160837	Copper	Wang TH	Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.	Oncotarget	2015	23
11752579	Zinc	Narla G	KLF6, a candidate tumor suppressor gene mutated in prostate cancer.	Science	2001	126
16971064	Zinc	Guo Y	Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.	Gene	2006	104
19797115	Zinc	Dennler S	Cloning of the human GLI2 Promoter: transcriptional activation by transforming growth factor-beta via SMAD3/beta-catenin cooperation.	The Journal of biological chemistry	2009	48
21993621	Zinc	Yusa K	Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells.	Nature	2011	192
22341971	Zinc	Quadri M	Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease.	American journal of human genetics	2012	65
22341972	Zinc	Tuschl K	Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man.	American journal of human genetics	2012	52
22689922	Zinc	Alder H	Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer.	Carcinogenesis	2012	34
22937066	Zinc	Lin ZS	Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.	PloS one	2012	39
25531323	Zinc	Weber CE	Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.	Oncogene	2015	30
26551060	Zinc	Wang J	Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.	Nature biotechnology	2015	48
26566661	Zinc	Schjoldager KT	Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.	EMBO reports	2015	16
28211215	Zinc	Yao Z	ZKSCAN1 gene and its related circular RNA (circZKSCAN1) both inhibit hepatocellular carcinoma cell growth, migration, and invasion but through different signaling pathways.	Molecular oncology	2017	22
28481222	Zinc	Lin W	Hepatic metal ion transporter ZIP8 regulates manganese homeostasis and manganese-dependent enzyme activity.	The Journal of clinical investigation	2017	10
28536273	Zinc	Aydemir TB	Metal Transporter Zip14 (Slc39a14) Deletion in Mice Increases Manganese Deposition and Produces Neurotoxic Signatures and Diminished Motor Activity.	The Journal of neuroscience 	2017	6
6300903	Iron	Dautry-Varsat A	pH and the recycling of transferrin during receptor-mediated endocytosis.	Proceedings of the National Academy of Sciences of the United States of America	1983	262
9380735	Iron	Poss KD	Heme oxygenase 1 is required for mammalian iron reutilization.	Proceedings of the National Academy of Sciences of the United States of America	1997	217
9482913	Iron	Zhou XY	HFE gene knockout produces mouse model of hereditary hemochromatosis.	Proceedings of the National Academy of Sciences of the United States of America	1998	113
9884342	Iron	Yachie A	Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency.	The Journal of clinical investigation	1999	257
10409623	Iron	Kawabata H	Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family.	The Journal of biological chemistry	1999	106
10573511	Iron	Angulo P	Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.	Hepatology	1999	237
10747949	Iron	Abboud S	A novel mammalian iron-regulated protein involved in intracellular iron metabolism.	The Journal of biological chemistry	2000	246
11113132	Iron	Pigeon C	A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload.	The Journal of biological chemistry	2001	327
11812557	Iron	Beutler E	Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.	Lancet	2002	119
12393428	Iron	Weinstein DA	Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease.	Blood	2002	109
12433676	Iron	Nemeth E	Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.	Blood	2003	263
12606179	Iron	Bridle KR	Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.	Lancet	2003	135
12809815	Iron	Clark JM	The prevalence and etiology of elevated aminotransferase levels in the United States.	The American journal of gastroenterology	2003	274
14647275	Iron	Papanikolaou G	Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis.	Nature genetics	2004	207
15124018	Iron	Nemeth E	IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.	The Journal of clinical investigation	2004	477
15514116	Iron	Nemeth E	Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.	Science	2004	906
15831703	Iron	Cooperman SS	Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.	Blood	2005	69
15858186	Iron	Adams PC	Hemochromatosis and iron-overload screening in a racially diverse population.	The New England journal of medicine	2005	136
15886319	Iron	Kemna E	Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS.	Blood	2005	110
15998830	Iron	Lin L	Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin.	Blood	2005	89
16075059	Iron	Huang FW	A mouse model of juvenile hemochromatosis.	The Journal of clinical investigation	2005	119
16604073	Iron	Babitt JL	Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.	Nature genetics	2006	294
16848710	Iron	Nemeth E	Regulation of iron metabolism by hepcidin.	Annual review of nutrition	2006	144
16894358	Iron	Mense SM	Heme: a versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinases.	Cell research	2006	76
16946298	Iron	Verga Falzacappa MV	STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation.	Blood	2007	144
16952548	Iron	Bekri S	Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.	Gastroenterology	2006	92
17475779	Iron	De Domenico I	The molecular mechanism of hepcidin-mediated ferroportin down-regulation.	Molecular biology of the cell	2007	114
17488680	Iron	Origa R	Liver iron concentrations and urinary hepcidin in beta-thalassemia.	Haematologica	2007	85
17540841	Iron	Lin L	Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4.	Blood	2007	77
17557118	Iron	Peyssonnaux C	Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).	The Journal of clinical investigation	2007	161
17607365	Iron	Babitt JL	Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance.	The Journal of clinical investigation	2007	155
17699374	Iron	Wish JB	Assessing iron status: beyond serum ferritin and transferrin saturation.	Clinical journal of the American Society of Nephrology 	2006	65
17721544	Iron	Tanno T	High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.	Nature medicine	2007	193
17938254	Iron	Silvestri L	Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis.	Blood	2008	80
18166790	Iron	Kemna EH	Hepcidin: from discovery to differential diagnosis.	Haematologica	2008	55
18199861	Iron	Allen KJ	Iron-overload-related disease in HFE hereditary hemochromatosis.	The New England journal of medicine	2008	106
18326817	Iron	Xia Y	Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.	Blood	2008	81
18326822	Iron	Pinto JP	Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha.	Blood	2008	64
18408718	Iron	Finberg KE	Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).	Nature genetics	2008	164
18511687	Iron	Shi H	A cytosolic iron chaperone that delivers iron to ferritin.	Science	2008	105
18760763	Iron	Whatley SD	C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload.	American journal of human genetics	2008	51
19084217	Iron	Benyamin B	Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels.	American journal of human genetics	2009	51
19254567	Iron	Gao J	Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression.	Cell metabolism	2009	95
19286138	Iron	Tai AW	A functional genomic screen identifies cellular cofactors of hepatitis C virus replication.	Cell host & microbe	2009	206
19293425	Iron	Theurl I	Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.	Blood	2009	79
19321419	Iron	Soe-Lin S	Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2009	47
19352007	Iron	Mastrogiannaki M	HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice.	The Journal of clinical investigation	2009	130
19414861	Iron	Tanno T	Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.	Blood	2009	109
19650691	Iron	Tolosano E	Heme scavenging and the other facets of hemopexin.	Antioxidants & redox signaling	2010	63
19805308	Iron	Huang ML	Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant.	Proceedings of the National Academy of Sciences of the United States of America	2009	52
19931264	Iron	Valenti L	HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.	Gastroenterology	2010	50
20200349	Iron	Finberg KE	Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.	Blood	2010	45
20471131	Iron	European Association For The Study Of The Liver.	EASL clinical practice guidelines for HFE hemochromatosis.	Journal of hepatology	2010	47
20542038	Iron	Pietrangelo A	Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.	Gastroenterology	2010	87
20682781	Iron	Zhao N	ZRT/IRT-like protein 14 (ZIP14) promotes the cellular assimilation of iron from transferrin.	The Journal of biological chemistry	2010	47
20870325	Iron	Shovlin CL	Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment.	Blood reviews	2010	83
20887198	Iron	Ganz T	Hepcidin and disorders of iron metabolism.	Annual review of medicine	2011	121
21099112	Iron	Gardenghi S	Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.	The Journal of clinical investigation	2010	69
21346250	Iron	Ganz T	Hepcidin and iron regulation, 10 years later.	Blood	2011	178
21572427	Iron	Portugal S	Host-mediated regulation of superinfection in malaria.	Nature medicine	2011	91
21718726	Iron	Dongiovanni P	Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.	Journal of hepatology	2011	61
21855608	Iron	Brissot P	Non-transferrin bound iron: a key role in iron overload and iron toxicity.	Biochimica et biophysica acta	2012	82
21953442	Iron	Kowdley KV	Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.	Hepatology	2012	75
22052915	Iron	Boyle JJ	Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection.	Circulation research	2012	34
22055506	Iron	Nandal A	Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2.	Cell metabolism	2011	43
22085723	Iron	Gkouvatsos K	Regulation of iron transport and the role of transferrin.	Biochimica et biophysica acta	2012	60
22093287	Iron	Bode JG	Hepatic acute phase proteins--regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling.	European journal of cell biology	2012	70
22154776	Iron	Finn AV	Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques.	Journal of the American College of Cardiology	2012	54
22306005	Iron	Ganz T	Hepcidin and iron homeostasis.	Biochimica et biophysica acta	2012	166
22441209	Iron	Ganz T	Macrophages and systemic iron homeostasis.	Journal of innate immunity	2012	51
22682227	Iron	Qiao B	Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination.	Cell metabolism	2012	57
22703180	Iron	Pantopoulos K	Mechanisms of mammalian iron homeostasis.	Biochemistry	2012	71
22719876	Iron	Kawaguchi T	Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.	PloS one	2012	50
22998881	Iron	Rostoker G	Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.	The American journal of medicine	2012	33
23114598	Iron	Liu Q	Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis.	The Journal of clinical investigation	2012	50
23139325	Iron	Drakesmith H	Hepcidin and the iron-infection axis.	Science	2012	133
23291219	Iron	Haase VH	Regulation of erythropoiesis by hypoxia-inducible factors.	Blood reviews	2013	70
23640898	Iron	Leidgens S	Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin.	The Journal of biological chemistry	2013	29
23754414	Iron	Martin DN	Identification of transferrin receptor 1 as a hepatitis C virus entry factor.	Proceedings of the National Academy of Sciences of the United States of America	2013	70
24186312	Iron	Fung E	Manipulation of the hepcidin pathway for therapeutic purposes.	Haematologica	2013	32
24200681	Iron	Meynard D	The liver: conductor of systemic iron balance.	Blood	2014	30
24598129	Iron	Sonnweber T	Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB.	Gut	2014	25
24843120	Iron	Frey AG	Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase.	Proceedings of the National Academy of Sciences of the United States of America	2014	24
24904118	Iron	Wu XG	HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression.	Blood	2014	21
24910614	Iron	Spottiswoode N	Iron, anemia and hepcidin in malaria.	Frontiers in pharmacology	2014	24
25306858	Iron	Kühn LC	Iron regulatory proteins and their role in controlling iron metabolism.	Metallomics 	2015	22
25389409	Iron	Schaer DJ	Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development.	Frontiers in physiology	2014	34
25713362	Iron	Lakhal-Littleton S	Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function.	Proceedings of the National Academy of Sciences of the United States of America	2015	17
25843914	Iron	Silva B	An overview of molecular basis of iron metabolism regulation and the associated pathologies.	Biochimica et biophysica acta	2015	22
25858146	Iron	Tesfay L	Hepcidin regulation in prostate and its disruption in prostate cancer.	Cancer research	2015	20
26403645	Iron	Sun X	Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.	Hepatology	2016	34
26471505	Iron	Pavlides M	Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.	Journal of hepatology	2016	14
26685902	Iron	Zhou Z	Hepatocytes: a key cell type for innate immunity.	Cellular & molecular immunology	2016	13
26794443	Iron	Xie Y	Ferroptosis: process and function.	Cell death and differentiation	2016	40
26975792	Iron	Powell LW	Haemochromatosis.	Lancet	2016	14
9500542	Adenosine Triphosphate	Bull LN	A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis.	Nature genetics	1998	117
11098051	Adenosine Triphosphate	Pecqueur C	Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation.	The Journal of biological chemistry	2001	87
11739410	Adenosine Triphosphate	Madesh M	VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release.	The Journal of cell biology	2001	114
12438266	Adenosine Triphosphate	Cuezva JM	The bioenergetic signature of cancer: a marker of tumor progression.	Cancer research	2002	96
12717402	Adenosine Triphosphate	Neuschwander-Tetri BA	Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.	Hepatology	2003	371
14576852	Adenosine Triphosphate	Ambudkar SV	P-glycoprotein: from genomics to mechanism.	Oncogene	2003	169
15766665	Adenosine Triphosphate	Gumireddy K	ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent.	Cancer cell	2005	84
15841208	Adenosine Triphosphate	Timmins JM	Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.	The Journal of clinical investigation	2005	149
15845415	Adenosine Triphosphate	Leslie EM	Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.	Toxicology and applied pharmacology	2005	197
17006453	Adenosine Triphosphate	Krishnamurthy PC	Identification of a mammalian mitochondrial porphyrin transporter.	Nature	2006	105
17237342	Adenosine Triphosphate	Satrústegui J	Mitochondrial transporters as novel targets for intracellular calcium signaling.	Physiological reviews	2007	65
17615395	Adenosine Triphosphate	Lutsenko S	Function and regulation of human copper-transporting ATPases.	Physiological reviews	2007	160
18393293	Adenosine Triphosphate	Komuta M	Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.	Hepatology	2008	74
18521185	Adenosine Triphosphate	Chen WM	Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels.	The Journal of clinical investigation	2008	75
19666485	Adenosine Triphosphate	Gottschalk AJ	Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler.	Proceedings of the National Academy of Sciences of the United States of America	2009	126
19711346	Adenosine Triphosphate	Zhu Z	Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.	International journal of cancer	2010	106
19900593	Adenosine Triphosphate	Bogoyevitch MA	c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges.	Biochimica et biophysica acta	2010	69
20442200	Adenosine Triphosphate	Yang XR	High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.	Gut	2010	73
20683952	Adenosine Triphosphate	Wang XQ	Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway.	Hepatology	2010	56
21216854	Adenosine Triphosphate	Schmid AI	Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes.	Diabetes care	2011	39
21878559	Adenosine Triphosphate	Hardwick RN	Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease.	Drug metabolism and disposition	2011	40
21932399	Adenosine Triphosphate	Borel F	Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs.	Hepatology	2012	44
22266115	Adenosine Triphosphate	Zaytseva YY	Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.	Cancer research	2012	35
22460906	Adenosine Triphosphate	Liu L	Deregulated MYC expression induces dependence upon AMPK-related kinase 5.	Nature	2012	83
23049480	Adenosine Triphosphate	Kushnareva Y	Bax activation initiates the assembly of a multimeric catalyst that facilitates Bax pore formation in mitochondrial outer membranes.	PLoS biology	2012	39
23175232	Adenosine Triphosphate	Oikawa T	Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers.	Hepatology	2013	51
23237509	Adenosine Triphosphate	Eklund KK	Immune functions of serum amyloid A.	Critical reviews in immunology	2012	38
23409044	Adenosine Triphosphate	Plovanich M	MICU2, a paralog of MICU1, resides within the mitochondrial uniporter complex to regulate calcium handling.	PloS one	2013	84
23449803	Adenosine Triphosphate	Shirasaki T	MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells.	Journal of virology	2013	55
23483818	Adenosine Triphosphate	Basaranoglu M	From fatty liver to fibrosis: a tale of "second hit".	World journal of gastroenterology	2013	39
23688078	Adenosine Triphosphate	Choi YH	ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.	Current pharmaceutical design	2014	42
23776229	Adenosine Triphosphate	Feng S	Canonical transient receptor potential 3 channels regulate mitochondrial calcium uptake.	Proceedings of the National Academy of Sciences of the United States of America	2013	26
24385509	Adenosine Triphosphate	Westerterp M	ATP-binding cassette transporters, atherosclerosis, and inflammation.	Circulation research	2014	55
24407242	Adenosine Triphosphate	Win S	JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death.	Cell death & disease	2014	28
24459177	Adenosine Triphosphate	Keppler D	The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia.	Drug metabolism and disposition	2014	23
24550282	Adenosine Triphosphate	Faubert B	Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α.	Proceedings of the National Academy of Sciences of the United States of America	2014	49
24652937	Adenosine Triphosphate	Morais VA	PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling.	Science	2014	65
24746669	Adenosine Triphosphate	Wang Z	Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression.	Developmental cell	2014	37
24751933	Adenosine Triphosphate	Hussain MM	Intestinal lipid absorption and lipoprotein formation.	Current opinion in lipidology	2014	26
24781191	Adenosine Triphosphate	Arif T	Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo.	Molecular therapy. Nucleic acids	2014	23
25262208	Adenosine Triphosphate	Miranda-Lorenzo I	Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.	Nature methods	2014	36
25475361	Adenosine Triphosphate	Nigam SK	What do drug transporters really do?	Nature reviews. Drug discovery	2015	55
25801706	Adenosine Triphosphate	Israelson A	Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.	Neuron	2015	19
26499806	Adenosine Triphosphate	Chen Z	Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.	Cancer letters	2016	53
26744319	Adenosine Triphosphate	Wang MD	HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stress.	Oncotarget	2016	11
27144356	Adenosine Triphosphate	Lee JY	Crystal structure of the human sterol transporter ABCG5/ABCG8.	Nature	2016	19
27940374	Adenosine Triphosphate	Adorni MP	Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages.	Atherosclerosis	2017	5
8033210	Cysteine	Warren AJ	The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development.	Cell	1994	157
11113131	Cysteine	Park CH	Hepcidin, a urinary antimicrobial peptide synthesized in the liver.	The Journal of biological chemistry	2001	352
14581476	Cysteine	Cirman T	Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins.	The Journal of biological chemistry	2004	97
14871816	Cysteine	Caldwell GM	The Wnt antagonist sFRP1 in colorectal tumorigenesis.	Cancer research	2004	75
14988435	Cysteine	Wu G	Glutathione metabolism and its implications for health.	The Journal of nutrition	2004	361
18783549	Cysteine	Gressner OA	Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases.	Liver international 	2008	73
20213804	Cysteine	Sonnylal S	Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.	Arthritis and rheumatism	2010	57
20683959	Cysteine	Tuyama AC	Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis.	Hepatology	2010	67
24854385	Cysteine	Shen WJ	Scavenger receptor class B type I (SR-BI): a versatile receptor with multiple functions and actions.	Metabolism	2014	22
26170293	Cysteine	McGlinchey RP	Cysteine cathepsins are essential in lysosomal degradation of α-synuclein.	Proceedings of the National Academy of Sciences of the United States of America	2015	16
26667407	Cysteine	Yadav PK	Biosynthesis and Reactivity of Cysteine Persulfides in Signaling.	Journal of the American Chemical Society	2016	23
26760765	Cysteine	Reina S	VDAC3 as a sensor of oxidative state of the intermembrane space of mitochondria: the putative role of cysteine residue modifications.	Oncotarget	2016	15
28336545	Cysteine	Karl JP	Changes in intestinal microbiota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiological stress.	American journal of physiology. Gastrointestinal and liver physiology	2017	11
10037799	Hyaluronic Acid	Banerji S	LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan.	The Journal of cell biology	1999	303
11731267	Hyaluronic Acid	Csoka AB	The six hyaluronidase-like genes in the human and mouse genomes.	Matrix biology 	2001	112
16055434	Hyaluronic Acid	Adams LA	Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.	Clinical chemistry	2005	88
21248167	Hyaluronic Acid	Jiang D	Hyaluronan as an immune regulator in human diseases.	Physiological reviews	2011	178
23523583	Hyaluronic Acid	Lichtinghagen R	The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.	Journal of hepatology	2013	34
24256086	Hyaluronic Acid	Nobili V	Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.	American journal of respiratory and critical care medicine	2014	23
16082501	Urea	Curis E	Almost all about citrulline in mammals.	Amino acids	2005	71
16317693	Urea	Calès P	A novel panel of blood markers to assess the degree of liver fibrosis.	Hepatology	2005	88
16945998	Urea	Herrera MB	Isolation and characterization of a stem cell population from adult human liver.	Stem cells	2006	93
18243183	Urea	Campard D	Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.	Gastroenterology	2008	56
19736565	Urea	Song Z	Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells.	Cell research	2009	121
20821352	Urea	Ghodsizadeh A	Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells.	Stem cell reviews	2010	44
22031499	Urea	Tostões RM	Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing.	Hepatology	2012	31
22095466	Urea	Chen YF	Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol.	Hepatology	2012	72
22795084	Urea	Siarheyeva A	An allosteric inhibitor of protein arginine methyltransferase 3.	Structure	2012	31
23352505	Urea	Kostadinova R	A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.	Toxicology and applied pharmacology	2013	49
24440487	Urea	Schwartz RE	Pluripotent stem cell-derived hepatocyte-like cells.	Biotechnology advances	2014	56
25700560	Urea	Polletta L	SIRT5 regulation of ammonia-induced autophagy and mitophagy.	Autophagy	2015	25
27070809	Urea	Miller PG	Design and demonstration of a pumpless 14 compartment microphysiological system.	Biotechnology and bioengineering	2016	14
9806540	Bile Acids and Salts	Strautnieks SS	A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.	Nature genetics	1998	142
10334992	Bile Acids and Salts	Makishima M	Identification of a nuclear receptor for bile acids.	Science	1999	413
11030331	Bile Acids and Salts	Lu TT	Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.	Molecular cell	2000	294
11030332	Bile Acids and Salts	Goodwin B	A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.	Molecular cell	2000	365
11248086	Bile Acids and Salts	Xie W	An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.	Proceedings of the National Academy of Sciences of the United States of America	2001	134
11387316	Bile Acids and Salts	Ananthanarayanan M	Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.	The Journal of biological chemistry	2001	115
12093894	Bile Acids and Salts	Pullinger CR	Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype.	The Journal of clinical investigation	2002	82
12202460	Bile Acids and Salts	Chiang JY	Bile acid regulation of gene expression: roles of nuclear hormone receptors.	Endocrine reviews	2002	93
12208868	Bile Acids and Salts	Yu L	Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol.	The Journal of clinical investigation	2002	135
12663868	Bile Acids and Salts	Trauner M	Bile salt transporters: molecular characterization, function, and regulation.	Physiological reviews	2003	165
12815072	Bile Acids and Salts	Holt JA	Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis.	Genes & development	2003	166
14699511	Bile Acids and Salts	Kullak-Ublick GA	Enterohepatic bile salt transporters in normal physiology and liver disease.	Gastroenterology	2004	88
15102878	Bile Acids and Salts	Khovidhunkit W	Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host.	Journal of lipid research	2004	240
16037564	Bile Acids and Salts	Claudel T	The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.	Arteriosclerosis, thrombosis, and vascular biology	2005	69
16541101	Bile Acids and Salts	Houten SM	Endocrine functions of bile acids.	The EMBO journal	2006	120
16749856	Bile Acids and Salts	Zollner G	Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.	Molecular pharmaceutics	2006	61
16908160	Bile Acids and Salts	Lee FY	FXR, a multipurpose nuclear receptor.	Trends in biochemical sciences	2006	67
17116003	Bile Acids and Salts	Lundåsen T	Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.	Journal of internal medicine	2006	96
17291602	Bile Acids and Salts	Geier A	Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration.	Biochimica et biophysica acta	2007	65
17404808	Bile Acids and Salts	Alrefai WA	Bile acid transporters: structure, function, regulation and pathophysiological implications.	Pharmaceutical research	2007	68
17571164	Bile Acids and Salts	Temel RE	Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.	The Journal of clinical investigation	2007	101
19185005	Bile Acids and Salts	Schaap FG	High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis.	Hepatology	2009	54
19346330	Bile Acids and Salts	Chiang JY	Bile acids: regulation of synthesis.	Journal of lipid research	2009	245
19346331	Bile Acids and Salts	Hylemon PB	Bile acids as regulatory molecules.	Journal of lipid research	2009	165
19758712	Bile Acids and Salts	Fiorucci S	Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.	Trends in pharmacological sciences	2009	51
20103563	Bile Acids and Salts	Klaassen CD	Xenobiotic, bile acid, and cholesterol transporters: function and regulation.	Pharmacological reviews	2010	166
20193641	Bile Acids and Salts	Amaral JD	The role of p53 in apoptosis.	Discovery medicine	2010	55
20623580	Bile Acids and Salts	Li T	Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice.	Hepatology	2010	59
20730630	Bile Acids and Salts	Itoh N	Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.	Cell and tissue research	2010	47
20970497	Bile Acids and Salts	Zhang Y	Role of nuclear receptor SHP in metabolism and cancer.	Biochimica et biophysica acta	2011	66
21103971	Bile Acids and Salts	Stieger B	The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.	Handbook of experimental pharmacology	2011	44
21145931	Bile Acids and Salts	Pols TW	The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation.	Journal of hepatology	2011	68
21195347	Bile Acids and Salts	Chopra AR	Cellular energy depletion resets whole-body energy by promoting coactivator-mediated dietary fuel absorption.	Cell metabolism	2011	35
21953282	Bile Acids and Salts	Zweers SJ	The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.	Hepatology	2012	32
21965623	Bile Acids and Salts	Dawson S	In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.	Drug metabolism and disposition	2012	39
22111624	Bile Acids and Salts	Lorbek G	Cytochrome P450s in the synthesis of cholesterol and bile acids--from mouse models to human diseases.	The FEBS journal	2012	35
22134839	Bile Acids and Salts	Beysen C	Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.	Diabetologia	2012	32
22264787	Bile Acids and Salts	Quante M	Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.	Cancer cell	2012	102
22403795	Bile Acids and Salts	Camilleri M	Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.	American journal of physiology. Gastrointestinal and liver physiology	2012	34
22414897	Bile Acids and Salts	Calkin AC	Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.	Nature reviews. Molecular cell biology	2012	149
22609541	Bile Acids and Salts	Matsubara T	FXR signaling in the enterohepatic system.	Molecular and cellular endocrinology	2013	53
22638681	Bile Acids and Salts	Simonen M	Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass.	Obesity surgery	2012	35
22652341	Bile Acids and Salts	Adorini L	Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis.	Drug discovery today	2012	35
22766017	Bile Acids and Salts	Baptissart M	Bile acids: from digestion to cancers.	Biochimie	2013	25
23141891	Bile Acids and Salts	Poupon R	Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action.	Clinics and research in hepatology and gastroenterology	2012	33
23217254	Bile Acids and Salts	Angelin B	Circulating fibroblast growth factors as metabolic regulators--a critical appraisal.	Cell metabolism	2012	55
23292666	Bile Acids and Salts	Uriarte I	Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice.	Gut	2013	39
23299969	Bile Acids and Salts	Bechmann LP	Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.	Hepatology	2013	34
23391614	Bile Acids and Salts	Lake AD	Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease.	Toxicology and applied pharmacology	2013	30
23641933	Bile Acids and Salts	Cassol E	Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors.	BMC infectious diseases	2013	29
23801799	Bile Acids and Salts	Gerhard GS	A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass.	Diabetes care	2013	40
23956101	Bile Acids and Salts	Morgan RE	A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.	Toxicological sciences 	2013	28
23982684	Bile Acids and Salts	Schaap FG	Bile acid receptors as targets for drug development.	Nature reviews. Gastroenterology & hepatology	2014	61
23988487	Bile Acids and Salts	Li Y	Bile acid receptors in non-alcoholic fatty liver disease.	Biochemical pharmacology	2013	27
24268772	Bile Acids and Salts	Anakk S	Bile acids activate YAP to promote liver carcinogenesis.	Cell reports	2013	31
24317697	Bile Acids and Salts	Zhou X	Structural basis of the alternating-access mechanism in a bile acid transporter.	Nature	2014	22
24531544	Bile Acids and Salts	Lien F	Metformin interferes with bile acid homeostasis through AMPK-FXR crosstalk.	The Journal of clinical investigation	2014	21
24625896	Bile Acids and Salts	Ridlon JM	Bile acids and the gut microbiome.	Current opinion in gastroenterology	2014	91
24700501	Bile Acids and Salts	Liu R	Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.	Hepatology	2014	27
24711282	Bile Acids and Salts	Oehler N	Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism.	Hepatology	2014	27
24799086	Bile Acids and Salts	Aleo MD	Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.	Hepatology	2014	25
24819989	Bile Acids and Salts	Zhou H	Bile acids are nutrient signaling hormones.	Steroids	2014	32
24867799	Bile Acids and Salts	Vaz FM	Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype.	Hepatology	2015	27
24988476	Bile Acids and Salts	Napolitano A	Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.	PloS one	2014	33
25073467	Bile Acids and Salts	Li T	Bile acid signaling in metabolic disease and drug therapy.	Pharmacological reviews	2014	72
25194674	Bile Acids and Salts	Lieu T	The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice.	Gastroenterology	2014	30
25346390	Bile Acids and Salts	Uriarte I	Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development.	International journal of cancer	2015	17
25418280	Bile Acids and Salts	Peng L	The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B.	Hepatology	2015	17
25584736	Bile Acids and Salts	Li T	Bile acids as metabolic regulators.	Current opinion in gastroenterology	2015	27
25617503	Bile Acids and Salts	Mueller M	Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity.	Journal of hepatology	2015	19
25636263	Bile Acids and Salts	Woolbright BL	Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.	Toxicology and applied pharmacology	2015	33
25705637	Bile Acids and Salts	Ali AH	Recent advances in the development of farnesoid X receptor agonists.	Annals of translational medicine	2015	30
26197299	Bile Acids and Salts	Flynn CR	Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.	Nature communications	2015	19
26418580	Bile Acids and Salts	Zhou M	Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice.	Hepatology	2016	15
26420419	Bile Acids and Salts	Reich M	TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro.	Gut	2016	16
26706784	Bile Acids and Salts	Copple BL	Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules.	Pharmacological research	2016	13
26838806	Bile Acids and Salts	Zhang Y	Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function.	Scientific reports	2016	17
27196572	Bile Acids and Salts	Duparc T	Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.	Gut	2017	14
27358174	Bile Acids and Salts	Arab JP	Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.	Hepatology	2017	22
27770549	Bile Acids and Salts	Zhang L	Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay.	Hepatology	2017	12
27780972	Bile Acids and Salts	Wesolowski SR	Developmental origins of NAFLD: a womb with a clue.	Nature reviews. Gastroenterology & hepatology	2017	7
3264384	Cyclophosphamide	Rosenberg SA	Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.	The New England journal of medicine	1988	261
19075267	Cyclophosphamide	Yeo W	Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.	Journal of clinical oncology 	2009	99
20631380	Cyclophosphamide	Campbell KJ	Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.	Blood	2010	44
21852944	Cyclophosphamide	Cojocaru V	Structure and dynamics of the membrane-bound cytochrome P450 2C9.	PLoS computational biology	2011	44
25584002	Cyclophosphamide	Le DT	Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.	Journal of clinical oncology 	2015	101
28298546	Cyclophosphamide	Lee H	64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer.	Clinical cancer research 	2017	10
10458228	Doxorubicin	Van Glabbeke M	Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.	Journal of clinical oncology 	1999	96
17239480	Doxorubicin	Varela M	Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.	Journal of hepatology	2007	155
19584283	Doxorubicin	Fornari F	MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.	Cancer research	2009	117
20388796	Doxorubicin	Yoo BK	Molecular mechanism of chemoresistance by astrocyte elevated gene-1.	Cancer research	2010	46
20501828	Doxorubicin	Fornari F	MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.	Cancer research	2010	129
20682318	Doxorubicin	Cheung ST	Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance.	Gastroenterology	2011	40
21055388	Doxorubicin	Henry JC	miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines.	Biochemical and biophysical research communications	2010	48
21527554	Doxorubicin	Chen J	Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.	Cancer research	2011	42
22773548	Doxorubicin	Chen HP	Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.	Gut	2013	68
23278683	Doxorubicin	Tacar O	Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.	The Journal of pharmacy and pharmacology	2013	184
23563091	Doxorubicin	Gao AM	Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway.	Carcinogenesis	2013	26
24211739	Doxorubicin	Xu L	MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.	Journal of hepatology	2014	35
24565101	Doxorubicin	Zhao N	MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.	Molecular cancer	2014	32
24937669	Doxorubicin	Golfieri R	Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.	British journal of cancer	2014	40
28079894	Doxorubicin	Jin F	MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.	Cell death & disease	2017	16
10935643	Dexamethasone	Xie W	Humanized xenobiotic response in mice expressing nuclear receptor SXR.	Nature	2000	148
19026649	Dexamethasone	Basma H	Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.	Gastroenterology	2009	148
19245695	Dexamethasone	Haram K	The HELLP syndrome: clinical issues and management. A Review.	BMC pregnancy and childbirth	2009	55
21127173	Dexamethasone	England SJ	Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus.	Blood	2011	45
8035341	Carcinogens	Shimada T	Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.	The Journal of pharmacology and experimental therapeutics	1994	232
12644700	Carcinogens	Xie W	Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor.	Proceedings of the National Academy of Sciences of the United States of America	2003	79
14727734	Carcinogens	Klaunig JE	PPARalpha agonist-induced rodent tumors: modes of action and human relevance.	Critical reviews in toxicology	2003	103
15072585	Carcinogens	Sugimura T	Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish.	Cancer science	2004	114
20924108	Carcinogens	Elyakim E	hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy.	Cancer research	2010	42
10504381	Glucocorticoids	Uhlar CM	Serum amyloid A, the major vertebrate acute-phase reactant.	European journal of biochemistry	1999	218
11250914	Glucocorticoids	Seckl JR	Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action.	Endocrinology	2001	104
20591431	Glucocorticoids	Harris A	Glucocorticoids, prenatal stress and the programming of disease.	Hormones and behavior	2011	159
21864867	Glucocorticoids	Peckett AJ	The effects of glucocorticoids on adipose tissue lipid metabolism.	Metabolism	2011	67
23665916	Glucocorticoids	Grøntved L	C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements.	The EMBO journal	2013	48
23899562	Glucocorticoids	Chapman K	11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.	Physiological reviews	2013	77
26714851	Glucocorticoids	John K	The glucocorticoid receptor: cause of or cure for obesity?	American journal of physiology. Endocrinology and metabolism	2016	14
16146333	Antineoplastic Agents	Mao Q	Role of the breast cancer resistance protein (ABCG2) in drug transport.	The AAPS journal	2005	86
16890600	Antineoplastic Agents	Takayasu K	Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.	Gastroenterology	2006	144
17327609	Antineoplastic Agents	Vonderheide RH	Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.	Journal of clinical oncology 	2007	126
18212742	Antineoplastic Agents	Ben Sahra I	The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.	Oncogene	2008	260
18691054	Antineoplastic Agents	Zhou SF	Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.	Current medicinal chemistry	2008	75
20215559	Antineoplastic Agents	Gonzalez-Angulo AM	Metformin: a therapeutic opportunity in breast cancer.	Clinical cancer research 	2010	58
24361892	Antineoplastic Agents	Cheng P	Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.	Biochemical and biophysical research communications	2014	20
24874432	Antineoplastic Agents	Takahashi K	Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy.	Molecular cancer research 	2014	29
15763604	Fluorouracil	Walko CM	Capecitabine: a review.	Clinical therapeutics	2005	77
19417905	Fluorouracil	Sung JH	A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs.	Lab on a chip	2009	64
19622726	Fluorouracil	Yoo BK	Identification of genes conferring resistance to 5-fluorouracil.	Proceedings of the National Academy of Sciences of the United States of America	2009	57
20697159	Fluorouracil	Haraguchi N	CD13 is a therapeutic target in human liver cancer stem cells.	The Journal of clinical investigation	2010	135
20978511	Fluorouracil	Tomimaru Y	MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells.	British journal of cancer	2010	57
24018051	Fluorouracil	Chen Z	MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.	Cellular signalling	2013	26
24323901	Fluorouracil	Touil Y	Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.	Clinical cancer research 	2014	40
25820415	Fluorouracil	Kawai T	Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.	Clinical cancer research 	2015	23
9270026	Cisplatin	Kool M	Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.	Cancer research	1997	114
12686563	Cisplatin	Lai J	Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer.	The Journal of biological chemistry	2003	90
16234567	Cisplatin	Yeo W	A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.	Journal of the National Cancer Institute	2005	120
17103105	Cisplatin	Marelli L	Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.	Cardiovascular and interventional radiology	2007	137
20145120	Cisplatin	Holland SJ	R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.	Cancer research	2010	121
21327457	Cisplatin	Yang Z	Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation.	Annals of surgical oncology	2011	221
21442631	Cisplatin	Schrader J	Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells.	Hepatology	2011	81
21726833	Cisplatin	Lee TK	CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.	Cell stem cell	2011	148
22440905	Cisplatin	Zager RA	Plasma and urinary heme oxygenase-1 in AKI.	Journal of the American Society of Nephrology 	2012	33
22713463	Cisplatin	Xu N	Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell.	Biochemical and biophysical research communications	2012	37
22846564	Cisplatin	Xu N	Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell.	Biochemical and biophysical research communications	2012	33
23483142	Cisplatin	Xu Y	miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells.	Oncology reports	2013	39
23542177	Cisplatin	Mao B	SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma.	Oncogene	2014	30
23746666	Cisplatin	Vermorken JB	Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.	The Lancet. Oncology	2013	69
25385148	Cisplatin	Dai T	Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway.	The Journal of pathology	2015	19
26822397	Cisplatin	Fujitani K	Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.	The Lancet. Oncology	2016	32
26859293	Cisplatin	Su YC	Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma.	PloS one	2016	11
27071093	Cisplatin	Menghi F	The tandem duplicator phenotype as a distinct genomic configuration in cancer.	Proceedings of the National Academy of Sciences of the United States of America	2016	10
28027578	Cisplatin	Li D	Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis.	Hepatology	2017	17
28240761	Cisplatin	Elia G	Hepatocellular carcinoma and CXCR3 chemokines: a narrative review.	La Clinica terapeutica	2017	6
2471267	Growth Hormone	Cunningham BC	High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis.	Science	1989	329
8897022	Growth Hormone	Florini JR	Growth hormone and the insulin-like growth factor system in myogenesis.	Endocrine reviews	1996	152
16543404	Growth Hormone	Waxman DJ	Growth hormone regulation of sex-dependent liver gene expression.	Molecular endocrinology	2006	121
17183314	Growth Hormone	Niedernhofer LJ	A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis.	Nature	2006	235
18500379	Growth Hormone	Velloso CP	Regulation of muscle mass by growth hormone and IGF-I.	British journal of pharmacology	2008	60
25902704	Growth Hormone	Longo VD	Interventions to Slow Aging in Humans: Are We Ready?	Aging cell	2015	77
3283935	Cholesterol	Mahley RW	Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.	Science	1988	637
8349823	Cholesterol	Ishibashi S	Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.	The Journal of clinical investigation	1993	348
8833906	Cholesterol	Shimano H	Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.	The Journal of clinical investigation	1996	190
8878485	Cholesterol	Janowski BA	An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha.	Nature	1996	347
9163428	Cholesterol	Kozarsky KF	Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.	Nature	1997	129
9356497	Cholesterol	Rigotti A	A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism.	Proceedings of the National Academy of Sciences of the United States of America	1997	197
9794114	Cholesterol	Pickup JC	Is type II diabetes mellitus a disease of the innate immune system?	Diabetologia	1998	161
10430941	Cholesterol	Trigatti B	Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology.	Proceedings of the National Academy of Sciences of the United States of America	1999	114
10657556	Cholesterol	Yudkin JS	Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?	Atherosclerosis	2000	233
10872459	Cholesterol	Krieger M	Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI.	Annual review of biochemistry	1999	105
11035776	Cholesterol	Venkateswaran A	Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha.	Proceedings of the National Academy of Sciences of the United States of America	2000	196
11099417	Cholesterol	Berge KE	Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.	Science	2000	215
11135616	Cholesterol	Chinetti G	PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.	Nature medicine	2001	173
11149950	Cholesterol	Laffitte BA	LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.	Proceedings of the National Academy of Sciences of the United States of America	2001	139
11375416	Cholesterol	Werstuck GH	Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways.	The Journal of clinical investigation	2001	156
11473047	Cholesterol	Marchesini G	Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.	Diabetes	2001	400
11882522	Cholesterol	Eichner JE	Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.	American journal of epidemiology	2002	159
12105842	Cholesterol	Bugianesi E	Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.	Gastroenterology	2002	260
12193651	Cholesterol	Tangirala RK	Identification of macrophage liver X receptors as inhibitors of atherosclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2002	97
12297848	Cholesterol	Forns X	Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.	Hepatology	2002	175
12444248	Cholesterol	Yu L	Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion.	Proceedings of the National Academy of Sciences of the United States of America	2002	131
12518001	Cholesterol	Francis GA	Nuclear receptors and the control of metabolism.	Annual review of physiology	2003	122
12611609	Cholesterol	Díez JJ	The role of the novel adipocyte-derived hormone adiponectin in human disease.	European journal of endocrinology	2003	165
12668987	Cholesterol	Marchesini G	Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.	Hepatology	2003	457
12690094	Cholesterol	Tontonoz P	Liver X receptor signaling pathways in cardiovascular disease.	Molecular endocrinology	2003	143
12730697	Cholesterol	Abifadel M	Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.	Nature genetics	2003	408
12788804	Cholesterol	Rigotti A	The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues.	Endocrine reviews	2003	109
12883485	Cholesterol	Kugelmas M	Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.	Hepatology	2003	88
14592845	Cholesterol	Rye KA	Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.	Arteriosclerosis, thrombosis, and vascular biology	2004	78
15130581	Cholesterol	Fayard E	LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis.	Trends in cell biology	2004	95
15178557	Cholesterol	Dubuc G	Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia.	Arteriosclerosis, thrombosis, and vascular biology	2004	125
15188351	Cholesterol	Nishimoto N	Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.	Arthritis and rheumatism	2004	125
15210959	Cholesterol	Wang N	ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.	Proceedings of the National Academy of Sciences of the United States of America	2004	194
15538359	Cholesterol	Soutschek J	Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.	Nature	2004	459
15677715	Cholesterol	Maxwell KN	Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.	Proceedings of the National Academy of Sciences of the United States of America	2005	79
15805190	Cholesterol	Rashid S	Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.	Proceedings of the National Academy of Sciences of the United States of America	2005	161
15925013	Cholesterol	Ginsberg HN	Regulation of plasma triglycerides in insulin resistance and diabetes.	Archives of medical research	2005	88
16054053	Cholesterol	Kennedy MA	ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation.	Cell metabolism	2005	177
16183915	Cholesterol	Oram JF	ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease.	Physiological reviews	2005	128
16249437	Cholesterol	Hanley AJ	Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.	Diabetes	2005	85
16272564	Cholesterol	Mandard S	The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity.	The Journal of biological chemistry	2006	97
16403839	Cholesterol	Vaziri ND	Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.	American journal of physiology. Renal physiology	2006	90
16460270	Cholesterol	Kalaany NY	LXRS and FXR: the yin and yang of cholesterol and fat metabolism.	Annual review of physiology	2006	147
16511589	Cholesterol	Lefebvre P	Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis.	The Journal of clinical investigation	2006	191
16565705	Cholesterol	Zimmermann TS	RNAi-mediated gene silencing in non-human primates.	Nature	2006	302
16567568	Cholesterol	Ix JH	Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.	Circulation	2006	64
16709608	Cholesterol	Dumitrescu AM	Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice.	Endocrinology	2006	70
17095732	Cholesterol	Oram JF	ATP-Binding cassette cholesterol transporters and cardiovascular disease.	Circulation research	2006	115
17242417	Cholesterol	Graham MJ	Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice.	Journal of lipid research	2007	58
17380167	Cholesterol	Soutar AK	Mechanisms of disease: genetic causes of familial hypercholesterolemia.	Nature clinical practice. Cardiovascular medicine	2007	84
17387133	Cholesterol	Tardif JC	Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.	JAMA	2007	143
17495599	Cholesterol	Lara-Castro C	Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.	Current opinion in lipidology	2007	63
17676061	Cholesterol	Wu Z	The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction.	Nature structural & molecular biology	2007	99
17936707	Cholesterol	Li X	SIRT1 deacetylates and positively regulates the nuclear receptor LXR.	Molecular cell	2007	204
17989073	Cholesterol	Infante RE	Purified NPC1 protein. I. Binding of cholesterol and oxysterols to a 1278-amino acid membrane protein.	The Journal of biological chemistry	2008	65
18053320	Cholesterol	Klonoff DC	Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.	Current medical research and opinion	2008	153
18160725	Cholesterol	Packard RR	Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction.	Clinical chemistry	2008	191
18223541	Cholesterol	Williams KJ	Rapid regression of atherosclerosis: insights from the clinical and experimental literature.	Nature clinical practice. Cardiovascular medicine	2008	70
18250299	Cholesterol	Kwon HJ	Molecular basis for LDL receptor recognition by PCSK9.	Proceedings of the National Academy of Sciences of the United States of America	2008	84
18252893	Cholesterol	Zhang X	Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.	Diabetes	2008	175
18271871	Cholesterol	Tall AR	Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins.	Journal of internal medicine	2008	125
18368051	Cholesterol	Elmén J	LNA-mediated microRNA silencing in non-human primates.	Nature	2008	503
18462017	Cholesterol	Schadt EE	Mapping the genetic architecture of gene expression in human liver.	PLoS biology	2008	497
18522832	Cholesterol	Ge L	The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.	Cell metabolism	2008	72
18612115	Cholesterol	Ix JH	Fetuin-A and incident diabetes mellitus in older persons.	JAMA	2008	67
18633113	Cholesterol	Stefan N	Plasma fetuin-A levels and the risk of type 2 diabetes.	Diabetes	2008	74
18654640	Cholesterol	Reed BD	Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes.	PLoS genetics	2008	78
18752326	Cholesterol	Ma KL	Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.	Hepatology	2008	59
18782619	Cholesterol	Hong C	Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors.	Current opinion in genetics & development	2008	66
19029462	Cholesterol	Weikert C	Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.	Circulation	2008	62
19064999	Cholesterol	Rader DJ	The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis.	Journal of lipid research	2009	148
19164855	Cholesterol	Semple RK	Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis.	The Journal of clinical investigation	2009	85
19203419	Cholesterol	Elahi MM	Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice.	The British journal of nutrition	2009	47
19221221	Cholesterol	McGillicuddy FC	Inflammation impairs reverse cholesterol transport in vivo.	Circulation	2009	118
19231010	Cholesterol	Caballero F	Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH.	Journal of hepatology	2009	62
19291789	Cholesterol	Gastaldelli A	Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.	Hepatology	2009	64
19629071	Cholesterol	Shackelford DB	The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.	Nature reviews. Cancer	2009	446
19837721	Cholesterol	Zhao C	Liver X receptor in cholesterol metabolism.	The Journal of endocrinology	2010	71
19948145	Cholesterol	Laplante M	An emerging role of mTOR in lipid biosynthesis.	Current biology 	2009	156
20037595	Cholesterol	Villablanca EJ	Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses.	Nature medicine	2010	51
20375212	Cholesterol	Sell H	Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.	The Journal of clinical endocrinology and metabolism	2010	51
20385826	Cholesterol	Neale BM	Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).	Proceedings of the National Academy of Sciences of the United States of America	2010	159
20392876	Cholesterol	Pearen MA	Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease.	Molecular endocrinology	2010	90
20466882	Cholesterol	Najafi-Shoushtari SH	MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.	Science	2010	279
20466885	Cholesterol	Rayner KJ	MiR-33 contributes to the regulation of cholesterol homeostasis.	Science	2010	348
20530747	Cholesterol	Sun L	A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese.	Diabetes care	2010	61
20541520	Cholesterol	Sato R	Sterol metabolism and SREBP activation.	Archives of biochemistry and biophysics	2010	41
20566875	Cholesterol	Marquart TJ	miR-33 links SREBP-2 induction to repression of sterol transporters.	Proceedings of the National Academy of Sciences of the United States of America	2010	182
20631351	Cholesterol	Calkin AC	Liver x receptor signaling pathways and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2010	75
20686566	Cholesterol	Musunuru K	From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus.	Nature	2010	357
20739751	Cholesterol	Rashid ST	Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.	The Journal of clinical investigation	2010	173
20809793	Cholesterol	Jia L	Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.	Annual review of physiology	2011	37
20816088	Cholesterol	Kjolby M	Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export.	Cell metabolism	2010	63
21084752	Cholesterol	Burkhardt R	Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice.	The Journal of clinical investigation	2010	42
21183072	Cholesterol	Carone BR	Paternally induced transgenerational environmental reprogramming of metabolic gene expression in mammals.	Cell	2010	238
21226579	Cholesterol	Vergeer M	Genetic variant of the scavenger receptor BI in humans.	The New England journal of medicine	2011	73
21226820	Cholesterol	Tremblay AJ	Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes.	Diabetes, obesity & metabolism	2011	41
21243009	Cholesterol	Degoma EM	Novel HDL-directed pharmacotherapeutic strategies.	Nature reviews. Cardiology	2011	58
21258337	Cholesterol	Bartelt A	Brown adipose tissue activity controls triglyceride clearance.	Nature medicine	2011	321
21293192	Cholesterol	Stein S	Protective roles of SIRT1 in atherosclerosis.	Cell cycle	2011	60
21350215	Cholesterol	Chinetti-Gbaguidi G	Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways.	Circulation research	2011	79
21459322	Cholesterol	Seo YK	Genome-wide localization of SREBP-2 in hepatic chromatin predicts a role in autophagy.	Cell metabolism	2011	49
21497090	Cholesterol	Bosch M	Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility.	Current biology 	2011	52
21525259	Cholesterol	Azadbakht L	The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients.	The Journal of nutrition	2011	42
21548778	Cholesterol	Moore KJ	The role of microRNAs in cholesterol efflux and hepatic lipid metabolism.	Annual review of nutrition	2011	41
21576456	Cholesterol	Dávalos A	miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling.	Proceedings of the National Academy of Sciences of the United States of America	2011	188
21795660	Cholesterol	Sano M	A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease.	Neurology	2011	52
21878637	Cholesterol	Li D	MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.	The Journal of biological chemistry	2011	85
21885853	Cholesterol	Ramirez CM	MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1.	Arteriosclerosis, thrombosis, and vascular biology	2011	62
21909109	Cholesterol	Kim YJ	Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits.	Nature genetics	2011	83
21987488	Cholesterol	Bambha K	Ethnicity and nonalcoholic fatty liver disease.	Hepatology	2012	40
22009537	Cholesterol	Park JK	miR-221 silencing blocks hepatocellular carcinoma and promotes survival.	Cancer research	2011	59
22048958	Cholesterol	Maue RA	A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.	Human molecular genetics	2012	32
22119192	Cholesterol	Kim J	MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression.	Experimental neurology	2012	54
22183689	Cholesterol	Lomonaco R	Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.	Hepatology	2012	56
22245895	Cholesterol	Zelber-Sagi S	Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up.	Journal of hepatology	2012	33
22258222	Cholesterol	Jopling C	Liver-specific microRNA-122: Biogenesis and function.	RNA biology	2012	62
22271511	Cholesterol	Kim D	Nonalcoholic fatty liver disease is associated with coronary artery calcification.	Hepatology	2012	59
22436747	Cholesterol	Rottiers V	MicroRNAs in metabolism and metabolic disorders.	Nature reviews. Molecular cell biology	2012	246
22541735	Cholesterol	Jakobsson T	Liver X receptor biology and pharmacology: new pathways, challenges and opportunities.	Trends in pharmacological sciences	2012	58
22560219	Cholesterol	Min HK	Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease.	Cell metabolism	2012	90
22741595	Cholesterol	Liu CJ	Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.	Journal of gastroenterology and hepatology	2012	39
22751103	Cholesterol	Strong A	Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism.	The Journal of clinical investigation	2012	59
22773877	Cholesterol	Yuan M	Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.	The Journal of biological chemistry	2012	49
22820288	Cholesterol	Hsu SH	Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.	The Journal of clinical investigation	2012	184
23206728	Cholesterol	Musso G	Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis.	Progress in lipid research	2013	49
23303913	Cholesterol	Tchernof A	Pathophysiology of human visceral obesity: an update.	Physiological reviews	2013	249
23349936	Cholesterol	Gonzalez-Quintela A	Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity.	PloS one	2013	30
23459944	Cholesterol	Wang L	MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition.	Molecular and cellular biology	2013	39
23485521	Cholesterol	Bernstein DL	Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease.	Journal of hepatology	2013	47
23583734	Cholesterol	Hirschfield GM	The genetics of complex cholestatic disorders.	Gastroenterology	2013	29
23584084	Cholesterol	Klop B	Dyslipidemia in obesity: mechanisms and potential targets.	Nutrients	2013	93
23690465	Cholesterol	Tavori H	Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.	Circulation	2013	42
23727030	Cholesterol	Yamada H	Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.	Clinica chimica acta; international journal of clinical chemistry	2013	41
23746901	Cholesterol	Yang G	Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010.	Lancet	2013	276
23782937	Cholesterol	Yu XH	Foam cells in atherosclerosis.	Clinica chimica acta; international journal of clinical chemistry	2013	55
23885072	Cholesterol	Paul D	Morphological and biochemical characterization of the membranous hepatitis C virus replication compartment.	Journal of virology	2013	70
23959186	Cholesterol	Spann NJ	Sterols and oxysterols in immune cell function.	Nature immunology	2013	44
23973703	Cholesterol	Urban D	Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.	Journal of the American College of Cardiology	2013	37
23981342	Cholesterol	Shen Y	Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease.	Cardiovascular diabetology	2013	26
24097125	Cholesterol	Park S	The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	21
24162852	Cholesterol	Neculai D	Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36.	Nature	2013	49
24401224	Cholesterol	Tardy C	CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.	Atherosclerosis	2014	20
24506872	Cholesterol	Gustafsen C	The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion.	Cell metabolism	2014	33
24603306	Cholesterol	Miranda MX	The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.	European heart journal	2015	19
24625727	Cholesterol	Seidah NG	PCSK9: a key modulator of cardiovascular health.	Circulation research	2014	57
24664998	Cholesterol	Vance JE	Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin.	Journal of lipid research	2014	24
24692351	Cholesterol	Mullur R	Thyroid hormone regulation of metabolism.	Physiological reviews	2014	99
24936472	Cholesterol	Maetzel D	Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells.	Stem cell reports	2014	45
25306266	Cholesterol	Nabavi S	Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease.	Journal of dairy science	2014	21
25341796	Cholesterol	Roche-Molina M	Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.	Arteriosclerosis, thrombosis, and vascular biology	2015	22
25425283	Cholesterol	Vanier MT	Complex lipid trafficking in Niemann-Pick disease type C.	Journal of inherited metabolic disease	2015	33
25524771	Cholesterol	Meiler S	MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2015	19
25754609	Cholesterol	Berbée JF	Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development.	Nature communications	2015	39
25756439	Cholesterol	Besseling J	Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus.	JAMA	2015	28
26085104	Cholesterol	Butkinaree C	Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other.	The Journal of biological chemistry	2015	16
26099511	Cholesterol	Zhang XL	Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials.	BMC medicine	2015	31
26296894	Cholesterol	Kiyotake R	Human Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses.	The Journal of biological chemistry	2015	20
26333678	Cholesterol	Giunzioni I	Local effects of human PCSK9 on the atherosclerotic lesion.	The Journal of pathology	2016	14
26501192	Cholesterol	Wagschal A	Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis.	Nature medicine	2015	36
26556368	Cholesterol	Yki-Järvinen H	Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.	Nutrients	2015	16
26662987	Cholesterol	Novák J	Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis.	Advances in experimental medicine and biology	2015	22
26663205	Cholesterol	Lan X	A novel long noncoding RNA Lnc-HC binds hnRNPA2B1 to regulate expressions of Cyp7a1 and Abca1 in hepatocytic cholesterol metabolism.	Hepatology	2016	13
26892966	Cholesterol	Sorci-Thomas MG	Microdomains, Inflammation, and Atherosclerosis.	Circulation research	2016	18
27009502	Cholesterol	Vienberg S	MicroRNAs in metabolism.	Acta physiologica	2017	20
27077736	Cholesterol	Salvoza NC	Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.	PloS one	2016	12
27540175	Cholesterol	Franzén O	Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases.	Science	2016	25
27592805	Cholesterol	Kaufman HL	Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.	The Lancet. Oncology	2016	81
27986651	Cholesterol	Reyes-Soffer G	Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.	Circulation	2017	12
28057795	Cholesterol	Oesterle A	Pleiotropic Effects of Statins on the Cardiovascular System.	Circulation research	2017	15
28167322	Cholesterol	Mridha AR	NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.	Journal of hepatology	2017	12
28585217	Cholesterol	Engin A	Obesity-associated Breast Cancer: Analysis of risk factors.	Advances in experimental medicine and biology	2017	7
12512033	Creatinine	Wiesner R	Model for end-stage liver disease (MELD) and allocation of donor livers.	Gastroenterology	2003	259
12709468	Creatinine	Imai Y	Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome.	JAMA	2003	106
18094680	Creatinine	Portilla D	Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery.	Kidney international	2008	82
19536068	Creatinine	Tzvetkov MV	The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.	Clinical pharmacology and therapeutics	2009	50
21252674	Creatinine	Devarajan P	Biomarkers for the early detection of acute kidney injury.	Current opinion in pediatrics	2011	56
21527524	Creatinine	Galesloot TE	Serum hepcidin: reference ranges and biochemical correlates in the general population.	Blood	2011	50
22093507	Creatinine	Krawczeski CD	Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass.	Journal of the American College of Cardiology	2011	55
22240130	Creatinine	Nickolas TL	Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study.	Journal of the American College of Cardiology	2012	75
22278680	Creatinine	Sancho-Bru P	Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis.	Hepatology	2012	44
22311920	Creatinine	Ferguson MA	Established and emerging markers of kidney function.	Clinical chemistry	2012	30
23115326	Creatinine	Vanmassenhove J	Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature.	Nephrology, dialysis, transplantation 	2013	67
23273292	Creatinine	Metra M	Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.	Journal of the American College of Cardiology	2013	63
23599408	Creatinine	Parikh CR	Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.	Clinical journal of the American Society of Nephrology 	2013	57
23689653	Creatinine	McCullough PA	Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference.	Contributions to nephrology	2013	36
24375576	Creatinine	Belcher JM	Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.	Hepatology	2014	37
25316431	Creatinine	Fufaa GD	Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.	Diabetologia	2015	21
25882434	Creatinine	Basu RK	Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study.	BMC nephrology	2015	17
26399868	Creatinine	Müller MJ	Metabolic adaptation to caloric restriction and subsequent refeeding: the Minnesota Starvation Experiment revisited.	The American journal of clinical nutrition	2015	23
27339817	Creatinine	Leung JC	Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients.	Hepatology	2017	9
27474473	Creatinine	Schrezenmeier EV	Biomarkers in acute kidney injury - pathophysiological basis and clinical performance.	Acta physiologica	2017	8
28076311	Creatinine	Kashani K	Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption.	Clinical chemistry and laboratory medicine	2017	8
10225972	Triglycerides	Raabe M	Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice.	The Journal of clinical investigation	1999	100
11481335	Triglycerides	Cases S	Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members.	The Journal of biological chemistry	2001	155
11818366	Triglycerides	Perlemuter G	Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis.	FASEB journal 	2002	133
11856796	Triglycerides	Oral EA	Leptin-replacement therapy for lipodystrophy.	The New England journal of medicine	2002	203
11967537	Triglycerides	Agarwal AK	AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.	Nature genetics	2002	104
12401889	Triglycerides	Attie AD	Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia.	Journal of lipid research	2002	83
12668986	Triglycerides	Musso G	Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis.	Hepatology	2003	121
14976145	Triglycerides	Fu L	Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.	Endocrinology	2004	134
15842581	Triglycerides	Huang MA	One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.	The American journal of gastroenterology	2005	83
15983199	Triglycerides	Javor ED	Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.	Diabetes	2005	65
16081640	Triglycerides	Köster A	Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.	Endocrinology	2005	111
16150821	Triglycerides	Lake AC	Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members.	Journal of lipid research	2005	75
16182514	Triglycerides	Carmen GY	Signalling mechanisms regulating lipolysis.	Cellular signalling	2006	87
16611275	Triglycerides	Capanni M	Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.	Alimentary pharmacology & therapeutics	2006	77
17680645	Triglycerides	Joshi-Barve S	Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes.	Hepatology	2007	65
18193044	Triglycerides	Kathiresan S	Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.	Nature genetics	2008	496
18384521	Triglycerides	Leite NC	Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.	Liver international 	2009	88
18399797	Triglycerides	Ooi EM	Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.	Clinical science	2008	62
18421281	Triglycerides	Larson-Meyer DE	Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.	Obesity	2008	54
18556336	Triglycerides	Vaxillaire M	The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.	Diabetes	2008	55
18678614	Triglycerides	Orho-Melander M	Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.	Diabetes	2008	97
19060906	Triglycerides	Kathiresan S	Common variants at 30 loci contribute to polygenic dyslipidemia.	Nature genetics	2009	487
19336658	Triglycerides	Takeuchi K	Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis.	American journal of physiology. Endocrinology and metabolism	2009	89
19706383	Triglycerides	Fabbrini E	Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.	Proceedings of the National Academy of Sciences of the United States of America	2009	223
19948243	Triglycerides	Unger RH	Lipid homeostasis, lipotoxicity and the metabolic syndrome.	Biochimica et biophysica acta	2010	136
19958841	Triglycerides	Muoio DM	Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused?	Biochimica et biophysica acta	2010	49
20034933	Triglycerides	He S	A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis.	The Journal of biological chemistry	2010	140
20335584	Triglycerides	Petersen KF	Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.	The New England journal of medicine	2010	98
20368524	Triglycerides	Zheng C	Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.	Circulation	2010	57
20648472	Triglycerides	Speliotes EK	PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.	Hepatology	2010	77
20675007	Triglycerides	Li H	Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.	Journal of hepatology	2010	69
20816089	Triglycerides	Kim HS	Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis.	Cell metabolism	2010	128
20888482	Triglycerides	Reynolds R	Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration.	Ophthalmology	2010	43
21068004	Triglycerides	Basantani MK	Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome.	Journal of lipid research	2011	55
21407177	Triglycerides	Zhang K	The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis.	The EMBO journal	2011	88
21515403	Triglycerides	Pérez E	Modulation of RXR function through ligand design.	Biochimica et biophysica acta	2012	50
21700865	Triglycerides	Cohen JC	Human fatty liver disease: old questions and new insights.	Science	2011	488
21803291	Triglycerides	Pihlajamäki J	Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis.	Cell metabolism	2011	38
21846782	Triglycerides	Wong VW	Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.	Gut	2012	68
22056763	Triglycerides	Tailleux A	Roles of PPARs in NAFLD: potential therapeutic targets.	Biochimica et biophysica acta	2012	52
22063269	Triglycerides	Mattijssen F	Regulation of triglyceride metabolism by Angiopoietin-like proteins.	Biochimica et biophysica acta	2012	40
22105854	Triglycerides	Santoro N	Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents.	Hepatology	2012	30
22213436	Triglycerides	Sullivan S	Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease.	Hepatology	2012	37
22302940	Triglycerides	Hugo SE	A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting.	Genes & development	2012	34
22328022	Triglycerides	Eguchi Y	Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.	Journal of gastroenterology	2012	38
22466652	Triglycerides	Ai D	Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice.	The Journal of clinical investigation	2012	35
22809513	Triglycerides	Zhang R	Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels.	Biochemical and biophysical research communications	2012	71
22952180	Triglycerides	Sevastianova K	Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans.	The American journal of clinical nutrition	2012	40
23150577	Triglycerides	Quagliarini F	Atypical angiopoietin-like protein that regulates ANGPTL3.	Proceedings of the National Academy of Sciences of the United States of America	2012	83
23396737	Triglycerides	Wong VW	Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study.	Annals of hepatology	2013	43
23535911	Triglycerides	Kitamoto T	Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.	Human genetics	2013	39
23542898	Triglycerides	Graham MJ	Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.	Circulation research	2013	54
23665283	Triglycerides	Zhang HJ	Irisin is inversely associated with intrahepatic triglyceride contents in obese adults.	Journal of hepatology	2013	35
24369119	Triglycerides	Pingitore P	Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function.	Biochimica et biophysica acta	2014	23
24390345	Triglycerides	SIGMA Type 2 Diabetes Consortium.	Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico.	Nature	2014	84
24511104	Triglycerides	Ruhanen H	PNPLA3 mediates hepatocyte triacylglycerol remodeling.	Journal of lipid research	2014	23
24721265	Triglycerides	Kersten S	Physiological regulation of lipoprotein lipase.	Biochimica et biophysica acta	2014	54
24927523	Triglycerides	Mahdessian H	TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content.	Proceedings of the National Academy of Sciences of the United States of America	2014	44
24941081	Triglycerides	TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute.	Loss-of-function mutations in APOC3, triglycerides, and coronary disease.	The New England journal of medicine	2014	182
24941082	Triglycerides	Jørgensen AB	Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.	The New England journal of medicine	2014	132
25038053	Triglycerides	Goedeke L	Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice.	EMBO molecular medicine	2014	35
25111690	Triglycerides	Choi YJ	Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes.	Laboratory investigation; a journal of technical methods and pathology	2014	25
25125366	Triglycerides	Xu X	Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis.	Hepatology	2015	21
25145475	Triglycerides	Maximos M	The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.	Hepatology	2015	20
25457209	Triglycerides	Zhou Y	Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.	Journal of hepatology	2015	16
25885947	Triglycerides	Portillo-Sanchez P	High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.	The Journal of clinical endocrinology and metabolism	2015	27
25893821	Triglycerides	Grandone A	TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children.	Pediatric obesity	2016	11
26100857	Triglycerides	Xu Y	A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism.	Nature communications	2015	21
26215532	Triglycerides	Wei JL	Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.	The American journal of gastroenterology	2015	19
26239609	Triglycerides	Patni N	Congenital generalized lipodystrophies--new insights into metabolic dysfunction.	Nature reviews. Endocrinology	2015	22
26853749	Triglycerides	Schlein C	FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues.	Cell metabolism	2016	18
26858343	Triglycerides	Wieser V	Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors.	Gut	2017	9
27411590	Triglycerides	Gomes AL	Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma.	Cancer cell	2016	13
8900274	Fatty Acids	Devchand PR	The PPARalpha-leukotriene B4 pathway to inflammation control.	Nature	1996	204
12021254	Fatty Acids	Hajri T	Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice.	The Journal of clinical investigation	2002	87
12242452	Fatty Acids	Frayn KN	Adipose tissue as a buffer for daily lipid flux.	Diabetologia	2002	103
12663460	Fatty Acids	Savage DB	Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma.	Diabetes	2003	80
12959938	Fatty Acids	Kelley DE	Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.	American journal of physiology. Endocrinology and metabolism	2003	76
14676196	Fatty Acids	Schoch GA	Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site.	The Journal of biological chemistry	2004	74
14679176	Fatty Acids	Weisberg SP	Obesity is associated with macrophage accumulation in adipose tissue.	The Journal of clinical investigation	2003	2083
14960743	Fatty Acids	Petersen KF	Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.	The New England journal of medicine	2004	490
15592481	Fatty Acids	Heilbronn L	Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus.	International journal of obesity and related metabolic disorders 	2004	92
16011470	Fatty Acids	Sampath H	Polyunsaturated fatty acid regulation of genes of lipid metabolism.	Annual review of nutrition	2005	96
16226238	Fatty Acids	Schlame M	Molecular symmetry in mitochondrial cardiolipins.	Chemistry and physics of lipids	2005	90
16251601	Fatty Acids	Jump DB	Fatty acid regulation of hepatic gene transcription.	The Journal of nutrition	2005	83
16424607	Fatty Acids	Chmurzyńska A	The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism.	Journal of applied genetics	2006	107
16492686	Fatty Acids	Wei Y	Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells.	American journal of physiology. Endocrinology and metabolism	2006	206
16603729	Fatty Acids	Reddy JK	Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.	American journal of physiology. Gastrointestinal and liver physiology	2006	177
16709632	Fatty Acids	Daval M	Functions of AMP-activated protein kinase in adipose tissue.	The Journal of physiology	2006	68
16912127	Fatty Acids	Burgert TS	Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.	The Journal of clinical endocrinology and metabolism	2006	79
16936205	Fatty Acids	Yoon MJ	Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha.	Diabetes	2006	99
16968800	Fatty Acids	Utzschneider KM	Review: The role of insulin resistance in nonalcoholic fatty liver disease.	The Journal of clinical endocrinology and metabolism	2006	103
17130488	Fatty Acids	Wolins NE	OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization.	Diabetes	2006	103
17684197	Fatty Acids	Zivkovic AM	Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease.	The American journal of clinical nutrition	2007	82
17704301	Fatty Acids	Westerbacka J	Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.	Diabetes	2007	80
18242210	Fatty Acids	Fabbrini E	Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.	Gastroenterology	2008	104
18360697	Fatty Acids	Kohjima M	SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.	International journal of molecular medicine	2008	68
18400702	Fatty Acids	Chong MF	Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding.	The American journal of clinical nutrition	2008	50
18430557	Fatty Acids	Gentile CL	The role of fatty acids in the development and progression of nonalcoholic fatty liver disease.	The Journal of nutritional biochemistry	2008	54
18433732	Fatty Acids	Hardwick JP	Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases.	Biochemical pharmacology	2008	65
18434349	Fatty Acids	Macfarlane DP	Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome.	The Journal of endocrinology	2008	71
18565848	Fatty Acids	Adiels M	Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.	Arteriosclerosis, thrombosis, and vascular biology	2008	135
18775919	Fatty Acids	Hajer GR	Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.	European heart journal	2008	242
18830996	Fatty Acids	Yang W	Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production.	Hepatology	2008	55
18952573	Fatty Acids	Zechner R	Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores.	Journal of lipid research	2009	147
18987271	Fatty Acids	Jensen MD	Role of body fat distribution and the metabolic complications of obesity.	The Journal of clinical endocrinology and metabolism	2008	129
19050312	Fatty Acids	Ginsberg HN	The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism.	Journal of lipid research	2009	52
19072831	Fatty Acids	Vinciguerra M	Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes.	Hepatology	2009	53
19119140	Fatty Acids	Li ZZ	Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.	The Journal of biological chemistry	2009	112
19421860	Fatty Acids	Kusminski CM	Diabetes and apoptosis: lipotoxicity.	Apoptosis 	2009	71
19483103	Fatty Acids	Waxman DJ	Sex differences in the expression of hepatic drug metabolizing enzymes.	Molecular pharmacology	2009	136
19694967	Fatty Acids	Schreurs M	Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.	Obesity reviews 	2010	50
19723556	Fatty Acids	Galic S	Adipose tissue as an endocrine organ.	Molecular and cellular endocrinology	2010	309
19803417	Fatty Acids	Eklund CM	Proinflammatory cytokines in CRP baseline regulation.	Advances in clinical chemistry	2009	51
19805739	Fatty Acids	Brooks GA	Cell-cell and intracellular lactate shuttles.	The Journal of physiology	2009	122
20167786	Fatty Acids	Zhao S	Regulation of cellular metabolism by protein lysine acetylation.	Science	2010	554
20303349	Fatty Acids	Lee JH	A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis.	Gastroenterology	2010	51
20370677	Fatty Acids	Bugianesi E	Insulin resistance in nonalcoholic fatty liver disease.	Current pharmaceutical design	2010	55
20538623	Fatty Acids	Yang X	Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver.	Genome research	2010	72
20556549	Fatty Acids	Cusi K	The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes.	Current diabetes reports	2010	79
20668154	Fatty Acids	D'Adamo E	Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.	Diabetes care	2010	52
20936127	Fatty Acids	Rakhshandehroo M	Peroxisome proliferator-activated receptor alpha target genes.	PPAR research	2010	127
20978091	Fatty Acids	Schauer IE	Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.	Diabetes	2011	56
21029304	Fatty Acids	Ferré P	Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.	Diabetes, obesity & metabolism	2010	94
21042023	Fatty Acids	Wree A	Obesity affects the liver - the link between adipocytes and hepatocytes.	Digestion	2011	45
21145849	Fatty Acids	Begriche K	Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.	Journal of hepatology	2011	48
21270117	Fatty Acids	Miquilena-Colina ME	Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.	Gut	2011	68
21514287	Fatty Acids	Koek GH	The role of oxidative stress in non-alcoholic steatohepatitis.	Clinica chimica acta; international journal of clinical chemistry	2011	64
21551454	Fatty Acids	Cui X	Seipin ablation in mice results in severe generalized lipodystrophy.	Human molecular genetics	2011	41
21664213	Fatty Acids	Aubert J	Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.	Clinics and research in hepatology and gastroenterology	2011	51
21734787	Fatty Acids	Buechler C	Adiponectin, a key adipokine in obesity related liver diseases.	World journal of gastroenterology	2011	51
21745271	Fatty Acids	Svegliati-Baroni G	Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.	Liver international 	2011	64
21979150	Fatty Acids	Kazantzis M	Fatty acid transport proteins, implications in physiology and disease.	Biochimica et biophysica acta	2012	51
21985374	Fatty Acids	Tang Y	Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.	Clinical and experimental immunology	2011	47
22009142	Fatty Acids	Jensen-Urstad AP	Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?	Biochimica et biophysica acta	2012	34
22162139	Fatty Acids	Halestrap AP	The monocarboxylate transporter family--role and regulation.	IUBMB life	2012	103
22200617	Fatty Acids	Harwood HJ Jr	The adipocyte as an endocrine organ in the regulation of metabolic homeostasis.	Neuropharmacology	2012	51
22230555	Fatty Acids	Fanali G	Human serum albumin: from bench to bedside.	Molecular aspects of medicine	2012	104
22326434	Fatty Acids	Cusi K	Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.	Gastroenterology	2012	130
22450341	Fatty Acids	Shehzad A	Adiponectin: regulation of its production and its role in human diseases.	Hormones	2012	46
22704720	Fatty Acids	Wahli W	PPARs at the crossroads of lipid signaling and inflammation.	Trends in endocrinology and metabolism	2012	105
22749135	Fatty Acids	Lottenberg AM	The role of dietary fatty acids in the pathology of metabolic syndrome.	The Journal of nutritional biochemistry	2012	36
22753171	Fatty Acids	Matsuzaka T	Elovl6 promotes nonalcoholic steatohepatitis.	Hepatology	2012	37
22886304	Fatty Acids	Carracedo A	A metabolic prosurvival role for PML in breast cancer.	The Journal of clinical investigation	2012	65
22984005	Fatty Acids	Kihara A	Very long-chain fatty acids: elongation, physiology and related disorders.	Journal of biochemistry	2012	58
23023705	Fatty Acids	Li JZ	Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.	The Journal of clinical investigation	2012	52
23547260	Fatty Acids	Goedeke L	A regulatory role for microRNA 33* in controlling lipid metabolism gene expression.	Molecular and cellular biology	2013	44
23550081	Fatty Acids	Hocking S	Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots.	Endocrine reviews	2013	33
23749645	Fatty Acids	Muir K	Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma.	Cancer research	2013	39
23781214	Fatty Acids	Kwon H	Adipokines mediate inflammation and insulin resistance.	Frontiers in endocrinology	2013	73
23792151	Fatty Acids	Hijmans BS	Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences.	Biochimie	2014	32
23839524	Fatty Acids	Villarroya J	An endocrine role for brown adipose tissue?	American journal of physiology. Endocrinology and metabolism	2013	37
23855294	Fatty Acids	Roh YS	Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.	Journal of gastroenterology and hepatology	2013	55
24125941	Fatty Acids	Yamashita A	Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms.	Progress in lipid research	2014	29
24187406	Fatty Acids	Jialal I	Toll-like receptor status in obesity and metabolic syndrome: a translational perspective.	The Journal of clinical endocrinology and metabolism	2014	30
24206663	Fatty Acids	Rong X	LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition.	Cell metabolism	2013	60
24297848	Fatty Acids	Kurdiova T	Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies.	The Journal of physiology	2014	50
24316260	Fatty Acids	Lambert JE	Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.	Gastroenterology	2014	78
24362249	Fatty Acids	Nakamura MT	Regulation of energy metabolism by long-chain fatty acids.	Progress in lipid research	2014	80
24500438	Fatty Acids	Thumser AE	Fatty acid binding proteins: tissue-specific functions in health and disease.	Current opinion in clinical nutrition and metabolic care	2014	20
24670948	Fatty Acids	Shao M	Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARα axis signalling.	Nature communications	2014	24
24692138	Fatty Acids	Rui L	Energy metabolism in the liver.	Comprehensive Physiology	2014	103
24837835	Fatty Acids	Nassir F	Role of mitochondria in nonalcoholic fatty liver disease.	International journal of molecular sciences	2014	27
24848981	Fatty Acids	Albert JS	Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes.	The New England journal of medicine	2014	30
25083607	Fatty Acids	Fisher FM	Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.	Gastroenterology	2014	37
25242319	Fatty Acids	Huang	HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression.	Cell reports	2014	39
25458898	Fatty Acids	Gajda AM	Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine.	Prostaglandins, leukotrienes, and essential fatty acids	2015	15
25961460	Fatty Acids	Fu X	MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.	The Journal of clinical investigation	2015	24
26170839	Fatty Acids	Papaetis GS	Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.	Archives of medical science 	2015	16
26355033	Fatty Acids	Boden G	Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men.	Science translational medicine	2015	15
26415887	Fatty Acids	Sears B	The role of fatty acids in insulin resistance.	Lipids in health and disease	2015	24
26488817	Fatty Acids	Haghikia A	Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.	Immunity	2015	52
26619117	Fatty Acids	Denechaud PD	E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis.	The Journal of clinical investigation	2016	13
26724859	Fatty Acids	Chen CL	NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.	Cell metabolism	2016	15
27188459	Fatty Acids	Brunt EM	Nonalcoholic fatty liver disease.	Nature reviews. Disease primers	2015	24
27264722	Fatty Acids	Cao D	Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells.	Liver international 	2017	7
27908782	Fatty Acids	Raefsky SM	Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.	Free radical biology & medicine	2017	16
28041958	Fatty Acids	Oishi Y	SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism.	Cell metabolism	2017	13
28132808	Fatty Acids	Maus M	Store-Operated Ca2+ Entry Controls Induction of Lipolysis and the Transcriptional Reprogramming to Lipid Metabolism.	Cell metabolism	2017	10
28267621	Fatty Acids	Tacke F	Targeting hepatic macrophages to treat liver diseases.	Journal of hepatology	2017	23
15639293	Antiviral Agents	Janssen HL	Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial.	Lancet	2005	165
15737993	Antiviral Agents	Li K	Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes.	The Journal of biological chemistry	2005	118
15765399	Antiviral Agents	Romero-Gómez M	Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.	Gastroenterology	2005	124
16107837	Antiviral Agents	Feld JJ	Mechanism of action of interferon and ribavirin in treatment of hepatitis C.	Nature	2005	240
16108059	Antiviral Agents	Helbig KJ	Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector.	Hepatology	2005	79
16299039	Antiviral Agents	Walsh MJ	Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1.	Gut	2006	65
16495264	Antiviral Agents	Malcolm BA	SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells.	Antimicrobial agents and chemotherapy	2006	66
16501110	Antiviral Agents	Kash JC	Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence.	Journal of virology	2006	74
16611910	Antiviral Agents	Ank N	Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.	Journal of virology	2006	172
17087946	Antiviral Agents	Marcello T	Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.	Gastroenterology	2006	196
17101330	Antiviral Agents	Randall G	Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection.	Gastroenterology	2006	60
19933795	Antiviral Agents	Hopkins S	SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro.	Antimicrobial agents and chemotherapy	2010	43
20683951	Antiviral Agents	Asahina Y	Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection.	Hepatology	2010	48
20685314	Antiviral Agents	Fofana I	Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.	Gastroenterology	2010	55
21146244	Antiviral Agents	Zeisel MB	Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.	Journal of hepatology	2011	55
21199525	Antiviral Agents	Yuen MF	Treatment of chronic hepatitis B: Evolution over two decades.	Journal of gastroenterology and hepatology	2011	44
21423260	Antiviral Agents	Kwon H	Hepatitis B therapy.	Nature reviews. Gastroenterology & hepatology	2011	71
21440548	Antiviral Agents	Abu Dayyeh BK	A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.	Gastroenterology	2011	43
21480318	Antiviral Agents	Bitetto D	Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.	Hepatology	2011	41
21488075	Antiviral Agents	Trépo E	Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.	Hepatology	2011	55
21793032	Antiviral Agents	Gal-Tanamy M	Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.	Hepatology	2011	37
22248663	Antiviral Agents	Thomas E	HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.	Gastroenterology	2012	103
22806323	Antiviral Agents	Lai CL	Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy.	Hepatology	2013	41
22878466	Antiviral Agents	Schaefer M	Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.	Journal of hepatology	2012	38
22996292	Antiviral Agents	Wilkins C	IFITM1 is a tight junction protein that inhibits hepatitis C virus entry.	Hepatology	2013	59
23103614	Antiviral Agents	Li F	Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice.	Gastroenterology	2013	27
23337478	Antiviral Agents	Singal AG	Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?	The American journal of gastroenterology	2013	38
23466307	Antiviral Agents	Sangro B	A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.	Journal of hepatology	2013	98
24102757	Antiviral Agents	Saab S	Impact of coffee on liver diseases: a systematic review.	Liver international 	2014	22
24107395	Antiviral Agents	Gordon SC	Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.	Clinical gastroenterology and hepatology 	2014	29
24269472	Antiviral Agents	Younossi ZM	Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients.	Journal of hepatology	2014	34
24557582	Antiviral Agents	Watashi K	NTCP and beyond: opening the door to unveil hepatitis B virus entry.	International journal of molecular sciences	2014	22
24557838	Antiviral Agents	Lucifora J	Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.	Science	2014	152
24615378	Antiviral Agents	Cho JY	Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.	Gut	2014	25
24848265	Antiviral Agents	Xiao F	Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.	Gut	2015	22
24983321	Antiviral Agents	Meissner EG	Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.	The Journal of clinical investigation	2014	37
25048716	Antiviral Agents	Rehermann B	Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.	Hepatology	2015	32
25559326	Antiviral Agents	Menne S	Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.	Journal of hepatology	2015	22
25581573	Antiviral Agents	Coppola N	TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.	Liver international 	2015	15
25754160	Antiviral Agents	Serti E	Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.	Gastroenterology	2015	30
26446606	Antiviral Agents	Tao X	Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease.	Journal of virology	2016	16
28288626	Antiviral Agents	Baumert TF	Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.	BMC medicine	2017	6
12028371	Fatty Acids, Nonesterified	Boden G	Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.	European journal of clinical investigation	2002	220
12406438	Fatty Acids, Nonesterified	Day CP	Pathogenesis of steatohepatitis.	Best practice & research. Clinical gastroenterology	2002	90
15239102	Fatty Acids, Nonesterified	Feldstein AE	Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway.	Hepatology	2004	162
16932311	Fatty Acids, Nonesterified	Roden M	Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.	Nature clinical practice. Endocrinology & metabolism	2006	76
17285001	Fatty Acids, Nonesterified	Delarue J	Free fatty acids and insulin resistance.	Current opinion in clinical nutrition and metabolic care	2007	87
17470478	Fatty Acids, Nonesterified	Malhi H	Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity.	Gut	2007	79
17605313	Fatty Acids, Nonesterified	Holland WL	Lipid mediators of insulin resistance.	Nutrition reviews	2007	75
18196982	Fatty Acids, Nonesterified	Stanhope KL	Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance.	Current opinion in lipidology	2008	62
18474251	Fatty Acids, Nonesterified	Kotronen A	Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.	Gastroenterology	2008	56
18956292	Fatty Acids, Nonesterified	Malhi H	Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease.	Seminars in liver disease	2008	141
19637289	Fatty Acids, Nonesterified	Johnson NA	Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.	Hepatology	2009	93
19780876	Fatty Acids, Nonesterified	Zheng L	Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD.	Journal of gastroenterology and hepatology	2010	41
20371664	Fatty Acids, Nonesterified	Donga E	A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects.	The Journal of clinical endocrinology and metabolism	2010	79
21841783	Fatty Acids, Nonesterified	Ohtsubo K	Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.	Nature medicine	2011	39
22041134	Fatty Acids, Nonesterified	Shearer GC	Fish oil -- how does it reduce plasma triglycerides?	Biochimica et biophysica acta	2012	38
23666091	Fatty Acids, Nonesterified	Gaggini M	Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.	Nutrients	2013	86
23855299	Fatty Acids, Nonesterified	Schuppan D	Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.	Journal of gastroenterology and hepatology	2013	56
26424075	Fatty Acids, Nonesterified	Nath A	Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.	Scientific reports	2015	20
26622051	Fatty Acids, Nonesterified	Dhindsa S	Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.	Diabetes care	2016	16
26650570	Fatty Acids, Nonesterified	Wilson CG	Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.	Endocrinology	2016	17
26780287	Fatty Acids, Nonesterified	Luukkonen PK	Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.	Journal of hepatology	2016	20
27799461	Fatty Acids, Nonesterified	Wolf Greenstein A	Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.	The Journal of endocrinology	2017	5
28323973	Fatty Acids, Nonesterified	Søndergaard E	How to Measure Adipose Tissue Insulin Sensitivity.	The Journal of clinical endocrinology and metabolism	2017	5
10856709	Carnitine	Kerner J	Fatty acid import into mitochondria.	Biochimica et biophysica acta	2000	90
14512887	Carnitine	Pérez-Carreras M	Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.	Hepatology	2003	111
15363638	Carnitine	Bonnefont JP	Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.	Molecular aspects of medicine	2004	91
16602102	Carnitine	Longo N	Disorders of carnitine transport and the carnitine cycle.	American journal of medical genetics. Part C, Seminars in medical genetics	2006	68
19553674	Carnitine	Noland RC	Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control.	The Journal of biological chemistry	2009	93
20054868	Carnitine	Stienstra R	Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity.	Hepatology	2010	85
21826694	Carnitine	Mandrekar P	An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.	Hepatology	2011	68
25534430	Carnitine	Lake AD	Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease.	Amino acids	2015	17
15082532	Diethylnitrosamine	Kalinichenko VV	Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor.	Genes & development	2004	143
15565109	Diethylnitrosamine	Lee JS	Application of comparative functional genomics to identify best-fit mouse models to study human cancer.	Nature genetics	2004	150
21465510	Diethylnitrosamine	Park O	In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression.	Hepatology	2011	65
21575863	Diethylnitrosamine	Bard-Chapeau EA	Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.	Cancer cell	2011	87
21674558	Diethylnitrosamine	Jiang R	Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.	Hepatology	2011	64
21778049	Diethylnitrosamine	Monnier J	CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells.	European journal of cancer	2012	33
22267597	Diethylnitrosamine	Schneider C	Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.	Gut	2012	32
22473819	Diethylnitrosamine	Callegari E	Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.	Hepatology	2012	50
22898879	Diethylnitrosamine	Wu K	Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.	Hepatology	2012	45
23813475	Diethylnitrosamine	Bertran E	Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells.	Hepatology	2013	31
24582836	Diethylnitrosamine	Lau CC	Viral-human chimeric transcript predisposes risk to liver cancer development and progression.	Cancer cell	2014	50
25010260	Diethylnitrosamine	Perra A	YAP activation is an early event and a potential therapeutic target in liver cancer development.	Journal of hepatology	2014	49
25783764	Diethylnitrosamine	Zavattari P	Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis.	Hepatology	2015	17
26028023	Diethylnitrosamine	Chen CC	The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation.	Oncogene	2016	14
26933995	Diethylnitrosamine	Li C	Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels.	Oncotarget	2016	10
10573521	Acetaminophen	Theise ND	The canals of Hering and hepatic stem cells in humans.	Hepatology	1999	119
16820551	Acetaminophen	Watkins PB	Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.	JAMA	2006	81
17185352	Acetaminophen	Henderson NC	Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure.	Gut	2007	68
18046720	Acetaminophen	Zakhari S	Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease.	Hepatology	2007	82
19246379	Acetaminophen	Wang K	Circulating microRNAs, potential biomarkers for drug-induced liver injury.	Proceedings of the National Academy of Sciences of the United States of America	2009	311
19416960	Acetaminophen	Harrill AH	Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans.	Genome research	2009	57
20020268	Acetaminophen	Hinson JA	Mechanisms of acetaminophen-induced liver necrosis.	Handbook of experimental pharmacology	2010	131
21745276	Acetaminophen	Jaeschke H	Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity.	Liver international 	2012	88
22045675	Acetaminophen	Starkey Lewis PJ	Circulating microRNAs as potential markers of human drug-induced liver injury.	Hepatology	2011	127
22229890	Acetaminophen	Jaeschke H	Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity.	Drug metabolism reviews	2012	138
22266604	Acetaminophen	Antoine DJ	Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.	Journal of hepatology	2012	116
22291093	Acetaminophen	Hur KY	IRE1α activation protects mice against acetaminophen-induced hepatotoxicity.	The Journal of experimental medicine	2012	42
22334567	Acetaminophen	Antoniades CG	Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans.	Hepatology	2012	51
22378043	Acetaminophen	McGill MR	The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.	The Journal of clinical investigation	2012	139
22532075	Acetaminophen	Marques PE	Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure.	Hepatology	2012	51
23223517	Acetaminophen	Hardwick RN	Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease.	Drug metabolism and disposition	2013	25
23390034	Acetaminophen	Antoine DJ	Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.	Hepatology	2013	96
23453390	Acetaminophen	Han D	Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria.	Trends in pharmacological sciences	2013	33
23462933	Acetaminophen	McGill MR	Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis.	Pharmaceutical research	2013	70
24118944	Acetaminophen	Thulin P	Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts.	Liver international 	2014	21
24290406	Acetaminophen	Bateman DN	Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial.	Lancet	2014	21
24440789	Acetaminophen	Williams CD	Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans.	Toxicology and applied pharmacology	2014	40
24700364	Acetaminophen	Rodrigo-Torres D	The biliary epithelium gives rise to liver progenitor cells.	Hepatology	2014	38
24905542	Acetaminophen	Xie Y	Mechanisms of acetaminophen-induced cell death in primary human hepatocytes.	Toxicology and applied pharmacology	2014	48
25092309	Acetaminophen	Ward J	Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis.	Proceedings of the National Academy of Sciences of the United States of America	2014	42
25359176	Acetaminophen	Krauskopf J	Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.	Toxicological sciences 	2015	22
25568858	Acetaminophen	Krenkel O	Immune mechanisms in acetaminophen-induced acute liver failure.	Hepatobiliary surgery and nutrition	2014	21
25708609	Acetaminophen	Yang X	Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children.	Toxicology and applied pharmacology	2015	19
25724911	Acetaminophen	Bruderer R	Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues.	Molecular & cellular proteomics 	2015	39
26055245	Acetaminophen	Szabo G	Inflammasome activation and function in liver disease.	Nature reviews. Gastroenterology & hepatology	2015	51
26344055	Acetaminophen	Stutchfield BM	CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure.	Gastroenterology	2015	21
26489516	Acetaminophen	Vliegenthart AD	Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury.	Scientific reports	2015	21
26708719	Acetaminophen	Cubero FJ	Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.	Gastroenterology	2016	13
26756674	Acetaminophen	Bhise NS	A liver-on-a-chip platform with bioprinted hepatic spheroids.	Biofabrication	2016	26
27142208	Acetaminophen	Sarges P	Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.	Drug safety	2016	12
27913221	Acetaminophen	Woolbright BL	Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure.	Journal of hepatology	2017	16
3003504	Glutathione	Carlberg I	Glutathione reductase.	Methods in enzymology	1985	215
10385608	Glutathione	Lu SC	Regulation of hepatic glutathione synthesis: current concepts and controversies.	FASEB journal 	1999	121
11563810	Glutathione	Whitfield JB	Gamma glutamyl transferase.	Critical reviews in clinical laboratory sciences	2001	138
14556645	Glutathione	Videla LA	Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients.	Clinical science	2004	78
15346644	Glutathione	Lee DH	Is serum gamma glutamyltransferase a marker of oxidative stress?	Free radical research	2004	108
18158646	Glutathione	Franco R	The central role of glutathione in the pathophysiology of human diseases.	Archives of physiology and biochemistry	2007	86
18601945	Glutathione	Lu SC	Regulation of glutathione synthesis.	Molecular aspects of medicine	2009	216
18786561	Glutathione	Yuan L	Glutathione in liver diseases and hepatotoxicity.	Molecular aspects of medicine	2009	54
20032990	Glutathione	Uitto J	Pseudoxanthoma elasticum: molecular genetics and putative pathomechanisms.	The Journal of investigative dermatology	2010	54
21182908	Glutathione	Piao MJ	Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis.	Toxicology letters	2011	67
22525041	Glutathione	Crawford A	Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease.	Gene	2012	31
25793315	Glutathione	Sun L	cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions.	Cell research	2015	20
26950115	Glutathione	Zeeshan HM	Endoplasmic Reticulum Stress and Associated ROS.	International journal of molecular sciences	2016	26
27628030	Glutathione	Mehmood T	Deoxyelephantopin induces apoptosis in HepG2 cells via oxidative stress, NF-κB inhibition and mitochondrial dysfunction.	BioFactors	2017	6
3056758	Fructose	Reaven GM	Banting lecture 1988. Role of insulin resistance in human disease.	Diabetes	1988	1244
11780753	Fructose	Joost HG	The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review).	Molecular membrane biology	2001	99
12399260	Fructose	Elliott SS	Fructose, weight gain, and the insulin resistance syndrome.	The American journal of clinical nutrition	2002	180
15181085	Fructose	Teff KL	Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.	The Journal of clinical endocrinology and metabolism	2004	146
15723702	Fructose	Basciano H	Fructose, insulin resistance, and metabolic dyslipidemia.	Nutrition & metabolism	2005	138
15971409	Fructose	Havel PJ	Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism.	Nutrition reviews	2005	139
17158419	Fructose	Lê KA	A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans.	The American journal of clinical nutrition	2006	79
18327257	Fructose	Vitart V	SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout.	Nature genetics	2008	191
18395287	Fructose	Ouyang X	Fructose consumption as a risk factor for non-alcoholic fatty liver disease.	Journal of hepatology	2008	150
18641190	Fructose	Thuy S	Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.	The Journal of nutrition	2008	81
18769702	Fructose	Vos MB	Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey.	Medscape journal of medicine	2008	96
19254570	Fructose	Nagai Y	The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance.	Cell metabolism	2009	60
19381015	Fructose	Stanhope KL	Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.	The Journal of clinical investigation	2009	324
20048381	Fructose	Dong B	Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters.	Journal of lipid research	2010	48
20086073	Fructose	Tappy L	Metabolic effects of fructose and the worldwide increase in obesity.	Physiological reviews	2010	200
21957486	Fructose	Sharma S	GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.	PloS one	2011	47
22585902	Fructose	Moore MC	Regulation of hepatic glucose uptake and storage in vivo.	Advances in nutrition	2012	58
23035112	Fructose	Lanaspa MA	Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.	The Journal of biological chemistry	2012	75
23112875	Fructose	Lanaspa MA	Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.	PloS one	2012	43
23129794	Fructose	Douard V	The role of fructose transporters in diseases linked to excessive fructose intake.	The Journal of physiology	2013	27
23482247	Fructose	Basaranoglu M	Fructose as a key player in the development of fatty liver disease.	World journal of gastroenterology	2013	47
24569542	Fructose	Chiu S	Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials.	European journal of clinical nutrition	2014	34
24652725	Fructose	Bray GA	Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar.	Diabetes care	2014	62
25099546	Fructose	Chung M	Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis.	The American journal of clinical nutrition	2014	30
25111123	Fructose	Jin R	Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD.	Nutrients	2014	22
25825943	Fructose	Schwarz JM	Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.	The Journal of clinical endocrinology and metabolism	2015	25
27387598	Fructose	Herman MA	The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis.	Trends in endocrinology and metabolism	2016	17
27669460	Fructose	Kim MS	ChREBP regulates fructose-induced glucose production independently of insulin signaling.	The Journal of clinical investigation	2016	22
28123933	Fructose	Fisher FM	A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.	Molecular metabolism	2017	17
28214020	Fructose	Mosca A	Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents.	Journal of hepatology	2017	11
11289033	C-Peptide	Ryan EA	Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.	Diabetes	2001	95
14693724	C-Peptide	Palmer JP	C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.	Diabetes	2004	122
17595248	C-Peptide	Kotronen A	Liver fat in the metabolic syndrome.	The Journal of clinical endocrinology and metabolism	2007	80
17977954	C-Peptide	Taksali SE	High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype.	Diabetes	2008	76
19917848	Somatostatin	Missiaglia E	Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway.	Journal of clinical oncology 	2010	97
20664473	Somatostatin	Boudreaux JP	The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum.	Pancreas	2010	58
25698782	Somatostatin	Herrmann K	Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor.	Journal of nuclear medicine 	2015	20
10522552	Nitric Oxide	Ponka P	Cell biology of heme.	The American journal of the medical sciences	1999	112
10646872	Nitric Oxide	Jaiswal M	Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism.	Cancer research	2000	112
15690474	Nitric Oxide	Sirica AE	Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy.	Hepatology	2005	98
15728243	Nitric Oxide	Barshes NR	Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.	Journal of leukocyte biology	2005	91
17030071	Nitric Oxide	Malhi H	Cholangiocarcinoma: modern advances in understanding a deadly old disease.	Journal of hepatology	2006	69
17933965	Nitric Oxide	Palm F	Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.	American journal of physiology. Heart and circulatory physiology	2007	75
19789382	Nitric Oxide	Vollmar B	The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair.	Physiological reviews	2009	72
21951555	Nitric Oxide	Soleymaninejadian E	Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.	American journal of reproductive immunology	2012	49
22711689	Nitric Oxide	Metz P	Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.	Hepatology	2012	55
25130427	Nitric Oxide	Gu Q	Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting.	Hepatology	2014	21
26750181	Nitric Oxide	Ellulu MS	Atherosclerotic cardiovascular disease: a review of initiators and protective factors.	Inflammopharmacology	2016	13
26871664	Nitric Oxide	Ince C	THE ENDOTHELIUM IN SEPSIS.	Shock	2016	19
16289418	Oligonucleotides, Antisense	Sieghart W	Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.	Journal of hepatology	2006	62
18073344	Oligonucleotides, Antisense	Fabani MM	miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates.	RNA	2008	77
18371932	Oligonucleotides, Antisense	Hua Y	Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice.	American journal of human genetics	2008	144
21979052	Oligonucleotides, Antisense	Hua Y	Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.	Nature	2011	194
22333591	Oligonucleotides, Antisense	Cirera-Salinas D	Mir-33 regulates cell proliferation and cell cycle progression.	Cell cycle	2012	56
26282675	Oligonucleotides, Antisense	Wu H	MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.	Gut	2016	17
26538546	Oligonucleotides, Antisense	Graham MJ	Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans.	Journal of lipid research	2016	12
26582900	Oligonucleotides, Antisense	Hong D	AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.	Science translational medicine	2015	33
12764143	Phosphatidylinositols	Mottet D	Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells.	The Journal of biological chemistry	2003	87
15707893	Phosphatidylinositols	Krylova IN	Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1.	Cell	2005	139
17363567	Phosphatidylinositols	Saxena NK	Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.	Cancer research	2007	118
19208038	Phosphatidylinositols	Chen JS	Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.	Hepatology research 	2009	69
19668216	Phosphatidylinositols	Bielas SL	Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies.	Nature genetics	2009	124
21320503	Phosphatidylinositols	Ke AW	CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells.	Gastroenterology	2011	43
24703947	Phosphatidylinositols	Wang H	Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.	Molecular cell	2014	198
25475121	Phosphatidylinositols	Huang XP	MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.	The FEBS journal	2015	20
25503676	Phosphatidylinositols	Wei JX	Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells.	Hepatology	2015	25
25682869	Phosphatidylinositols	Zhu M	Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells.	Oncotarget	2015	20
26850495	Phosphatidylinositols	Mancina RM	The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.	Gastroenterology	2016	26
8008069	Sirolimus	Brown EJ	A mammalian protein targeted by G1-arresting rapamycin-receptor complex.	Nature	1994	424
15623621	Sirolimus	Sahin F	mTOR and P70 S6 kinase expression in primary liver neoplasms.	Clinical cancer research 	2004	78
17273556	Sirolimus	Le Bacquer O	Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2.	The Journal of clinical investigation	2007	97
17609423	Sirolimus	Mingozzi F	Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver.	Blood	2007	79
18184959	Sirolimus	Bissler JJ	Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.	The New England journal of medicine	2008	296
18393362	Sirolimus	Yin XM	Autophagy in the liver.	Hepatology	2008	76
18722871	Sirolimus	Curatolo P	Tuberous sclerosis.	Lancet	2008	171
19223493	Sirolimus	Yu G	Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer.	Clinical cancer research 	2009	51
20175032	Sirolimus	Hoshida Y	Molecular classification and novel targets in hepatocellular carcinoma: recent advancements.	Seminars in liver disease	2010	94
20187107	Sirolimus	Toso C	Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.	Hepatology	2010	59
20810185	Sirolimus	Rautou PE	Autophagy in liver diseases.	Journal of hepatology	2010	99
21147110	Sirolimus	Calvisi DF	Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.	Gastroenterology	2011	98
21269838	Sirolimus	Howell JJ	mTOR couples cellular nutrient sensing to organismal metabolic homeostasis.	Trends in endocrinology and metabolism	2011	113
21538343	Sirolimus	Zhu AX	Phase 1/2 study of everolimus in advanced hepatocellular carcinoma.	Cancer	2011	55
21915260	Sirolimus	Dabora SL	Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease.	PloS one	2011	48
21993994	Sirolimus	Ho C	AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways.	Hepatology	2012	55
22234835	Sirolimus	Fang Y	MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.	Hepatology	2012	103
22449814	Sirolimus	Bakan I	Connecting mTORC1 signaling to SREBP-1 activation.	Current opinion in lipidology	2012	39
22457330	Sirolimus	Menon S	Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice.	Science signaling	2012	51
22504094	Sirolimus	Chang Y	miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions.	Gastroenterology	2012	53
22983984	Sirolimus	Iwaya T	Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway.	Carcinogenesis	2012	50
22994804	Sirolimus	Akimova T	Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients.	American journal of transplantation 	2012	32
23973332	Sirolimus	Lamming DW	A Central role for mTOR in lipid homeostasis.	Cell metabolism	2013	72
24308993	Sirolimus	Matter MS	Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends.	Journal of hepatology	2014	41
24401568	Sirolimus	Liu B	Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation.	Autophagy	2014	29
24910242	Sirolimus	Umemura A	Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition.	Cell metabolism	2014	27
24943720	Sirolimus	Cholongitas E	Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review.	Transplant international 	2014	22
24947615	Sirolimus	Park HW	Hepatoprotective role of Sestrin2 against chronic ER stress.	Nature communications	2014	26
25082895	Sirolimus	Cornu M	Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
25099355	Sirolimus	Lu L	Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions.	Proceedings of the National Academy of Sciences of the United States of America	2014	33
25557953	Sirolimus	Cornella H	Unique genomic profile of fibrolamellar hepatocellular carcinoma.	Gastroenterology	2015	20
26476289	Sirolimus	Li L	Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.	Journal of hepatology	2016	12
26540343	Sirolimus	Ji J	LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway.	Oncotarget	2015	33
26788992	Sirolimus	Safinia N	Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation.	Oncotarget	2016	20
26826241	Sirolimus	Goh CC	Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.	Journal of immunology	2016	13
27597759	Sirolimus	Sargent G	PEX2 is the E3 ubiquitin ligase required for pexophagy during starvation.	The Journal of cell biology	2016	13
27671674	Sirolimus	Clark CA	Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.	Cancer research	2016	18
10385606	Antioxidants	Brigelius-Flohé R	Vitamin E: function and metabolism.	FASEB journal 	1999	154
11832451	Antioxidants	Okuda M	Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein.	Gastroenterology	2002	204
12708612	Antioxidants	Weber LW	Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model.	Critical reviews in toxicology	2003	208
15766528	Antioxidants	Kamata H	Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases.	Cell	2005	499
15842582	Antioxidants	Bugianesi E	A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.	The American journal of gastroenterology	2005	111
15985529	Antioxidants	Lee JM	Nrf2, a multi-organ protector?	FASEB journal 	2005	116
16923312	Antioxidants	Albano E	Alcohol, oxidative stress and free radical damage.	The Proceedings of the Nutrition Society	2006	97
17326724	Antioxidants	van der Pluijm I	Impaired genome maintenance suppresses the growth hormone--insulin-like growth factor 1 axis in mice with Cockayne syndrome.	PLoS biology	2007	84
17439363	Antioxidants	Traber MG	Vitamin E regulatory mechanisms.	Annual review of nutrition	2007	55
17569205	Antioxidants	Aggarwal BB	Curcumin: the Indian solid gold.	Advances in experimental medicine and biology	2007	188
17671740	Antioxidants	Kohjima M	Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.	International journal of molecular medicine	2007	76
19558212	Antioxidants	Marí M	Mitochondrial glutathione, a key survival antioxidant.	Antioxidants & redox signaling	2009	140
20231449	Antioxidants	Polyak SJ	Identification of hepatoprotective flavonolignans from silymarin.	Proceedings of the National Academy of Sciences of the United States of America	2010	52
20351271	Antioxidants	Suzuki S	Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.	Proceedings of the National Academy of Sciences of the United States of America	2010	177
20805291	Antioxidants	Hardwick RN	Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease.	Drug metabolism and disposition	2010	54
21031546	Antioxidants	Bhogal RH	Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation.	Liver transplantation 	2010	41
22226887	Antioxidants	Galli F	Oxidative stress and antioxidant therapy in cystic fibrosis.	Biochimica et biophysica acta	2012	33
22459037	Antioxidants	Jaeschke H	Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species.	Transplantation reviews	2012	53
22995213	Antioxidants	Lu SC	Glutathione synthesis.	Biochimica et biophysica acta	2013	154
23485523	Antioxidants	Hernández-Gea V	Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy.	Journal of hepatology	2013	40
23855308	Antioxidants	Tikhanovich I	Forkhead box class O transcription factors in liver function and disease.	Journal of gastroenterology and hepatology	2013	31
24928512	Antioxidants	Ge X	High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD).	The Journal of biological chemistry	2014	31
25009380	Antioxidants	Cichoż-Lach H	Oxidative stress as a crucial factor in liver diseases.	World journal of gastroenterology	2014	31
25576182	Antioxidants	Ruszkiewicz J	Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders.	Neurochemistry international	2015	19
25889822	Antioxidants	Gomez-Cabrera MC	Redox modulation of mitochondriogenesis in exercise. Does antioxidant supplementation blunt the benefits of exercise training?	Free radical biology & medicine	2015	18
25896253	Antioxidants	Shi L	MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.	Cellular physiology and biochemistry 	2015	16
26335400	Antioxidants	Richter K	Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences.	Redox biology	2015	25
26706242	Antioxidants	Peh HY	Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol.	Pharmacology & therapeutics	2016	11
14613934	Adenosine	Wang Q	Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene.	The Journal of biological chemistry	2004	137
14722619	Adenosine	Scott JW	CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.	The Journal of clinical investigation	2004	228
19240131	Adenosine	Katoh T	Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2.	Genes & development	2009	156
22033198	Adenosine	Fishman P	Pharmacological and therapeutic effects of A3 adenosine receptor agonists.	Drug discovery today	2012	54
23291631	Adenosine	Chen L	Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.	Nature medicine	2013	87
23766440	Adenosine	Chan TH	A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.	Gut	2014	35
24133372	Adenosine	Yuan H	The emerging and diverse roles of sirtuins in cancer: a clinical perspective.	OncoTargets and therapy	2013	49
24552284	Adenosine	Zhou Q	Early-onset stroke and vasculopathy associated with mutations in ADA2.	The New England journal of medicine	2014	47
27362366	Adenosine	Ben-Shoshan SO	ADAR1 deletion induces NFκB and interferon signaling dependent liver inflammation and fibrosis.	RNA biology	2017	7
15244495	Tacrolimus	Staatz CE	Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.	Clinical pharmacokinetics	2004	82
16868252	Tacrolimus	Jiang H	Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy.	Blood	2006	105
18798334	Tacrolimus	Zeremski M	Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.	Hepatology	2008	68
21237170	Tacrolimus	Washburn ML	A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.	Gastroenterology	2011	99
21804023	Tacrolimus	Hutchinson JA	Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients.	Journal of immunology	2011	48
23721554	Tacrolimus	Kaneku H	De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients.	American journal of transplantation 	2013	30
16258101	gemcitabine	Kindler HL	Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.	Journal of clinical oncology 	2005	107
18413796	gemcitabine	Melisi D	LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.	Molecular cancer therapeutics	2008	93
18509182	gemcitabine	Brunner TB	Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.	Journal of clinical oncology 	2008	51
21216939	gemcitabine	Carrasco RA	Antisense inhibition of survivin expression as a cancer therapeutic.	Molecular cancer therapeutics	2011	37
21783417	gemcitabine	Zhou C	Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.	The Lancet. Oncology	2011	839
23318457	gemcitabine	Sia D	Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies.	Oncogene	2013	49
23402814	gemcitabine	Yabuuchi S	Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer.	Cancer letters	2013	41
23983255	gemcitabine	Beatty GL	A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma.	Clinical cancer research 	2013	80
24147037	gemcitabine	Okamoto K	miR-29b, miR-205 and miR-221 enhance chemosensitivity to gemcitabine in HuH28 human cholangiocarcinoma cells.	PloS one	2013	28
24351397	gemcitabine	Valle JW	Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials.	Annals of oncology 	2014	52
24859161	gemcitabine	Li L	Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.	Gastroenterology	2014	29
25056373	gemcitabine	Koido S	Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer.	Clinical cancer research 	2014	26
26351344	gemcitabine	Hurwitz HI	Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.	Journal of clinical oncology 	2015	35
26817584	gemcitabine	Liu Y	MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.	Journal of experimental & clinical cancer research 	2016	11
27007129	gemcitabine	Ciccolini J	Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective.	Cancer chemotherapy and pharmacology	2016	14
27102149	gemcitabine	Chong DQ	The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets.	Oncotarget	2016	15
12171785	Reactive Oxygen Species	Brasier AR	Vascular inflammation and the renin-angiotensin system.	Arteriosclerosis, thrombosis, and vascular biology	2002	90
16496318	Reactive Oxygen Species	Zhan SS	Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo.	Hepatology	2006	68
17184177	Reactive Oxygen Species	Nishikawa T	Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications.	Antioxidants & redox signaling	2007	83
17567459	Reactive Oxygen Species	Pessayre D	Role of mitochondria in non-alcoholic fatty liver disease.	Journal of gastroenterology and hepatology	2007	65
17984303	Reactive Oxygen Species	Tsung A	HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling.	The Journal of experimental medicine	2007	176
18309108	Reactive Oxygen Species	Kim JA	Role of mitochondrial dysfunction in insulin resistance.	Circulation research	2008	193
18413749	Reactive Oxygen Species	Derdak Z	The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells.	Cancer research	2008	56
18635552	Reactive Oxygen Species	Szczesny B	Long patch base excision repair in mammalian mitochondrial genomes.	The Journal of biological chemistry	2008	66
18801366	Reactive Oxygen Species	Lim SO	Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.	Gastroenterology	2008	80
19236887	Reactive Oxygen Species	Liu J	Role of oxidative stress in cadmium toxicity and carcinogenesis.	Toxicology and applied pharmacology	2009	71
19398236	Reactive Oxygen Species	Mandrekar P	Signalling pathways in alcohol-induced liver inflammation.	Journal of hepatology	2009	115
19447517	Reactive Oxygen Species	Baffy G	Kupffer cells in non-alcoholic fatty liver disease: the emerging view.	Journal of hepatology	2009	107
19889935	Reactive Oxygen Species	Burdette D	Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway.	The Journal of general virology	2010	46
20019356	Reactive Oxygen Species	Klaunig JE	Oxidative stress and oxidative damage in carcinogenesis.	Toxicologic pathology	2010	171
20230822	Reactive Oxygen Species	Lin W	Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner.	Gastroenterology	2010	67
20578128	Reactive Oxygen Species	de Mochel NS	Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection.	Hepatology	2010	50
20583212	Reactive Oxygen Species	Senturk S	Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.	Hepatology	2010	53
20942471	Reactive Oxygen Species	Laleu B	First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.	Journal of medicinal chemistry	2010	75
21098019	Reactive Oxygen Species	Lin W	HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB.	The Journal of biological chemistry	2011	39
21106934	Reactive Oxygen Species	Amengual J	A mitochondrial enzyme degrades carotenoids and protects against oxidative stress.	FASEB journal 	2011	61
21350183	Reactive Oxygen Species	Chiang DJ	Obesity, diabetes mellitus, and liver fibrosis.	American journal of physiology. Gastrointestinal and liver physiology	2011	42
21386137	Reactive Oxygen Species	Ozden O	Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress.	Aging	2011	55
21931870	Reactive Oxygen Species	Ivanov AV	Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells.	PloS one	2011	42
22079466	Reactive Oxygen Species	Piao LS	CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma.	Cancer letters	2012	53
22454632	Reactive Oxygen Species	Ponugoti B	Role of forkhead transcription factors in diabetes-induced oxidative stress.	Experimental diabetes research	2012	51
22897481	Reactive Oxygen Species	Sheng SL	Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.	The FEBS journal	2012	42
22940046	Reactive Oxygen Species	Leung TM	CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.	Journal of hepatology	2013	65
23108410	Reactive Oxygen Species	Higgs MR	Hepatitis C virus-induced activation of β-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events.	Oncogene	2013	27
23688501	Reactive Oxygen Species	Sid B	Role of AMPK activation in oxidative cell damage: Implications for alcohol-induced liver disease.	Biochemical pharmacology	2013	31
23841983	Reactive Oxygen Species	Yu E	Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans.	Circulation	2013	34
24040957	Reactive Oxygen Species	Paik YH	Role of NADPH oxidases in liver fibrosis.	Antioxidants & redox signaling	2014	43
24509161	Reactive Oxygen Species	Crosas-Molist E	The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression.	Free radical biology & medicine	2014	20
24636985	Reactive Oxygen Species	Wu T	Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis.	Genes & development	2014	44
24832602	Reactive Oxygen Species	Park EJ	β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells.	Cell death & disease	2014	26
25818486	Reactive Oxygen Species	Roy K	NADPH oxidases and cancer.	Clinical science	2015	28
26099526	Reactive Oxygen Species	Xu MJ	Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.	Gastroenterology	2015	23
26222337	Reactive Oxygen Species	Lan T	Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.	PloS one	2015	26
26627594	Reactive Oxygen Species	Qian P	The Dlk1-Gtl2 Locus Preserves LT-HSC Function by Inhibiting the PI3K-mTOR Pathway to Restrict Mitochondrial Metabolism.	Cell stem cell	2016	19
26675351	Reactive Oxygen Species	Vinchi F	Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.	Blood	2016	27
26934227	Reactive Oxygen Species	Ma C	NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.	Nature	2016	37
14576474	Formaldehyde	Ordóñez NG	Application of mesothelin immunostaining in tumor diagnosis.	The American journal of surgical pathology	2003	82
18307259	Formaldehyde	Varnholt H	MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.	Hepatology	2008	132
19056857	Formaldehyde	Santini D	High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice.	The oncologist	2008	60
21145831	Formaldehyde	Gao P	Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis.	Journal of hepatology	2011	43
21303542	Formaldehyde	Deshpande V	Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma.	BMC cancer	2011	36
21594665	Formaldehyde	Razis E	Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.	Breast cancer research and treatment	2011	69
22173549	Formaldehyde	Vermaat JS	Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment.	Clinical cancer research 	2012	45
23295441	Formaldehyde	Sia D	Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.	Gastroenterology	2013	66
23320393	Formaldehyde	Rong M	Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.	BMC cancer	2013	44
24285342	Formaldehyde	He X	The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis.	International journal of molecular medicine	2014	29
24563076	Formaldehyde	Ross JS	New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.	The oncologist	2014	61
24771647	Formaldehyde	Manceau G	Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.	Clinical cancer research 	2014	23
10192396	Cholesterol, HDL	Jaye M	A novel endothelial-derived lipase that modulates HDL metabolism.	Nature genetics	1999	96
26543096	Cholesterol, HDL	Mendivil CO	Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans.	Arteriosclerosis, thrombosis, and vascular biology	2016	16
2549856	Cyclic AMP	Cohen P	The structure and regulation of protein phosphatases.	Annual review of biochemistry	1989	405
16400329	Cyclic AMP	Watanabe M	Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.	Nature	2006	409
19196246	Cyclic AMP	Richter EA	AMPK and the biochemistry of exercise: implications for human health and disease.	The Biochemical journal	2009	85
20640476	Cyclic AMP	Cantó C	AMP-activated protein kinase and its downstream transcriptional pathways.	Cellular and molecular life sciences 	2010	96
21102438	Cyclic AMP	Smith FD	AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade.	Nature cell biology	2010	57
21103974	Cyclic AMP	Keppler D	Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.	Handbook of experimental pharmacology	2011	55
21159641	Cyclic AMP	Maldonado EN	Free tubulin modulates mitochondrial membrane potential in cancer cells.	Cancer research	2010	46
21205641	Cyclic AMP	Egan DF	Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy.	Science	2011	612
21346730	Cyclic AMP	Altarejos JY	CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.	Nature reviews. Molecular cell biology	2011	233
22269949	Cyclic AMP	Chen W	Berardinelli-seip congenital lipodystrophy 2/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation.	Molecular and cellular biology	2012	31
15122762	Carbon Tetrachloride	Radaeva S	Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation.	Hepatology	2004	170
15765409	Carbon Tetrachloride	Julien B	Antifibrogenic role of the cannabinoid receptor CB2 in the liver.	Gastroenterology	2005	94
18823985	Carbon Tetrachloride	Taura K	Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.	Gastroenterology	2008	67
19399744	Carbon Tetrachloride	Tsai PC	The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis.	Liver transplantation 	2009	55
20618941	Carbon Tetrachloride	Fujii T	Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor.	BMC gastroenterology	2010	44
20625373	Carbon Tetrachloride	Marquez RT	Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.	Laboratory investigation; a journal of technical methods and pathology	2010	59
20890893	Carbon Tetrachloride	Roderburg C	Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.	Hepatology	2011	221
20978355	Carbon Tetrachloride	Berres ML	Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.	The Journal of clinical investigation	2010	46
21038415	Carbon Tetrachloride	Karlmark KR	The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.	Hepatology	2010	60
22198715	Carbon Tetrachloride	Gur C	NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis.	Gut	2012	31
23002959	Carbon Tetrachloride	Li T	Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis.	Stem cells and development	2013	102
23508104	Carbon Tetrachloride	Kim KH	Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts.	Molecular and cellular biology	2013	59
23842754	Carbon Tetrachloride	Tan Z	IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.	Journal of immunology	2013	45
24196965	Carbon Tetrachloride	Zhang Z	The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development.	The Journal of biological chemistry	2013	26
24415562	Carbon Tetrachloride	Affò S	CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis.	Gut	2014	29
24677197	Carbon Tetrachloride	Fuchs BC	Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.	Hepatology	2014	68
24728410	Carbon Tetrachloride	O'Brien AJ	Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2.	Nature medicine	2014	21
27001906	Carbon Tetrachloride	Hyun J	MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.	Nature communications	2016	20
27997988	Carbon Tetrachloride	Michalopoulos GK	Hepatostat: Liver regeneration and normal liver tissue maintenance.	Hepatology	2017	10
28378526	Carbon Tetrachloride	Li X	Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.	Journal of cellular and molecular medicine	2017	5
17135397	trichostatin A	Yoshikawa M	Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells.	Journal of the American Society of Nephrology 	2007	57
20842113	trichostatin A	Zhang J	microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.	British journal of cancer	2010	77
22419664	trichostatin A	Coulouarn C	Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma.	Cancer research	2012	46
22641068	trichostatin A	Buurman R	Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.	Gastroenterology	2012	52
23979134	trichostatin A	Yang Z	MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein.	The Journal of biological chemistry	2013	29
14578868	Immunosuppressive Agents	Watashi K	Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.	Hepatology	2003	110
17255842	Immunosuppressive Agents	Mackey AC	Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.	Journal of pediatric gastroenterology and nutrition	2007	64
20170205	Immunosuppressive Agents	Staatz CE	Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.	Clinical pharmacokinetics	2010	51
26247164	Immunosuppressive Agents	Axelrad J	Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents.	Clinical gastroenterology and hepatology 	2016	11
15319715	Fluorodeoxyglucose F18	Fernandez FG	Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).	Annals of surgery	2004	81
15851598	Fluorodeoxyglucose F18	Hofmann M	Monitoring of bone marrow cell homing into the infarcted human myocardium.	Circulation	2005	205
16883008	Fluorodeoxyglucose F18	Kang WJ	Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction.	Journal of nuclear medicine 	2006	64
17033037	Fluorodeoxyglucose F18	Khatcheressian JL	American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.	Journal of clinical oncology 	2006	122
17538171	Fluorodeoxyglucose F18	Timmers HJ	Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.	Journal of clinical oncology 	2007	61
23129741	Fluorodeoxyglucose F18	Khatcheressian JL	Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.	Journal of clinical oncology 	2013	92
24337604	Fluorodeoxyglucose F18	Mortimer JE	Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.	Journal of nuclear medicine 	2014	32
26769866	Fluorodeoxyglucose F18	Vag T	First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers.	Journal of nuclear medicine 	2016	18
10454950	Hypoglycemic Agents	DeFronzo RA	Pharmacologic therapy for type 2 diabetes mellitus.	Annals of internal medicine	1999	114
12093242	Hypoglycemic Agents	Kirpichnikov D	Metformin: an update.	Annals of internal medicine	2002	188
12829629	Hypoglycemic Agents	Iwaki M	Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors.	Diabetes	2003	137
14749265	Hypoglycemic Agents	Ferré P	The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity.	Diabetes	2004	122
15669880	Hypoglycemic Agents	Krentz AJ	Oral antidiabetic agents: current role in type 2 diabetes mellitus.	Drugs	2005	137
16860976	Hypoglycemic Agents	Vuksan V	Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.	Nutrition, metabolism, and cardiovascular diseases 	2008	52
17609683	Hypoglycemic Agents	Shu Y	Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.	Clinical pharmacology and therapeutics	2008	98
20331505	Hypoglycemic Agents	Donadon V	Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.	Liver international 	2010	63
21955459	Hypoglycemic Agents	DeFronzo RA	The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia.	Diabetes, obesity & metabolism	2012	83
22194737	Hypoglycemic Agents	Mazza A	The role of metformin in the management of NAFLD.	Experimental diabetes research	2012	37
22236411	Hypoglycemic Agents	Vilsbøll T	Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.	BMJ	2012	128
24961373	Hypoglycemic Agents	Chen L	OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.	Proceedings of the National Academy of Sciences of the United States of America	2014	33
25242225	Hypoglycemic Agents	Soccio RE	Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes.	Cell metabolism	2014	52
26577417	Hypoglycemic Agents	Buse JB	Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5.	Diabetes care	2016	12
16335928	NAD	Napper AD	Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.	Journal of medicinal chemistry	2005	94
17718403	NAD	Zakhari S	Overview: how is alcohol metabolized by the body?	Alcohol research & health 	2006	116
18550784	NAD	Chen D	Tissue-specific regulation of SIRT1 by calorie restriction.	Genes & development	2008	188
19032584	NAD	Purohit V	Molecular mechanisms of alcoholic fatty liver.	Alcoholism, clinical and experimental research	2009	74
19299583	NAD	Ramsey KM	Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis.	Science	2009	310
21345154	NAD	Schug TT	Sirtuin 1 in lipid metabolism and obesity.	Annals of medicine	2011	69
22076378	NAD	Du J	Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase.	Science	2011	256
22553202	NAD	Nin V	Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.	The Journal of biological chemistry	2012	40
22811431	NAD	Nogueiras R	Sirtuin 1 and sirtuin 3: physiological modulators of metabolism.	Physiological reviews	2012	83
23339189	NAD	Portmann S	Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo.	Molecular cancer therapeutics	2013	25
23341587	NAD	Bellet MM	Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1.	Proceedings of the National Academy of Sciences of the United States of America	2013	29
23526469	NAD	Marquardt JU	Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients.	Hepatology	2013	30
24388149	NAD	Chang HC	SIRT1 and other sirtuins in metabolism.	Trends in endocrinology and metabolism	2014	109
26215259	NAD	Garten A	Physiological and pathophysiological roles of NAMPT and NAD metabolism.	Nature reviews. Endocrinology	2015	36
20022809	docetaxel	Mitsudomi T	Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.	The Lancet. Oncology	2010	870
22454414	docetaxel	Kelly WK	Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.	Journal of clinical oncology 	2012	143
22491949	docetaxel	Hrkach J	Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.	Science translational medicine	2012	221
23200175	docetaxel	Jänne PA	Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.	The Lancet. Oncology	2013	181
23306100	docetaxel	Gravis G	Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.	The Lancet. Oncology	2013	46
23724913	docetaxel	Shaw AT	Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.	The New England journal of medicine	2013	697
24616308	docetaxel	Goldkorn A	Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.	Journal of clinical oncology 	2014	50
26617202	docetaxel	Takashima T	Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.	The Lancet. Oncology	2016	11
27506431	docetaxel	Yadav MP	177Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment.	European journal of nuclear medicine and molecular imaging	2017	9
17162245	Ursodeoxycholic Acid	Dufour JF	Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.	Clinical gastroenterology and hepatology 	2006	64
18752324	Ursodeoxycholic Acid	Corpechot C	Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.	Hepatology	2008	56
20568301	Ursodeoxycholic Acid	Lleo A	Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis.	Hepatology	2010	58
22271046	Ursodeoxycholic Acid	Corpechot C	Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.	Hepatology	2012	35
22902550	Ursodeoxycholic Acid	Castro RE	miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.	Journal of hepatology	2013	59
23246637	Ursodeoxycholic Acid	Carbone M	Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid.	Gastroenterology	2013	27
25042122	Ursodeoxycholic Acid	Wang L	CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis.	Hepatology	2015	24
25500425	Ursodeoxycholic Acid	Hirschfield GM	Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.	Gastroenterology	2015	62
25678132	Ursodeoxycholic Acid	Ghonem NS	Fibrates and cholestasis.	Hepatology	2015	17
25920087	Ursodeoxycholic Acid	Beuers U	New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond.	Journal of hepatology	2015	26
27207975	Ursodeoxycholic Acid	Sabino J	Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.	Gut	2016	18
8557660	Adenosine Monophosphate	Stapleton D	Mammalian AMP-activated protein kinase subfamily.	The Journal of biological chemistry	1996	142
14614828	Adenosine Monophosphate	Woods A	LKB1 is the upstream kinase in the AMP-activated protein kinase cascade.	Current biology 	2003	431
16621799	Adenosine Monophosphate	Wang Y	Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex.	The Journal of biological chemistry	2006	60
17021375	Adenosine Monophosphate	Ahima RS	Adipose tissue as an endocrine organ.	Obesity	2006	127
18202144	Adenosine Monophosphate	Ahima RS	Adipokines and the peripheral and neural control of energy balance.	Molecular endocrinology	2008	56
19276890	Adenosine Monophosphate	Gong J	CIDE proteins and metabolic disorders.	Current opinion in lipidology	2009	60
19416711	Adenosine Monophosphate	Zhang BB	AMPK: an emerging drug target for diabetes and the metabolic syndrome.	Cell metabolism	2009	206
20960377	Adenosine Monophosphate	Sozio MS	The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis.	Seminars in liver disease	2010	44
21567395	Adenosine Monophosphate	Lim JY	AMP-activated protein kinase inhibits TGF-β-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300.	Journal of cellular physiology	2012	33
22318606	Adenosine Monophosphate	Lin YY	Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK.	Nature	2012	38
23720287	Adenosine Monophosphate	Treyer A	Hepatocyte polarity.	Comprehensive Physiology	2013	35
24026768	Adenosine Monophosphate	Matsuda M	Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.	Reviews in endocrine & metabolic disorders	2014	20
25018645	Adenosine Monophosphate	Coughlan KA	AMPK activation: a therapeutic target for type 2 diabetes?	Diabetes, metabolic syndrome and obesity 	2014	43
19168210	Acetaldehyde	Schuckit MA	Alcohol-use disorders.	Lancet	2009	89
23872024	Acetaldehyde	Shearn CT	Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis.	Free radical biology & medicine	2013	25
25548474	Acetaldehyde	Ceni E	Pathogenesis of alcoholic liver disease: role of oxidative metabolism.	World journal of gastroenterology	2014	34
17476361	Metformin	Shu Y	Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.	The Journal of clinical investigation	2007	182
18945255	Metformin	Loomba R	Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.	Alimentary pharmacology & therapeutics	2009	54
19591196	Metformin	Nies AT	Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.	Hepatology	2009	76
21521847	Metformin	Lavine JE	Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.	JAMA	2011	172
22326465	Metformin	Baffy G	Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.	Journal of hepatology	2012	152
22355097	Metformin	Dowling RJ	Metformin in cancer: translational challenges.	Journal of molecular endocrinology	2012	77
22467080	Metformin	Bhalla K	Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis.	Cancer prevention research	2012	41
23942093	Metformin	Zheng L	Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.	Clinical cancer research 	2013	43
26571396	Metformin	Satapati S	Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.	The Journal of clinical investigation	2015	39
26780750	Metformin	McCreight LJ	Metformin and the gastrointestinal tract.	Diabetologia	2016	28
27378194	Metformin	Gadducci A	Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.	Critical reviews in oncology/hematology	2016	11
27500523	Metformin	Zhou K	Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.	Nature genetics	2016	13
28089566	Metformin	Howell JJ	Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.	Cell metabolism	2017	14
10189543	troglitazone	-	The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.	Diabetes care	1999	189
16007195	decitabine	Niwa Y	Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.	Oncogene	2005	93
16763620	decitabine	Mann J	Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis.	Cell death and differentiation	2007	64
16882708	decitabine	Kantarjian H	Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.	Blood	2007	163
17079474	decitabine	Wehbe H	Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.	Cancer research	2006	60
17241887	decitabine	Isomoto H	Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.	Gastroenterology	2007	66
17621267	decitabine	Meng F	Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes.	Oncogene	2008	85
19843643	decitabine	Furuta M	miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.	Carcinogenesis	2010	176
21625215	decitabine	Braconi C	microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer.	Oncogene	2011	175
21703189	decitabine	Alpini G	Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.	Journal of hepatology	2011	41
21747116	decitabine	Stefanska B	Definition of the landscape of promoter DNA hypomethylation in liver cancer.	Cancer research	2011	57
22689435	decitabine	Neumann O	Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.	Hepatology	2012	42
23079745	decitabine	Kim JK	Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.	Hepatology	2013	68
23369223	decitabine	Karahoca M	Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy.	Clinical epigenetics	2013	56
23703729	decitabine	Song K	Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells.	Hepatology	2013	40
15896706	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Cao Y	Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo.	Biochemical and biophysical research communications	2005	129
22610073	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Li XJ	As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signaling.	Carcinogenesis	2012	38
23643356	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Wei J	MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling.	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie	2013	32
24194905	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Chai ZT	MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.	PloS one	2013	29
15517885	resveratrol	Aggarwal BB	Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.	Anticancer research	2004	204
15832402	resveratrol	de la Lastra CA	Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications.	Molecular nutrition & food research	2005	98
17452443	resveratrol	Qiang L	Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha.	Molecular and cellular biology	2007	70
18239056	resveratrol	You M	Involvement of mammalian sirtuin 1 in the action of ethanol in the liver.	American journal of physiology. Gastrointestinal and liver physiology	2008	76
18482975	resveratrol	Hou X	SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.	The Journal of biological chemistry	2008	218
20157535	resveratrol	Armour SM	Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy.	Aging	2009	65
20181810	resveratrol	Bakker GC	An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach.	The American journal of clinical nutrition	2010	45
21261636	resveratrol	Walle T	Bioavailability of resveratrol.	Annals of the New York Academy of Sciences	2011	94
21321189	resveratrol	Li Y	Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver.	FASEB journal 	2011	83
22055504	resveratrol	Timmers S	Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans.	Cell metabolism	2011	236
23102619	resveratrol	Yoshino J	Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance.	Cell metabolism	2012	86
24023672	resveratrol	Venturelli S	Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone corrected proteins in human-derived hepatoblastoma cells.	PloS one	2013	28
24184811	resveratrol	Li Y	Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.	Gastroenterology	2014	44
24314860	resveratrol	Wang S	Novel insights of dietary polyphenols and obesity.	The Journal of nutritional biochemistry	2014	80
24582567	resveratrol	Chachay VS	Resveratrol does not benefit patients with nonalcoholic fatty liver disease.	Clinical gastroenterology and hepatology 	2014	36
24629563	resveratrol	Yang SJ	Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation.	Metabolism	2014	20
25311610	resveratrol	Faghihzadeh F	Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.	Nutrition research	2014	30
25445538	resveratrol	Szkudelski T	Resveratrol and diabetes: from animal to human studies.	Biochimica et biophysica acta	2015	24
25577300	resveratrol	Chen S	Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.	Digestive and liver disease 	2015	23
25884904	resveratrol	Ji Q	Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.	BMC cancer	2015	28
25938543	resveratrol	Dai W	By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.	Oncotarget	2015	24
26234526	resveratrol	Faghihzadeh F	The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.	The British journal of nutrition	2015	19
28075467	resveratrol	Gao F	Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway.	Oncology reports	2017	6
28146130	resveratrol	Chen Q	Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD).	Nutrients	2017	6
10595928	Paraffin	De Marzo AM	Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.	The American journal of pathology	1999	167
23391413	Paraffin	Voss JS	Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.	Human pathology	2013	41
17080197	Cholesterol, LDL	Lagace TA	Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice.	The Journal of clinical investigation	2006	133
18033751	Cholesterol, LDL	Careskey HE	Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9.	Journal of lipid research	2008	63
18039658	Cholesterol, LDL	Poirier S	The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2.	The Journal of biological chemistry	2008	82
18695239	Cholesterol, LDL	Frank-Kamenetsky M	Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates.	Proceedings of the National Academy of Sciences of the United States of America	2008	150
20525997	Cholesterol, LDL	Welder G	High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol.	Journal of lipid research	2010	46
23415864	Cholesterol, LDL	Zhang R	Emerging roles of Lipasin as a critical lipid regulator.	Biochemical and biophysical research communications	2013	30
24811298	Cholesterol, LDL	Diffenderfer MR	The composition and metabolism of large and small LDL.	Current opinion in lipidology	2014	21
25101658	Cholesterol, LDL	Strong A	Sortilin and lipoprotein metabolism: making sense out of complexity.	Current opinion in lipidology	2014	20
26437365	Cholesterol, LDL	Goedeke L	MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.	Nature medicine	2015	28
26503748	Cholesterol, LDL	Bergeron N	Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk.	Circulation	2015	15
14998849	oxaliplatin	Rubbia-Brandt L	Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.	Annals of oncology 	2004	141
16622265	oxaliplatin	Zhu AX	Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.	Journal of clinical oncology 	2006	75
17060484	oxaliplatin	Rubbia-Brandt L	Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery.	Annals of oncology 	2007	62
19383922	oxaliplatin	Kopetz S	Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress.	Cancer research	2009	48
21103969	oxaliplatin	Nies AT	Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy.	Handbook of experimental pharmacology	2011	79
21228335	oxaliplatin	Bokemeyer C	Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.	Annals of oncology 	2011	181
21825039	oxaliplatin	Ding ZB	Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.	Clinical cancer research 	2011	38
23510984	oxaliplatin	Cohn AL	A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer.	Annals of oncology 	2013	30
23881988	oxaliplatin	Hurwitz HI	Efficacy and safety of bevacizumab in metastatic colorectal cancer: pooled analysis from seven randomized controlled trials.	The oncologist	2013	31
24122958	oxaliplatin	Huang D	miRNA27a is a biomarker for predicting chemosensitivity and prognosis in metastatic or recurrent gastric cancer.	Journal of cellular biochemistry	2014	26
24356622	oxaliplatin	Peeters M	Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer.	Annals of oncology 	2014	23
24585723	oxaliplatin	Goldstein J	Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H).	Annals of oncology 	2014	32
24717919	oxaliplatin	Primrose J	Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial.	The Lancet. Oncology	2014	46
25862517	oxaliplatin	Simkens LH	Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group.	Lancet	2015	49
25979230	oxaliplatin	James MI	Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.	Cancer letters	2015	16
26540314	oxaliplatin	Leone F	Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).	Cancer	2016	11
27729273	oxaliplatin	Yin X	Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.	Gene	2017	7
19269153	epigallocatechin gallate	Tsang WP	Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells.	The Journal of nutritional biochemistry	2010	81
21827739	epigallocatechin gallate	Singh BN	Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.	Biochemical pharmacology	2011	171
17464996	Indocyanine Green	Cai J	Directed differentiation of human embryonic stem cells into functional hepatic cells.	Hepatology	2007	146
18292207	Indocyanine Green	Agarwal S	Efficient differentiation of functional hepatocytes from human embryonic stem cells.	Stem cells	2008	103
22659344	Indocyanine Green	Takayama K	Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1α transduction.	Journal of hepatology	2012	36
24037576	Indocyanine Green	Harimoto N	Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma.	The British journal of surgery	2013	40
24254203	Indocyanine Green	Ishizawa T	Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma.	Annals of surgical oncology	2014	21
9808609	Acyl Coenzyme A	Staels B	Mechanism of action of fibrates on lipid and lipoprotein metabolism.	Circulation	1998	197
21562928	Acyl Coenzyme A	Kida K	PPARα is regulated by miR-21 and miR-27b in human liver.	Pharmaceutical research	2011	36
25592151	Acyl Coenzyme A	Cui M	Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway.	Cancer research	2015	71
10836148	Uridine Diphosphate	Tukey RH	Human UDP-glucuronosyltransferases: metabolism, expression, and disease.	Annual review of pharmacology and toxicology	2000	208
16176115	Uridine Diphosphate	Anderson GD	Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.	Clinical pharmacokinetics	2005	139
18480185	Uridine Diphosphate	Nakamura A	Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines.	Drug metabolism and disposition	2008	77
18838504	Uridine Diphosphate	Ohno S	Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction.	Drug metabolism and disposition	2009	67
20451521	Uridine Diphosphate	Czaja AJ	Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis.	Gastroenterology	2010	51
22448619	Uridine Diphosphate	Brill MJ	Impact of obesity on drug metabolism and elimination in adults and children.	Clinical pharmacokinetics	2012	33
26417955	Uridine Diphosphate	Gammal RS	Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.	Clinical pharmacology and therapeutics	2016	20
1608473	alpha 1-Antitrypsin	Lomas DA	The mechanism of Z alpha 1-antitrypsin accumulation in the liver.	Nature	1992	198
2786140	alpha 1-Antitrypsin	Costa RH	Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes.	Molecular and cellular biology	1989	158
15211360	alpha 1-Antitrypsin	Maachi M	Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women.	International journal of obesity and related metabolic disorders 	2004	72
11815407	Curcumin	Ireson CR	Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine.	Cancer epidemiology, biomarkers & prevention 	2002	86
16151628	Curcumin	Elsharkawy AM	The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis.	Apoptosis 	2005	98
20420526	Curcumin	Aggarwal BB	Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals.	Annual review of nutrition	2010	66
20924967	Curcumin	Goel A	Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs.	Nutrition and cancer	2010	83
22996381	Curcumin	Shishodia S	Molecular mechanisms of curcumin action: gene expression.	BioFactors	2013	28
23143785	Curcumin	Gupta SC	Therapeutic roles of curcumin: lessons learned from clinical trials.	The AAPS journal	2013	154
24138392	Curcumin	Zheng J	Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis.	The FEBS journal	2014	20
24368738	Curcumin	Heger M	The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer.	Pharmacological reviews	2014	32
12055599	pioglitazone	Galli A	Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro.	Gastroenterology	2002	83
12746275	pioglitazone	Lee CH	Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors.	Endocrinology	2003	157
14752837	pioglitazone	Promrat K	A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.	Hepatology	2004	114
21875310	pioglitazone	Smith BW	Non-alcoholic fatty liver disease.	Critical reviews in clinical laboratory sciences	2011	65
23718573	pioglitazone	Hoofnagle JH	Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.	Alimentary pharmacology & therapeutics	2013	29
24722248	pioglitazone	Kurtz CL	MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes.	Diabetes	2014	29
25516156	pioglitazone	Blednov YA	Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans.	Alcoholism, clinical and experimental research	2015	22
11477075	estrone sulfate	Tirona RG	Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans.	The Journal of biological chemistry	2001	86
21103968	estrone sulfate	Burckhardt G	In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy.	Handbook of experimental pharmacology	2011	38
25236865	estrone sulfate	Mao Q	Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update.	The AAPS journal	2015	45
17438130	pirinixic acid	Shah YM	Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation.	Molecular and cellular biology	2007	79
17601491	pirinixic acid	Lundåsen T	PPARalpha is a key regulator of hepatic FGF21.	Biochemical and biophysical research communications	2007	99
18288265	pirinixic acid	Rakhshandehroo M	Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling.	PPAR research	2007	62
19710929	pirinixic acid	Rakhshandehroo M	Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human.	PloS one	2009	68
9819447	Ribavirin	Davis GL	Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.	The New England journal of medicine	1998	153
11984517	Ribavirin	Poynard T	Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.	Gastroenterology	2002	161
15887125	Ribavirin	Chen L	Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.	Gastroenterology	2005	146
16136646	Ribavirin	Di Bisceglie AM	Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.	Journal of hepatology	2005	75
16960776	Ribavirin	Romero AI	Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.	The Journal of infectious diseases	2006	65
18467494	Ribavirin	Sarasin-Filipowicz M	Interferon signaling and treatment outcome in chronic hepatitis C.	Proceedings of the National Academy of Sciences of the United States of America	2008	229
19749758	Ribavirin	Suppiah V	IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.	Nature genetics	2009	536
19900446	Ribavirin	Chen L	Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection.	Gastroenterology	2010	43
20162613	Ribavirin	Petta S	Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.	Hepatology	2010	101
20173735	Ribavirin	Fellay J	ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.	Nature	2010	119
20389235	Ribavirin	Rallón NI	Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.	AIDS	2010	54
20434452	Ribavirin	Honda M	Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.	Gastroenterology	2010	138
20621700	Ribavirin	Mangia A	An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.	Gastroenterology	2010	87
20708617	Ribavirin	Fukuhara T	Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.	Gastroenterology	2010	55
20931559	Ribavirin	Urban TJ	IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.	Hepatology	2010	129
21111740	Ribavirin	Dill MT	Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.	Gastroenterology	2011	95
21254157	Ribavirin	Yu ML	Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients.	Hepatology	2011	63
21254160	Ribavirin	Thomas E	Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models.	Hepatology	2011	48
21480323	Ribavirin	Makowska Z	Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo.	Hepatology	2011	36
21741920	Ribavirin	Ahlenstiel G	Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.	Gastroenterology	2011	58
21931540	Ribavirin	Suppiah V	IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.	PLoS medicine	2011	43
21951981	Ribavirin	Asselah T	IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.	Journal of hepatology	2012	35
22212565	Ribavirin	European Association of the Study of the Liver.	2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines.	Liver international 	2012	36
23063572	Ribavirin	Heim MH	Innate immunity and HCV.	Journal of hepatology	2013	33
23323209	Ribavirin	Kuno A	A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis.	Scientific reports	2013	31
23356386	Ribavirin	Chung RT	Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.	American journal of transplantation 	2013	32
24645943	Ribavirin	Kamar N	Ribavirin for chronic hepatitis E virus infection in transplant recipients.	The New England journal of medicine	2014	48
25443342	Ribavirin	Heim MH	Innate and adaptive immune responses in HCV infections.	Journal of hepatology	2014	32
25619871	Ribavirin	Younossi ZM	Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection.	Alimentary pharmacology & therapeutics	2015	23
25820703	Ribavirin	Linas BP	The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.	Annals of internal medicine	2015	23
25909356	Ribavirin	Zeuzem S	Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial.	Annals of internal medicine	2015	75
25920094	Ribavirin	Pawlotsky JM	From non-A, non-B hepatitis to hepatitis C virus cure.	Journal of hepatology	2015	44
26033798	Ribavirin	Saxena V	Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis.	Hepatology	2015	18
26319013	Ribavirin	Negro F	Extrahepatic morbidity and mortality of chronic hepatitis C.	Gastroenterology	2015	28
26907736	Ribavirin	Manns M	Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.	The Lancet. Infectious diseases	2016	39
27296509	Ribavirin	Sarrazin C	Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir.	Gastroenterology	2016	22
11872682	rosiglitazone	Mayerson AB	The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.	Diabetes	2002	106
14512888	rosiglitazone	Neuschwander-Tetri BA	Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.	Hepatology	2003	101
15277403	rosiglitazone	Tiikkainen M	Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.	Diabetes	2004	78
16034410	rosiglitazone	Yang Q	Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.	Nature	2005	450
17040956	rosiglitazone	Wang Y	Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans.	Clinical chemistry	2007	103
17465001	rosiglitazone	Pazienza V	The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms.	Hepatology	2007	64
18503774	rosiglitazone	Ratziu V	Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial.	Gastroenterology	2008	103
18509062	rosiglitazone	Puri V	Cidea is associated with lipid droplets and insulin sensitivity in humans.	Proceedings of the National Academy of Sciences of the United States of America	2008	98
19800084	rosiglitazone	Zhang H	Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.	Metabolism	2010	56
19877169	rosiglitazone	Ratziu V	Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial.	Hepatology	2010	56
17408664	hydrogen sulfite	Park IY	Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.	Gastroenterology	2007	73
20890895	hydrogen sulfite	Sookoian S	Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter.	Hepatology	2010	54
21317930	hydrogen sulfite	Mudduluru G	Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer.	Oncogene	2011	75
21969817	hydrogen sulfite	He Y	Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma.	Neoplasia	2011	37
23916847	hydrogen sulfite	Murphy SK	Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.	Gastroenterology	2013	52
25608619	hydrogen sulfite	Zhang Z	microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.	Molecular cancer	2015	20
25641194	hydrogen sulfite	Zhuo H	The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma.	Molecular carcinogenesis	2016	33
19457834	gadolinium ethoxybenzyl DTPA	Kim SH	Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.	AJR. American journal of roentgenology	2009	59
20057319	gadolinium ethoxybenzyl DTPA	Sun HY	Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.	Investigative radiology	2010	41
20406852	gadolinium ethoxybenzyl DTPA	Leonhardt M	Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters.	Drug metabolism and disposition	2010	41
20413759	gadolinium ethoxybenzyl DTPA	Ahn SS	Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.	Radiology	2010	51
20501720	gadolinium ethoxybenzyl DTPA	Tsuboyama T	Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.	Radiology	2010	52
21626360	gadolinium ethoxybenzyl DTPA	Kitao A	The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging.	European radiology	2011	35
22504332	gadolinium ethoxybenzyl DTPA	Van Beers BE	Primovist, Eovist: what to expect?	Journal of hepatology	2012	39
12676886	efavirenz	Ward BA	The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity.	The Journal of pharmacology and experimental therapeutics	2003	145
17559344	efavirenz	Desta Z	Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro.	Pharmacogenomics	2007	65
18781911	efavirenz	Wang H	CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.	Current drug metabolism	2008	90
20335270	efavirenz	Ogburn ET	Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation.	Drug metabolism and disposition	2010	45
19020503	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Rebouissou S	Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours.	Nature	2009	108
21690253	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Pilati C	Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas.	The Journal of experimental medicine	2011	64
23136552	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Rose-John S	IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.	International journal of biological sciences	2012	106
24735922	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Pilati C	Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.	Cancer cell	2014	36
24986424	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Wolf J	Interleukin-6 and its receptors: a highly regulated and dynamic system.	Cytokine	2014	58
25136784	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Calabrese LH	IL-6 biology: implications for clinical targeting in rheumatic disease.	Nature reviews. Rheumatology	2014	37
26501953	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Levy G	Long-term culture and expansion of primary human hepatocytes.	Nature biotechnology	2015	21
26867490	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Schmidt-Arras D	IL-6 pathway in the liver: From physiopathology to therapy.	Journal of hepatology	2016	22
12644704	androstane	Huang W	Induction of bilirubin clearance by the constitutive androstane receptor (CAR).	Proceedings of the National Academy of Sciences of the United States of America	2003	78
17241619	androstane	Guillouzo A	The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.	Chemico-biological interactions	2007	70
19427329	androstane	di Masi A	Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects.	Molecular aspects of medicine	2009	55
26962021	androstane	Cave MC	Nuclear receptors and nonalcoholic fatty liver disease.	Biochimica et biophysica acta	2016	13
27889186	androstane	Kettner NM	Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.	Cancer cell	2016	21
18381447	gefitinib	Fuchs BC	Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.	Cancer research	2008	94
19706799	gefitinib	Desbois-Mouthon C	Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.	Clinical cancer research 	2009	59
22414764	gefitinib	Blivet-Van Eggelpoël MJ	Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells.	Journal of hepatology	2012	39
23045285	gefitinib	Gusenbauer S	HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors.	Oncogene	2013	37
24486412	gefitinib	Zhao D	Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.	Cellular signalling	2014	25
26724471	gefitinib	Lin JJ	Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs.	Journal of thoracic oncology 	2016	24
27083334	gefitinib	Park K	Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial.	The Lancet. Oncology	2016	78
28271729	gefitinib	Ahn MJ	EGFR TKI combination with immunotherapy in non-small cell lung cancer.	Expert opinion on drug safety	2017	10
21376046	entecavir	Lütgehetmann M	Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.	Gastroenterology	2011	35
24123097	entecavir	Wong GL	On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.	Hepatology	2014	26
25514302	entecavir	Huang H	Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.	JAMA	2014	22
11706036	GW 4064	Kast HR	Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor.	The Journal of biological chemistry	2002	126
19085950	GW 4064	Song KH	Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.	Hepatology	2009	94
21319191	GW 4064	Li T	Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.	Hepatology	2011	47
10632283	Alanine	Sulkowski MS	Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.	JAMA	2000	121
16391218	Alanine	Chen CJ	Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.	JAMA	2006	487
17021358	Alanine	Saukkonen JJ	An official ATS statement: hepatotoxicity of antituberculosis therapy.	American journal of respiratory and critical care medicine	2006	149
18054554	Alanine	Fraser A	Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.	Gastroenterology	2007	80
18291570	Alanine	Ozer J	The current state of serum biomarkers of hepatotoxicity.	Toxicology	2008	146
18940312	Alanine	Yuan X	Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.	American journal of human genetics	2008	122
19010326	Alanine	Goessling W	Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.	Gastroenterology	2008	66
19013463	Alanine	Patton HM	Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.	Gastroenterology	2008	53
19038698	Alanine	Kirpich IA	Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.	Alcohol	2008	78
19131466	Alanine	Fraser A	Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis.	Diabetes care	2009	77
19414484	Alanine	Johnson AD	Genome-wide association meta-analysis for total serum bilirubin levels.	Human molecular genetics	2009	57
19523535	Alanine	Shah AG	Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.	Clinical gastroenterology and hepatology 	2009	95
19585618	Alanine	Feldstein AE	Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.	Hepatology	2009	128
19844213	Alanine	Romeo S	Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent.	International journal of obesity	2010	56
20064512	Alanine	Schwimmer JB	SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.	Gastroenterology	2010	54
20889864	Alanine	Trung DT	Liver involvement associated with dengue infection in adults in Vietnam.	The American journal of tropical medicine and hygiene	2010	43
21109302	Alanine	Athyros VG	Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.	Lancet	2010	103
21139063	Alanine	Thomson EC	Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men.	Gut	2011	46
21319198	Alanine	Brunt EM	Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.	Hepatology	2011	138
21540183	Alanine	Gao Z	Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity.	The Journal of biological chemistry	2011	51
23696515	Alanine	Noureddin M	Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.	Hepatology	2013	65
23824655	Alanine	Fall T	The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis.	PLoS medicine	2013	53
23991091	Alanine	Miller AM	MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice.	PloS one	2013	35
24187469	Alanine	Ma YY	Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.	World journal of gastroenterology	2013	51
24436062	Alanine	Konerman MA	Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.	Hepatology	2014	23
24462733	Alanine	El-Serag HB	A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.	Gastroenterology	2014	34
24681128	Alanine	Fontana RJ	Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.	Gastroenterology	2014	26
25019921	Alanine	Weiß J	Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.	Deutsches Arzteblatt international	2014	22
25251399	Alanine	Dongiovanni P	Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.	Hepatology	2015	52
25482832	Alanine	Loomba R	Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial).	Hepatology	2015	51
25873639	Alanine	Kwok R	Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.	Gut	2016	18
26171685	Alanine	Koehler EM	Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.	Hepatology	2016	15
26352813	Alanine	Burton BK	A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.	The New England journal of medicine	2015	19
26409216	Alanine	Liang HW	Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122.	Journal of hepatology	2016	13
26457389	Alanine	Goffredo M	Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.	Hepatology	2016	14
26512983	Alanine	Anderson EL	The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis.	PloS one	2015	34
26547499	Alanine	Wilder JM	Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.	Hepatology	2016	14
26667191	Alanine	Ballestri S	Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.	Journal of gastroenterology and hepatology	2016	33
26677985	Alanine	Imajo K	Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.	Gastroenterology	2016	30
26714945	Alanine	Sun JJ	Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion.	Annals of surgical oncology	2016	15
27002799	Alanine	Nelson JE	Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?	The American journal of gastroenterology	2016	15
27151177	Alanine	Cui J	Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.	Journal of hepatology	2016	15
27224670	Alanine	Mikus M	Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.	Liver international 	2017	7
27296321	Alanine	Bracaglia C	Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.	Annals of the rheumatic diseases	2017	9
27725647	Alanine	McPherson S	Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.	The American journal of gastroenterology	2017	8
27995906	Alanine	Kwo PY	ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.	The American journal of gastroenterology	2017	8
28958502	Alanine	Wu YL	Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial.	The Lancet. Oncology	2017	10
17418145	TO-901317	Mitro N	T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR.	FEBS letters	2007	59
19887649	TO-901317	Kumar N	The benzenesulfoamide T0901317 N-(2,2,2-trifluoroethyl)-N-4-2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethylphenyl-benzenesulfonamide is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist.	Molecular pharmacology	2010	61
11259410	Amino Acids	Sampson DA	The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification.	The Journal of biological chemistry	2001	157
12739169	Amino Acids	Halestrap AP	The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.	Pflugers Archiv 	2004	170
16621917	Amino Acids	Horvath R	Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.	Brain 	2006	87
18388185	Amino Acids	Greco D	Gene expression in human NAFLD.	American journal of physiology. Gastrointestinal and liver physiology	2008	89
18559588	Amino Acids	Jeong EG	Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers.	Clinical cancer research 	2008	59
21393862	Amino Acids	Duggal P	A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children.	The Journal of clinical investigation	2011	47
23103253	Amino Acids	Elorza A	HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5.	Molecular cell	2012	33
23426947	Amino Acids	McIntosh J	Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.	Blood	2013	53
23728943	Amino Acids	Cleary SP	Identification of driver genes in hepatocellular carcinoma by exome sequencing.	Hepatology	2013	63
24550457	Amino Acids	Kratzer JT	Evolutionary history and metabolic insights of ancient mammalian uricases.	Proceedings of the National Academy of Sciences of the United States of America	2014	38
24628464	Amino Acids	Bajaj JS	Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis.	Alimentary pharmacology & therapeutics	2014	25
24861026	Amino Acids	Wree A	NLRP3 inflammasome activation is required for fibrosis development in NAFLD.	Journal of molecular medicine	2014	42
26389641	Amino Acids	Park YY	Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.	Hepatology	2016	14
26724577	Amino Acids	Bhutia YD	Glutamine transporters in mammalian cells and their functions in physiology and cancer.	Biochimica et biophysica acta	2016	12
26847265	Amino Acids	Sinclair M	Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions.	Alimentary pharmacology & therapeutics	2016	15
27318325	Amino Acids	Davuluri G	Metabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of l-leucine in cirrhosis.	Journal of hepatology	2016	12
28380384	Amino Acids	Krishnaiah SY	Clock Regulation of Metabolites Reveals Coupling between Transcription and Metabolism.	Cell metabolism	2017	9
23727264	obeticholic acid	Mudaliar S	Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.	Gastroenterology	2013	102
25468160	obeticholic acid	Neuschwander-Tetri BA	Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.	Lancet	2015	205
27170396	obeticholic acid	Weiskirchen R	Liver Fibrosis: From Pathogenesis to Novel Therapies.	Digestive diseases	2016	14
27646933	obeticholic acid	Rotman Y	Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease.	Gut	2017	20
19169683	lapatinib	Ramanathan RK	A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.	Cancer chemotherapy and pharmacology	2009	60
20736298	lapatinib	Cameron D	Lapatinib plus capecitabine in women with HER-2-positive advanced breast cancer: final survival analysis of a phase III randomized trial.	The oncologist	2010	52
21245432	lapatinib	Spraggs CF	HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer.	Journal of clinical oncology 	2011	56
22059152	lapatinib	Guo D	An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.	Cancer discovery	2011	70
22178589	lapatinib	Andersen JB	Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.	Gastroenterology	2012	86
22257673	lapatinib	Baselga J	Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.	Lancet	2012	236
22493419	lapatinib	Guarneri V	Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study.	Journal of clinical oncology 	2012	64
24656976	lapatinib	Yan M	HER2 aberrations in cancer: implications for therapy.	Cancer treatment reviews	2014	45
25130998	lapatinib	de Azambuja E	Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response.	The Lancet. Oncology	2014	50
25779558	lapatinib	Gelmon KA	Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31.	Journal of clinical oncology 	2015	18
26598744	lapatinib	Piccart-Gebhart M	Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial.	Journal of clinical oncology 	2016	25
16908937	sorafenib	Abou-Alfa GK	Phase II study of sorafenib in patients with advanced hepatocellular carcinoma.	Journal of clinical oncology 	2006	269
17178882	sorafenib	Liu L	Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.	Cancer research	2006	298
18304676	sorafenib	Llovet JM	Novel advancements in the management of hepatocellular carcinoma in 2008.	Journal of hepatology	2008	202
18650514	sorafenib	Llovet JM	Sorafenib in advanced hepatocellular carcinoma.	The New England journal of medicine	2008	2137
18821591	sorafenib	Llovet JM	Molecular targeted therapies in hepatocellular carcinoma.	Hepatology	2008	288
19228077	sorafenib	Keating GM	Sorafenib: a review of its use in advanced hepatocellular carcinoma.	Drugs	2009	80
19595305	sorafenib	Young A	Ras signaling and therapies.	Advances in cancer research	2009	86
19665249	sorafenib	Newell P	Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.	Journal of hepatology	2009	52
19726678	sorafenib	Bai S	MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.	The Journal of biological chemistry	2009	157
20059340	sorafenib	Villanueva A	Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.	Annual review of medicine	2010	66
20347499	sorafenib	Shimizu S	The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.	Journal of hepatology	2010	87
20799354	sorafenib	Hikita H	The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.	Hepatology	2010	50
21187475	sorafenib	Gedaly R	PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.	Anticancer research	2010	45
21205925	sorafenib	Chen KF	Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells.	The Journal of pharmacology and experimental therapeutics	2011	69
21220499	sorafenib	Nagai T	Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma.	Molecular cancer therapeutics	2011	39
21334406	sorafenib	Chen X	Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations.	Journal of hepatology	2011	38
21352471	sorafenib	Meng F	Functional analysis of microRNAs in human hepatocellular cancer stem cells.	Journal of cellular and molecular medicine	2012	41
21354226	sorafenib	Tai WT	Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma.	Journal of hepatology	2011	46
21538283	sorafenib	Nault JC	Genetics of hepatobiliary carcinogenesis.	Seminars in liver disease	2011	50
21691147	sorafenib	Shi YH	Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis.	Autophagy	2011	81
21816126	sorafenib	Sangro B	Radioembolization for hepatocellular carcinoma.	Journal of hepatology	2012	62
21858812	sorafenib	Shimizu S	Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.	International journal of cancer	2012	56
21985599	sorafenib	Marra M	Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.	Journal of translational medicine	2011	46
22146883	sorafenib	Chen HC	SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis.	Annals of surgical oncology	2012	41
22180308	sorafenib	Tai WT	Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3.	Molecular cancer therapeutics	2012	36
22314428	sorafenib	Burrel M	Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.	Journal of hepatology	2012	78
22322234	sorafenib	Lachenmayer A	Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib.	Journal of hepatology	2012	44
22374331	sorafenib	Llovet JM	Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.	Clinical cancer research 	2012	112
22414760	sorafenib	Personeni N	Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.	Journal of hepatology	2012	40
22451120	sorafenib	Xie B	Sorafenib for treatment of hepatocellular carcinoma: a systematic review.	Digestive diseases and sciences	2012	36
22473773	sorafenib	Shan J	Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.	Hepatology	2012	74
22811581	sorafenib	Lachenmayer A	Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.	Clinical cancer research 	2012	56
22890726	sorafenib	Arao T	FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma.	Hepatology	2013	25
22994652	sorafenib	Welker MW	Recurrent hepatocellular carcinoma after liver transplantation - an emerging clinical challenge.	Transplant international 	2013	35
23103770	sorafenib	Subramaniam A	Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma.	Biochimica et biophysica acta	2013	42
23111106	sorafenib	van Malenstein H	Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth.	Cancer letters	2013	36
23316005	sorafenib	Huang XY	αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma.	Hepatology	2013	38
23388504	sorafenib	Goyal L	Targeting the HGF/c-MET pathway in hepatocellular carcinoma.	Clinical cancer research 	2013	57
23392173	sorafenib	Tai WT	Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells.	Cell death & disease	2013	46
23471579	sorafenib	Xia H	MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.	Hepatology	2013	89
23787822	sorafenib	Reig M	Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design.	Hepatology	2013	28
23835194	sorafenib	Pez F	Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.	Journal of hepatology	2013	56
23862748	sorafenib	Yang F	MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.	Technology in cancer research & treatment	2014	26
23908138	sorafenib	Tai WT	Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma.	Hepatology	2014	24
23958557	sorafenib	Govaere O	Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.	Gut	2014	53
23980084	sorafenib	Johnson PJ	Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study.	Journal of clinical oncology 	2013	112
23980090	sorafenib	Llovet JM	Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.	Journal of clinical oncology 	2013	107
24045150	sorafenib	Giordano S	Met as a therapeutic target in HCC: facts and hopes.	Journal of hepatology	2014	29
24233839	sorafenib	Lee HJ	Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma.	Carcinogenesis	2014	21
24423918	sorafenib	El-Khoueiry AB	S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma.	British journal of cancer	2014	21
24510746	sorafenib	Scartozzi M	VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.	International journal of cancer	2014	22
24589894	sorafenib	Llovet JM	Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design.	Clinical cancer research 	2014	78
24651044	sorafenib	Liu L	Combination therapy of sorafenib and TACE for unresectable HCC: a systematic review and meta-analysis.	PloS one	2014	24
24687604	sorafenib	Horwitz E	Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment.	Cancer discovery	2014	21
24700742	sorafenib	Xiang Q	Cabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and MET.	Clinical cancer research 	2014	26
24705351	sorafenib	Zhai B	Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma.	Molecular cancer therapeutics	2014	45
24768112	sorafenib	Brose MS	Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.	Lancet	2014	142
24836552	sorafenib	Takeda H	Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan.	Liver international 	2015	17
24918061	sorafenib	Takahashi K	Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer.	FEBS open bio	2014	72
25040368	sorafenib	Vaira V	MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.	Liver international 	2015	17
25053293	sorafenib	Fernando J	A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells.	International journal of cancer	2015	23
25158999	sorafenib	Fitzmorris P	Management of hepatocellular carcinoma.	Journal of cancer research and clinical oncology	2015	17
25216638	sorafenib	Rudalska R	In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.	Nature medicine	2014	43
25422324	sorafenib	Wu Q	Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.	The Journal of biological chemistry	2015	15
25633810	sorafenib	Ohta K	MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.	Oncotarget	2015	34
25704960	sorafenib	Tavallai M	Nexavar/Stivarga and viagra interact to kill tumor cells.	Journal of cellular physiology	2015	20
25733155	sorafenib	Makarova-Rusher OV	The yin and yang of evasion and immune activation in HCC.	Journal of hepatology	2015	21
25832714	sorafenib	Delire B	The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications.	European journal of clinical investigation	2015	20
25865556	sorafenib	Han T	PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.	Journal of hepatology	2015	19
26045065	sorafenib	Liu K	miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN.	Oncology reports	2015	25
26095784	sorafenib	Zhu AX	Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial.	The Lancet. Oncology	2015	58
26099527	sorafenib	Zucman-Rossi J	Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.	Gastroenterology	2015	66
26311740	sorafenib	He C	MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.	Oncotarget	2015	22
26514126	sorafenib	Lou G	Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.	Journal of hematology & oncology	2015	38
26592953	sorafenib	Govaere O	Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche.	Journal of hepatology	2016	13
26655273	sorafenib	Xu Y	MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.	Cancer letters	2016	17
26790028	sorafenib	Firtina Karagonlar Z	Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells.	Cancer science	2016	14
26809111	sorafenib	Lencioni R	Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial.	Journal of hepatology	2016	54
26811478	sorafenib	Xu IM	Transketolase counteracts oxidative stress to drive cancer development.	Proceedings of the National Academy of Sciences of the United States of America	2016	18
26924089	sorafenib	Zhou SL	Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.	Gastroenterology	2016	22
26969090	sorafenib	Haas NB	Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.	Lancet	2016	41
27015352	sorafenib	Sun X	Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis.	Hepatology	2016	14
27100895	sorafenib	Zhang PF	Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling.	Cell death & disease	2016	15
27484637	sorafenib	Prieto-Domínguez N	Melatonin-induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy.	Journal of pineal research	2016	11
27732875	sorafenib	Sauzay C	Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma.	Clinica chimica acta; international journal of clinical chemistry	2016	13
27770556	sorafenib	Parikh ND	Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.	Hepatology	2017	6
27849399	sorafenib	Woo HY	New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?	Expert opinion on pharmacotherapy	2017	5
27849562	sorafenib	Bollard J	Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma.	Gut	2017	8
28147363	sorafenib	Kudo M	Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials.	Oncology	2017	17
28177886	sorafenib	Zhang X	Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.	Oncotarget	2017	7
28344323	sorafenib	Zhu YJ	New knowledge of the mechanisms of sorafenib resistance in liver cancer.	Acta pharmacologica Sinica	2017	12
21468124	telaprevir	Hofmann WP	A new standard of care for the treatment of chronic HCV infection.	Nature reviews. Gastroenterology & hepatology	2011	53
23669289	telaprevir	Hézode C	Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.	Journal of hepatology	2013	102
24691835	telaprevir	Petta S	Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.	Hepatology	2014	20
25218788	telaprevir	Gordon SC	Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.	Journal of hepatology	2015	23
25385103	telaprevir	Ottosen S	In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122.	Antimicrobial agents and chemotherapy	2015	30
20227758	mipomersen	Raal FJ	Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.	Lancet	2010	135
23060426	mipomersen	Stein EA	Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease.	Circulation	2012	42
24013058	mipomersen	Thomas GS	Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.	Journal of the American College of Cardiology	2013	32
23534542	miravirsen	Janssen HL	Treatment of HCV infection by targeting microRNA.	The New England journal of medicine	2013	502
24068553	miravirsen	Gebert LF	Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.	Nucleic acids research	2014	46
25218783	miravirsen	van der Ree MH	Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients.	Antiviral research	2014	29
11156649	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Bolondi L	Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.	Gut	2001	108
11343240	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Llovet JM	Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.	Hepatology	2001	85
12713871	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Shuda M	Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis.	Journal of hepatology	2003	106
15042359	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Zhang BH	Randomized controlled trial of screening for hepatocellular carcinoma.	Journal of cancer research and clinical oncology	2004	213
15508073	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Daniele B	Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.	Gastroenterology	2004	74
17000670	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Lee TK	Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.	Clinical cancer research 	2006	98
17570225	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Ma S	Identification and characterization of tumorigenic liver cancer stem/progenitor cells.	Gastroenterology	2007	312
17681183	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Meng F	MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.	Gastroenterology	2007	746
17891174	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Ma S	CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.	Oncogene	2008	209
18006828	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Yamashita T	Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.	Cancer research	2007	115
18069697	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Forner A	Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.	Hepatology	2008	134
18223217	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Jiang J	Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.	Clinical cancer research 	2008	175
18263735	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Tang Y	Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling.	Proceedings of the National Academy of Sciences of the United States of America	2008	106
18313787	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Kim M	Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells.	Journal of hepatology	2008	65
18316609	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Yamashita T	EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.	Cancer research	2008	185
18318435	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Lai JP	Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.	Hepatology	2008	68
18980227	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Palmer DH	A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.	Hepatology	2009	53
19111019	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Mishra L	Liver stem cells and hepatocellular carcinoma.	Hepatology	2009	99
19551889	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Xu MZ	Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma.	Cancer	2009	139
19723656	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Hoshida Y	Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.	Cancer research	2009	195
19852728	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	van Zijl F	Epithelial-mesenchymal transition in hepatocellular carcinoma.	Future oncology	2009	85
20066715	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Carr BI	Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.	Cancer	2010	46
20227042	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	He G	Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.	Cancer cell	2010	113
20371487	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Wei W	S-nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis.	Science translational medicine	2010	46
20385424	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Zender L	Cancer gene discovery in hepatocellular carcinoma.	Journal of hepatology	2010	47
20637208	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Saxena NK	Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma.	Gastroenterology	2010	45
21076472	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Xu MZ	AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma.	Oncogene	2011	55
21184757	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Kanwal F	Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection.	Gastroenterology	2011	100
21397858	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Sawey ET	Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening.	Cancer cell	2011	81
21721029	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Kogure T	Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth.	Hepatology	2011	151
21822264	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Li M	Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.	Nature genetics	2011	138
22014574	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Kim HS	SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.	Cancer cell	2011	128
22396537	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Santhekadur PK	Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221.	The Journal of biological chemistry	2012	38
22728651	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Lee CW	AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells.	Cancer research	2012	54
22807686	5,11,17,23-tetra-tert-butyl-25,27-bis(hydrazidecarbonylmethoxy)-26,28-dihydroxycalix(4)arene	Li S	GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.	PLoS genetics	2012	52
